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Abstract 
Collagen is the most abundant protein in mammals and is the main protein of connective 
tissue in animals [1]. It is a fibrous structural protein that is the major component of the 
extracellular matrix, which provides great tensile strength to ligaments, tendons, bone and 
skin, for example. Hsp47 is a procollagen and collagen specific chaperone that is thought to 
be involved in the correct assembly and transport of collagen chains. It is a non-inhibitory 
member of the serine protease inhibitor superfamily and uses a pH-dependent mechanism for 
binding and release to/from its substrate. 
 
In order to study the function of Hsp47 sufficient quantities of the protein need to be 
expressed and purified. Previous work on Hsp47 studied mammalian forms of the protein 
which expressed poorly in bacterial expression systems. This research studied Hsp47 in the 
poikilothermic vertebrate; Xenopus laevis, the ectothermic vertebrate; Danio rerio and the 
endothermic vertebrate; Mus musculus in a range of expression systems in order to overcome 
the low protein expression levels. Mus musculus Hsp47 proved the most successful as it 
yielded soluble protein that could be used for structural and functional characterisation.  
 
A reduction in the pH of the environment triggers a conformational change that is vital for the 
function of Hsp47. Understanding this structural change is important in understanding the 
function of Hsp47. Histidine residues are thought to play a vital role in the conformational 
transition of Hsp47. Histidine variants were made to identify possible binding sites and/or 
areas involved in the instigation of the structural change in Hsp47. The mutations allowed the 
first identification of a more stable, latent, serpin state of the protein. Interestingly, this latent 
form comprised of enhanced biological activity as it reduced collagen fibril formation. One of 
the mutants lacked any collagen binding ability, which may be an indication of a possible 
collagen binding site on Hsp47. 
 iii
The results presented in this thesis provide an insight into the function and structure of the 
non-inhibitory serpin Hsp47 and may enhance the understanding of the molecular mechanism 
by which the collagen-specific chaperone operates. 
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CHAPTER 1: Introduction 
 
1.1 Protein Folding 
Proteins are organic compounds that consist of amino acids which are joined by peptide bonds 
between the carboxyl and amino groups of adjacent amino acid residues [2]. Their amino acid 
sequence determines their folding and ability to function and turnover [3], [4]. Proteins are 
multifunctional macromolecules that control chemical processes in the cell. To become 
biologically active they must fold into a unique stable structure [5], which involves 
polypeptide self-organisation [3]. To reach a balance between stability and flexibility, the free 
energy of stabilisation of globular proteins in solution usually involves only a few weak 
intermolecular interactions.  
 
Protein folding is the process by which the primary amino acid sequence of a protein 
determines its specific three-dimensional conformation. The ability of a protein to fold 
depends upon the rotation of bonds in a protein chain. A fold is only marginally stable at 
room temperature. The more stable, native conformation, is stabilised by weak noncovalent 
interactions involving main chain and side chain atoms [6]. The findings that protein 
conformation can be disrupted by denaturants and refolding of the chain occurs following 
removal of denaturing agent, led to the proposal of the principle of self-assembly by Anfinsen 
[7]. This states that the amino acid sequence encodes all the information required for a protein 
chain to reach its correct conformation [6-8]. Internalisation of hydrophobic side chains inside 
the folded protein and exposure of the hydrophilic side chains to the aqueous environment is 
the major driving force for the phenomenon of spontaneous refolding [6]. Studies on smaller 
proteins suggest that a nucleation event is required, whereby a critical core is formed by 
several amino acids coming together, to drive the formation of the rest of the structure [9-11]. 
Vendruscolo and coworkers [11] found that definition of the overall architecture of the protein 
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fold by a small number of fundamental interactions was adequate for the instigation of the 
protein folding process.  
 
The Levinthal paradox, ‘how a sequence finds its specific native structure in a finite time’ has 
been key to discussion on protein folding for decades [5, 12]. An initial suggestion of a 
solution to this problem proposed that folding proteins follow specific predetermined 
pathways which involve a series of mandatory steps through well-defined partly folded states 
[5, 13, 14]. This classical pathway was thought to include folding intermediates for which the 
unfolding transitions can be cooperative or non-cooperative (Figure 1.1) [15, 16]. 
 
[17] 
Figure 1.1. A classical kinetic folding pathway. U represents the unfolded state, I1 and I2 are 
classical intermediate states whilst N is the native state [17].  
 
The Levinthal paradox could be avoided if these pathways were specific enough so that only a 
small region of conformational space would be sampled [5]. 
 
A more widely accepted theory states that the protein folding process involves a stochastic 
search of the conformations accessible to a polypeptide chain [17-19]. It describes protein 
folding in terms of energy surfaces and energy landscapes and proposes that folding involves 
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the organisation of statistical ensembles [5, 19]. This statistical landscape theory is 
represented as a funnel that has pockets which represent transiently trapped proteins as 
intermediate species (Figure 1.2). A rugged funnel-like model best represents the free energy 
landscape with a preferred direction of flow towards the native state. The folding landscape is 
rugged as biomolecular chains can take up many inappropriate conformations during the 
folding process and there are incorrect interactions between residues [19]. An ensemble of 
unfolded protein molecules occupies the top of the funnel. As proteins proceed down the 
funnel towards the native state, the energy pockets trap proteins in different intermediate 
conformations. Progression of the protein down the rest of the funnel requires overcoming of 
the energy barrier for each pocket. Therefore, in order for a trapped intermediate to be 
experimentally observed, the majority of molecules must occupy that particular state. Some of 
the trapped intermediates can act as precursors for aggregate formation, although it is thought 
that aggregate accumulation is prevented by an evolutionary fast-folding mechanism [20]. 
The folding pathway for each molecule is not necessarily identical to that of other protein 
molecules as it proceeds down the funnel towards the most stable, native state [19].  
 3
 Entropy 
Molten Globule States 
Unrelated structures 
Beginning of helix formation and collapse  
Energy 
Q 
Native Structure 
Enative 1.0
Discrete intermediates 
Intermediates 
Adapted from [19] 
Figure 1.2. A protein folding free energy landscape. There is an ensemble of unfolded protein 
molecules at the top of the funnel. As the proteins move towards the native state they are trapped in 
energy pockets as stable intermediates. The energy barrier for each pocket needs to be overcome 
before the protein can proceed to the native state. The solvent-averaged energy (E) and the fraction of 
native-like contacts (Q) describe the position of states within the funnel [19].  
 
The native protein conformation is generally the energetically most stable, having the lowest 
free energy [7]. Exceptions to this include haemagglutinin, the extracellular bacterial alpha-
lytic protease and more notably, the serpin protein superfamily (described in detail in section 
1.9). In these cases the native fold exhibits metastability, allowing for the structural flexibility 
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that is required for serpins to carry out their inhibitory function [21, 22]. This fragile 
equilibrium between stability and flexibility however is easily disrupted.  For example, small 
changes in temperature, pH or amino acid sequence can instigate large conformation changes 
and subsequent destabilisation of the native protein state to more stable but inactive protein 
conformations, such as amyloids. 
 
 
1.2 Protein misfolding and aggregation 
Under normal physiological conditions, cells have developed the ability to maintain extremely 
high protein concentrations whilst avoiding protein aggregation [23]. This is particularly 
difficult given that proteins exist in different protein forms depending on their specific 
biological functions in the cellular environment. For example, whilst fully folded proteins are 
necessary for enzyme activity, unfolded or partially folded protein conformations may be 
required for functions such as translocation across membranes [3]. 
 
Therefore proteins (unfolded and folded) have to be carefully managed in the cell. Indeed, any 
extent of misfolding can cause malfunction and disease. Many familial diseases, associated 
with protein misfolding, can be due to a single amino acid substitution that results in the loss 
of cellular control and thereby the death of the organism which the cell is a part of [24, 25]. 
Alzheimer’s disease, Creutzfeldt-Jakob’s disease, late onset diabetes, spongiform 
encephalopathies and cystic fibrosis are all examples of protein misfolding diseases [14, 26]. 
These diseases are thought to be a consequence of aberrant protein behaviour resulting from 
the conditions of biological systems changing at a much faster rate than that set by evolution 
[27].  
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Evolutionary selection has enabled cells in physiological conditions to concentrate proteins to 
very high levels whilst avoiding aggregation [23]. Loss of this maintenance of solubility 
results in molecular aggregation, which plays a fundamental role in a number of ageing and 
degeneration diseases [27-29]. Refolding studies have demonstrated irreversible aggregation 
of chains that fail to refold correctly, forming non-functional aggregates [30]. It is perhaps 
obvious that aggregation initially results in dimers [31] which may be soluble but continued 
aggregation produces insoluble moieties. Aggregation is thought to be caused by the 
association of partially folded intermediates rather that native proteins [32]. The specificity of 
protein aggregation, such that only identical or very similar chains can aggregate, was 
demonstrated by Goldberg and coworkers. They studied the renaturation of E. coli 
tryptophanase and reported that it refolded to a native-like conformation following 
denaturation with 8 M urea. Additionally, they showed that the addition of crude total extract 
in 8 M urea from E. coli cells free of tryptophanase to denatured tryptophanase in 8 M urea 
does not change the percentage of tryptophanase that aggregates upon dilution of the urea 
dialysis [33]. Furthermore, in vitro aggregation studies of the coat protein and tailspike 
protein of Salmonella bacteriophage P22, revealed that partially folded chains of these two 
proteins aggregate with themselves but not each other [34]. 
 
Misfolding is thought to be distinct from aggregation but there are two different views on its 
concept. The first view interprets misfolding as ‘a partially folded polypeptide conformation 
that is stable enough not to be able to proceed to its functional conformation on a biologically 
relevant timescale’ [30]. An alternative view is that misfolded chains are on the correct 
folding pathway but require some unfolding to reach their native state [35]. Current protein 
folding models view misfolded chains as partially folded chains that vary in their tendency to 
aggregate with one another [36]. Therefore, protein misfolding is considered to be the 
molecular basis of protein aggregation whereby a polypeptide loses its ability to attain its 
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closely packed, native structure and consequently populating non-folded, partially folded or 
incorrectly folded states. The loose packing of these non-native structures results in the 
exposure of the hydrophobic core to the solvent; enhancing the propensity to nucleate 
oligomeric assemblies [14, 29, 37, 38]. These ‘aggregation nuclei’ act as templates for the 
recruitment of other misfolded or partially folded molecules, increasing the size of the 
assemblies and consequently yielding fibrillar aggregates [39]. 
 
 
1.3 Macromolecular crowding 
Macromolecular crowding occurs in the inside of cells. Theories suggest that it effects 
interactions between macromolecules, resulting in it affecting the rates and equilibria of 
macromolecular reactions. Crowding, also termed ‘the excluded volume effect,’ describes the 
total concentration of macromolecules in the intracellular environment to be so high that a 
vast proportion of the interior of the cell is occupied and therefore unavailable to other 
molecules [23]. This volume exclusion is due to non-specific steric repulsion, whereby any 
two macromolecules cannot occupy the same place at the same time [40, 41]. The fraction of 
this excluded intracellular volume depends on the quantity, size and shape of the 
macromolecules in the cellular compartments [41]. Steric repulsion arises from the fact that 
each atom within a molecule occupies a certain amount of space. If atoms are brought too 
close together, there is an associated cost in energy due to overlapping of electron clouds, 
which may affect the preferred conformation and reactivity of the molecule. It is a 
destabilising interaction that causes an increase in the total free energy of a system.  
 
Crowding is thought to enhance two properties of protein folding; the collapse of polypeptide 
chains and the tendency of partly folded chains to associate into aggregates [6, 23]. This 
favouring of aggregation is due to the effect of increased thermodynamic activity of partially 
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folded polypeptide chains by crowding. Polypeptide chains that fold slowly are particularly 
aggregation-prone as faster folding chains are able to internalise hydrophobic residues before 
they encounter those on other chains. Furthermore, the functional activity of molecular 
chaperones (described in section 1.4) is also thought to be enhanced in crowded milieu in 
order to stimulate their association with partly folded chains [41]. The folding patterns of 
lysozyme have been studied to test these hypotheses, under both reductive and oxidative 
conditions [42-45]. The reduced form of the protein is known for its high susceptibility to 
aggregation [46], allowing comparison of the effects of crowding on aggregation-prone and 
aggregation-resistant states of the same protein [45]. In a crowded environment, the refolding 
of oxidised hen lysozyme from denaturant is rapid and highly efficient whereas the refolding 
of reduced lysozyme is greatly reduced due to aggregation [23]. Protein disulphide isomerase 
(PDI) prevents this aggregation by acting as a catalyst, increasing the rate of disulphide bond 
formation and acting as a molecular chaperone, shielding hydrophobic surfaces [23, 45, 47]. 
Van den Berg and coworkers observed a 30% increase in the refolding yields of lysozyme on 
addition of PDI, in the absence of crowding agents. Moreover, they found that presence of 
crowding agents enhanced this refolding further. For example, in the presence of BSA and 
Ficoll, the refolding yield of lysozyme increased from less than 3% in the absence of PDI to 
30-40% at the highest concentration of PDI used [45]. These findings suggest that the 
function of PDI is enhanced under crowded conditions. 
 
 
1.4 Molecular Chaperones in Protein Folding 
Frequently, the biological requirements of the cell are not met due to the low inherent 
efficiency of the folding process. Molecular chaperones function to overcome this problem 
without containing steric information that may facilitate correct protein folding [8]. 
Chaperones are prokaryotic and eukaryotic proteins that interact with unfolded or partially 
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folded protein subunits (for example, nascent chains emerging from the ribosome or extended 
chains being translocated across subcellular membranes) [6, 48, 49]. They recognise 
hydrophobic regions of proteins that are exposed to the solvent in the unfolded but not the 
native state [50]. 
 
The term ‘molecular chaperone’ was first applied to the acidic nuclear protein, nucleoplasmin 
by Laskey and coworkers [51]. Nucleoplasmin is required in Xenopus eggs for the assembly 
of nucleosomes from DNA and histones [49, 52, 53]. In the absence of nucleoplasmin the 
mixing of separated DNA and histones at physiological ionic strength gives rise to aggregate 
formation. In the presence of nucleoplasmin however, this aggregation is prevented and the 
formation of the nucleosome cores arises [49]. Nucleoplasmin interacts with histones in such 
a way that shields their positive charge without binding to either DNA or nucleosomes. 
Thereby, it mediates nucleosome assembly by preventing incorrect interactions between 
histones and DNA [54]. It reduces electrostatic repulsion between histones thereby promoting 
histone-histone interactions and competes with the electrostatic attraction between DNA and 
histones, minimising the formation of non-specific aggregates [49].  Nucleoplasmin is not a 
part of the nucleosome, nor does it comprise steric information for nucleosome assembly; it is 
required solely for assembly [52, 54]. 
 
Molecular chaperones have since been characterised from animal, plant and viral sources. For 
instance, immunoglobulin heavy chain binding protein or BiP is found in the lumen of the ER 
of lymphoid cells and binds non-covalently to newly synthesised immunoglobulin heavy 
chains [49]. BiP binds to Ig heavy chains that do not have light chains attached, recognising 
hydrophobic regions (on the heavy chain) that are later covered by light chains. It is therefore 
thought that BiP may be involved in preventing and reversing heavy-chain aggregate 
formation, thereby assisting assembly of immunoglobulin molecules in antibody secreting 
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cells [55]. Grp 78, an ER protein the same as BiP, is produced by fibroblasts that are depleted 
of glucose. A possible role of grp 78 may be to bind to underglycosylated proteins in these 
fibroblasts and prevent the formation of insoluble aggregates [56]. Mutant forms of viral 
haemagglutinin that are unable to fold correctly have been shown to bind to BiP for longer 
periods whereas unfolded haemagglutinin molecules only bind the chaperone transiently as 
they enter the ER [57]. The presence of BiP in a variety of  cells suggests that this heavy-
chain binding protein may play a role in enhancing the solubility of proteins other than 
immunoglobulins [49]. 
 
The primary structure of BiP is related to that of a major heat shock protein in animal cells, 
Hsp70 [55]. The Hsp70 multigene family consists of genes that are related to the major heat 
shock protein and encode chaperones that are involved in the correct folding and transport of 
proteins. They are present in all cells except for archaebacteria. The Hsp70s are a group of 
highly conserved ATPases with molecular weights of approximately 70 kDa [50, 58]. 
Constitutively expressed members of this family are involved in the stabilisation of 
polypeptide chains as they are being synthesised on ribosomes. The Hsp70 and Hsp60 protein 
chaperone families are involved in protein folding under both normal and stress conditions. 
The binding and release of substrate proteins by both classes of chaperone is regulated by 
ATP-binding and hydrolysis. Close association of the polypeptide chain and molecular 
chaperone is maintained during the translation and folding processes [50]. The primary role of 
these interactions is thought to be to prevent ineffective reactions that are not part of the 
pathway. These two chaperone proteins act by two different mechanisms and there are two 
distinct chaperone actions that occur. Hsp70, which can act as either a monomer or dimer, is 
involved primarily in shielding the hydrophobic surfaces on nascent polypeptide chains until 
approximately 100-200 amino acids are accessible for effective folding. In contrast, the 
Hsp60s form double ring structures comprising of an internal cavity that acts as a barrier 
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between the yet unfolded protein and the cellular surroundings. In doing so, they preclude 
protein aggregation as well as enabling folding to the native state in an ATP-dependent 
reaction (Figure 1.3) [59]. 
 
              (Adapted from [59]) 
Figure 1.3. The sequential action of molecular chaperones Hsp60 and Hsp70. The Hsp70 acts 
early in the life of the protein by recognising and binding to amino acid chains. The Hsp60 forms a 
structure into which misfolded proteins enter and are transferred. Both Hsp70 and Hsp60 hydrolyse 
ATP, which in turn allows the binding and release of the subsequent protein that helps the correct 
folding of the protein. 
 
Chaperones have been well studied in E. coli where it has been shown that functionality of 
Hsp70 and Hsp60 requires cooperation with other proteins. DnaK, the E. coli Hsp70, 
cooperates with DnaJ, another chaperone and GrpE, a nucleotide exchange factor. Both DnaK 
and its partner chaperone DnaJ have been shown to copurify with polyribosomes and have the 
ability to bind co-translationally to nascent polypeptide chains emerging from ribosomes. The 
binding of DnaJ to the unfolded protein requires the hydrolysis of DnaK-bound ATP and 
ADP. This allows the formation of a stable, ternary complex [60]. DnaJ stabilises the ADP-
bound state of DnaK which has a high affinity for the unfolded peptide. Whereas the 
prevention of protein aggregation requires the binding of DnaK/DnaJ to exposed hydrophobic 
polypeptide regions, folding of the protein to the native state requires the release of bound 
structures. This is dependent on the regulation of DnaK by the regulator protein GrpE [60]. 
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The regulation of low ATPase activity of DnaK is regulated by DnaJ so that ADP is tightly 
bound to DnaK, DnaJ and the unfolded protein complex. The interaction of GrpE with the 
ATPase domain of DnaK results in dissociation of ADP. Subsequently, there is binding of 
ATP to DnaK which results in dissociation of the ternary complex, allowing transfer of the 
unfolded protein to the bacterial Hsp60, GroEL. 
 
GroEL is a large complex, which comprises two stacked rings of seven 60 kDa subunits, 
forming a quaternary structured double-toroid with a central cavity [60-62]. GroES, an 
essential cofactor of GroEL, forms a 70 kDa heptameric ring that binds to GroEL and 
regulates its ATPase activity. ADP is bound to the binary GroEL: GroES complex. The 
substrate protein itself is thought to induce the exchange of ADP for ATP. The binding 
affinity of GroEL for ADP is decreased upon binding of the substrate protein to the interior of 
the GroEL cylinder. This initiates a reaction cycle which involves the hydrolysis and 
exchange of nucleotides [50, 62]. Transient dissociation of GroES occurs as a consequence of 
substrate-protein binding, permitting ATP binding to the GroEL toroid. This results in a 
reduction in the binding affinity of GroEL for substrate protein, allowing its release into the 
cavity where folding is initiated (Figure 1.4). Multiple rounds of interaction with GroEL may 
be essential for complete folding of most proteins [50].  
 12
cis cis 
         ATP1 
polypeptide 
ES release primed Polypeptide binding 
GroES
Folding triggered 
New cis
IUC
N or IC
OR
GroES
Discharge triggered  
                        (Adapted from [50, 63]) 
Figure 1.4. A simplified pathway of chaperone-assisted protein folding in the bacterial cytosol. 
Hsp70 (DnaK) and DnaJ interact with the polypeptide chain co-translationally. The ternary complex 
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between DnaK (in an ADP bound state), DnaJ and the unfolded polypeptide keeps the protein in the 
soluble form. Binding of GrpE to DnaK instigates a conformational change, leading to dissociation of 
ADP and binding of ATP. Subsequently, there is release of the bound polypeptide. Completion of 
folding of most polypeptides requires transportation to the GroEL-GroES reaction cycle. A GroEL-
GroES-ADP asymmetric complex binds to non-native polypeptides in a collapsed, unstructured state 
via hydrophobic interactions with its apical domains. Binding of ATP followed by GroES to the same 
ring as the polypeptide results in large conformational changes in the GroEL apical domains. This 
causes movement of the hydrophobic regions away from the surface of the cavity, allowing GroES to 
cap the GroEL ring, forming a cis folding-active complex. The polypeptide is then released into the 
central cavity where it folds in this sequestered chamber whose walls are not hydrophilic. This 
environment favours internalisation of hydrophobic side chains and exposure of hydrophilic ones.  
ATP hydrolysis weakens the cis complex, discharging the ligand from the cis ring. The released 
polypeptide may be in the native state (N) or one committed to it (IC), or may have failed to reach the 
native state (IUC), in which case it can bind GroEL for another attempt at folding. The binding of 
GroEL, ATP and polypeptide to the same ring forms a new cis complex on the previous trans ring to 
begin the cycle again. 
 
Bacteriophage head assembly had been known to affected by mutations in genes encoding 
GroEL and its co-factor GroES [64]. A yeast mutant, which affected the function of 
mitochondrial Hsp60, was unable to oligomerise proteins imported from the cytosol into the 
mitochondria, providing evidence for the essential function of chaperones in vivo. 
  
Chaperones are therefore a group of unrelated protein families that are involved in the 
stabilisation of unfolded polypeptide chains, unfolding of proteins for translocation across 
membranes or degradation and assistance to correct protein folding and assembly. 
  
Hsp47 shares similarities and differences with the GroEL chaperone. Similarly, it is involved 
in preventing the aggregation of unfolded or partially folded collagen chains as well as 
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maintaining incomplete collagen chains in the ER until they are folded correctly before 
transporting them to the Golgi complex. However, while GroEL is not specific for the 
polypeptide chain it acts on, Hsp47 is substrate specific. 
 
 
1.5 Hsp47 
Molecular chaperones are also linked to changes in cellular environment such as heat-shock 
and environmental stress, as the rate at which they are synthesised is greatly increased when 
cells are exposed, for very short periods, to elevated temperatures [48] or other stressful 
stimuli such as increased ionic stress, changes in pH and exposure to toxic agents and 
detergents. The heat shock or stress response is a transitory reaction to stressful conditions 
that provides cellular protection and prevents organisms from being severely damaged [65]. 
Hsp47 has been characterised as a stress induced protein in animals [66]. 
 
1.5.1 The Discovery of Hsp47 
In 1983, a glycoprotein of 47 kDa was isolated from mouse embryo parietal endoderm cells, 
which was shown to bind native type IV collagen and gelatin (denatured type I and type III 
collagen). As it possessed collagen binding abilities this protein was named colligin [67]. 
Subsequently a number of similar proteins were isolated from 3T3 fibroblasts and human 
epidermal keratinocytes, all of which were recognised as colligin [68], rat skeletal myoblasts 
(termed gp 46) [69], and chick embryo fibroblasts [70], which was termed Hsp47. Upon 
analysis of the gene sequences of the proteins, it was revealed that these proteins were highly 
similar and could be considered species variants of the same protein. 
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1.5.2 Expression of Hsp47 
Hsp47 is a heat shock protein; therefore its expression is heat inducible. This is an unusual 
property for ER localised stress proteins that are usually induced by an increase in the 
concentration of the unfolded protein folded in the ER. Hsp47 is unique in that it is the only 
ER resident protein that is induced not by ER stresses but by cytosolic stresses [71]. The 
Hsp47 gene contains a conserved heat shock element (HSE) that is located -180 bp from the 
transcription initiation site (Figure 1.5). The expression of Hsp47 is induced upon the binding 
of heat shock factor 1 (HSF1) to the HSE [72]. The binding of HSF1 is in response to stress in 
the cytoplasm, such as heat shock and treatment with arsenite [73]. 
 
 
Sp1 sites at -210 bp 
HSE: -180 bp Exon III 
Translation 
Elements involved in basal 
expression of Hsp47 
Exon I ATG: Start codon Exon II 
Figure 1.5. The regulatory elements of the Hsp47 gene. 
 
Analysis of the promoter region has revealed that a Sp1 binding site at -210 bp from the 
transcription initiation site is essential for the constitutive expression of Hsp47. However, it is 
not responsible for regulating the level of the expression. This is done by two elements of 
about 30 bp that are present in the first and second introns of the Hsp47 gene (Figure 1.5). 
Regulation by these elements is at a level that correlates with that of the cellular expression of 
collagen [74]. Experiments studying the induction of Hsp47 by forms of stress such as heat 
shock showed an increase in the amount of Hsp47 but the collagen levels were either 
unaffected or decreased slightly. Analysis of the Hsp47 gene [75] revealed a heat shock 
element –nAAGn– at the promoter region. This demonstrated that the induction of Hsp47 was 
due to a heat-shock-element-heat-shock-factor system.  
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Low levels of Hsp47 are also constitutively expressed and its expression is known to correlate 
with collagen in several cells and tissues. Malignant fibroblasts show reduced expression of 
Hsp47 whereas in differentiating F9 cell lines, there is an increase in Hsp47 expression. On 
the other hand, PC12 cells or mouse M1 cells that do not produce collagen show no 
production of Hsp47 [76]. 
 
 
1.6 Collagen biosynthesis 
Collagen is the most abundant mammalian structural protein and is a major component of the 
extracellular matrix where it forms supermolecular structures that provide mechanical 
strength and elasticity in connective tissues [59, 74]. It has many significant roles, such as 
controlling cell shape and differentiation, allowing regeneration of broken bones, providing a 
scaffold for cells in our bodies and permitting wound healing. 
 
Collagen, like other secretory proteins, is assembled, folded and processed in a specific 
manner. It is secreted from eukaryotic cells through the process of exocytosis and as with all 
proteins that undergo exocytosis, collagen enters the ER co-translationally during synthesis 
[77]. The ER provides an environment that promotes protein folding and resembles the 
extracellular space where the protein is ultimately localised. It also has a quality control 
mechanism, which ensures that the protein is correctly folded before it moves to the next 
stage of the secretory pathway [78].  
 
Assembly of Collagen 
At least 27 types of collagen have been identified in mammalian tissues, all of which are 
superpolymers with the same general structure of three collagen chains interwined to form a 
triple helix (Figure 1.6). The triple helices can either consist of three identical α chains and be 
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homotrimeric or consist of three different α chains and be heterotrimeric. A right-handed 
triple helix is formed when each individual left-handed helix associates with two other α 
chains. The α chains are initially synthesised as polypeptides with propeptides located at the 
C- and N- termini. Assembly of the triple helix, which uses a zipper-like mechanism, initiates 
at the C-terminal propeptide and progresses in the C to N terminal direction. Once on the cell 
surface, N- and C- propeptidases are used to cleave the N- and C- propeptides leaving the 
remaining triple helical regions. Consequently, each α chain consists of 1050 amino acids and 
the excision of the propeptides allows polymerization of collagen molecules into fibrils in the 
extracellular space. The stabilisation of the triple helix is partly due to the presence of glycine 
moieties on the inside of the triple helix and the hydroxylated proline residues. Van der Waals 
forces, extensive solvent hydrogen bonds and interchain disulphide bonds hold the triple helix 
together [74, 78-81]. 
 
B
 
 
Figure 1.6. The Structure of Collagen.  
(A) Diagram demonstrating the triple helical form of collagen.  
Gly-blue, proline-green and hydroxyproline-white.  
(B) A closer view of the triple helix and its constituent amino acids. 
Also shows the hydrogen bonds that form between the collagen 
chains. 
A 
B 
                            
The triple helical conformation is stabilized by a Gly-X-Y repeating motif, where X is any 
amino acid and Y is proline or hydroxyproline. The triple helical structure of collagen is due 
to the unusual abundance of three amino acids; glycine, proline and hydroxyproline. It is these 
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amino acids that make up the characteristic Gly-Pro-X motif and each amino acid has a 
specific function [59]. Hydroxylation of the proline residue occurs while it is co-
translationally transported to the ER. The glycine residue is highly conserved as its hydrogen 
sidechain is the only one small enough to accommodate the centre of the helix enabling the 
three strands to pack together tightly [79]. The three chains are held together by hydrogen 
bonds between the peptide bond NH of a glycine residue with a peptide carbonyl on an 
adjacent polypeptide chain. The fixed angle of the C-N peptidyl-proline or peptidyl-
hydroxyproline bond allows each polypeptide chain to fold into a helix with such a geometry 
that allows three triple helices to twist together to form a three-stranded helix [59]. 
 
The repeated Gly-X-Y motifs have globular domains at the N- and C- propeptide terminals. 
These short segments at each end of the collagen chain are particularly important in collagen 
fibril formation [79]. They do not assume the triple helical structure and comprise of the 
unusual amino acid, hydroxylysine (described below). Covalent aldol cross-links between two 
lysine or hydroxylysine residues at the C-terminus of one collagen molecule and two similar 
residues at the N-terminus of an adjacent molecule stabilise the side-by-side packing of 
collagen molecules, thereby forming a strong fibril.   
 
Collagen molecules are extensively post-translationally modified in the ER. Some of the 
proline residues in the Gly-X-Y motif are post-translationally modified via an ER resident 
enzyme, prolyl-4-hydroxylase, to form hydroxyproline. The addition of the hydroxyl group 
helps to stabilise the triple helical structure and facilitate the cross-linking of the secreted 
collagen molecules in the extracellular space. Lysine residues at the Y position can also be 
hydroxylated via a different enzyme, lysyl hydroxylase. This post-translational modification 
results in the production of hydroxylysine residues that again play a role in the cross-linking 
of secreted collagen molecules. Hydroxylysine residues are also sites for N-inked 
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glycosylations. These post-translational modifications can only occur on individual α chains 
prior to the formation of the triple helix. Once the collagen triple helical conformation is 
formed, the α chains can no longer act as substrates for the post translationally modifying 
enzymes [81, 82]. 
 
Vitamin C (ascorbate) is required for the numerous physiological functions in the human 
body, including synthesis of collagen. Vitamin C is known to induce lipid peroxidation and 
reactive aldehydes, a step thought to be required for collagen expression, collagen mRNA 
levels and collagen production in cultured human fibroblasts [83]. Vitamin C and iron it its 
ferrous state (+2) are required functional prolyl and lysyl hydroxylase. Iron is bound to the 
hydroxylase as a cofactor. Hydroxylation of proline and lysine results in the oxidation of iron 
from a ferrous state (+2) to a ferric (+3) state. Ascorbate acts as reducing agent, maintaining 
iron atoms in their reduced states. Thus, vitamin C enables the vital hydroxylation reactions to 
continue and subsequently the formation of collagen [84]. Vitamin C deficiency causes 
deactivation of prolyl hydroxylase which results in malformed collagen that denatures at 24 
oC. Severe vitamin C deficiency results in scurvy [85]. 
 
Following the formation of the triple helices, the procollagen molecules are transported from 
the ER to the Golgi body, continuing their journey along the secretory pathway (Figure 1.7). 
Progression through the Golgi body results in the association of collagen trimers that are 
required for fibril formation following exocytosis. The cleavage of the C- and N- terminal 
propeptides instigates a dramatic diminution in the solubility of collagen, thereby driving the 
assembly of stable collagen fibrils. 
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Figure 1.7. Collagen fibril formation. The formation of the procollagen helix requires three α 
helices. Disulphide bond formation and hydroxylation stabilise the triple helix, which moves from the 
ER to the Golgi apparatus. Subsequently, the procollagen is processed to transport vesicles that fuse 
with the plasma membrane, allowing the secretion of procollagen into the extracellular space. Once in 
the extracellular space, propeptidases cleave off the prodomain regions. Collagen fibrils are formed on 
polymerisation of the triple helices and lysyl oxidase enhances cross-linking and provides rigidity by 
the production of aldehydes. 
 
 
 
 B1.7 Hsp47 and collagen 
 
Hsp47 is a collagen-specific molecular chaperone. The glycoprotein is ubiquitous, abundant 
and highly conserved and like other molecular chaperones it assists in protein folding and 
refolding both in vivo and in vitro as well as protecting protein unfolding due to stress. 
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However, whilst it is likely that the majority of molecular chaperones interact with a large 
variety of globular proteins, Hsp47 specifically interacts only with polypeptides of 
procollagen and the fibrous protein collagen [86]. 
 
Immunofluorescence and immunogold-electron microscopy have been used to demonstrate 
that Hsp47 localises to the ER [87]. The amino terminal of Hsp47 consists of a signal 
sequence and the RDEL (Arg-Asp-Glu-Leu) sequence, an ER-retention sequence is found at 
the carboxyl terminal. Hsp47 also contains two glycosylation sites that are thought to be 
glycosylated by mannose-type sugar moieties. The presence of both the ER-retention 
sequence and the glycosylation sites are further evidence for Hsp47 localising to the ER. 
 
Whilst Hsp47 is localised to ER, collagen is processed to the Golgi body where it is secreted 
via exocytosis. If Hsp47 bound to collagen does get carried to the Golgi body via vesicular 
transport, the RDEL sequence at its C-terminus is recognised by specific receptors, which 
retrieve it and return it to the ER [79]. Artificial removal of this sequence results in the 
secretion of the protein from the cell by exocytosis. 
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Figure 1.8. The role of Hsp47 in procollagen synthesis. Hsp47 transiently binds to procollagen prior 
to its secretion. Binding takes place immediately after the co-translation of the nascent polypeptide 
chain into the ER. Subsequently, triple helix formation occurs by three α chains interacting at their 
carboxyl termini via inter-chain disulphide bonds. Correct helical formation is ensured by progression 
in the C- to N- direction, allowing accurate alignment and orientation of the helix. The triple helix then 
continues to the cis-golgi compartment where it dissociates from the Hsp47 before proceeding to the 
trans-golgi for secretion to the cell surface. Receptors in the cis-golgi recognise the RDEL peptide and 
cycle Hsp47 molecules back to the ER. Misfolded procollagen aggregates in the ER and has been 
shown to be eliminated via an autophagy-lysosome pathway. The red sphere represents a transport 
vesicle. 
 
1.7.1 The Ability of Hsp47 to Recognise the Triple Helix 
As mentioned in the previous section, in cultured cells, the expression of Hsp47 is correlated 
with various types of collagen. Furthermore, Hsp47 is known to be a collagen-specific 
molecular chaperone. However, the specificity of Hsp47 binding was unknown so 
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experiments using peptide-libraries were performed in order to determine the specific binding 
sites for Hsp47 using the recombinant chaperone protein and synthetic collagen model 
peptides [88]. Binding assays allowed the identification of structural requirements for 
substrate recognition and regulation of the binding. The peptide (Pro-Pro-Gly)n provided 
sufficient structural information necessary for recognition by Hsp47. A structure-activity 
relationship study using synthetic analogues of (Pro-Pro-Gly)n identified chain length and 
primary structure to be important for the interaction. Koide and coworkers previously 
identified that prolyl-4-hydroxylation of the second Pro residue in the Pro-Pro-Gly repeat 
abolishes the chaperone-substrate interaction. Thus, they proposed a model whereby the 
dissociation of Hsp47 from collagen occurred during prolyl-4-hydroxylation in the ER. The 
peptides used included (Pro-Pro-Gly)5, (Pro-Hyp-Gly)5, (Pro-Pro-Gly)10, (Pro-Hyp-Gly)10, 
polyglycine and poly-L-proline. Solid-phase binding assays were performed in which 
peptides and porcine Type I collagen were immobilised onto cyanogen bromide-activated-
Sepharose. Following incubation of Hsp47 lysate with affinity beads, proteins were analysed 
by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and visualised 
using coomassie brilliant blue (CBB) staining. A competition assay was also performed where 
a bed of type I collagen or (Pro-Pro-Gly)10-immobilised sepharose was incubated with Hsp47. 
After washing the beads, a competitive peptide was added to the mixture. Proteins present in 
the supernatant and those retained on the beads were analysed by SDS-PAGE and CBB 
staining [88-90].  
 
The results obtained showed that the residues that were found to be most frequently bound to 
the Xaa and Yaa positions were Pro and Hyp (4-hydroxyproline), respectively. Solid-phase 
pull down assays revealed that Hsp47 did not recognise a specific amino acid sequence but 
recognised structural similarities between these sequences. An initial assay contained poly-L-
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proline, polyglycine, (Pro-Pro-Gly)5 and (Pro-Pro-Gly)10. Rat Hsp47 did not interact with 
polyglycine, poly-L-proline or (PPG)5 [88]. 
 
The following points were noticed in relation to substrate recognition of Hsp47: 
(i) The minimum number of (PPG)n repeats required for the interaction is between 5 
and 10. 
(ii) It was thought that prolyl-4-hydroxylase (P4-H), an enzyme also present in the ER 
had similar substrate recognition to that of Hsp47. 
(iii) The Yaa position of Xaa-Yaa-Gly does not need prolyl 4-hydroxylation for Hsp47 
interaction. 
 
To further confirm these findings, analogues of (Pro-Pro-Gly)8 with different Pro and Gly 
arrangements were used. Some of the analogues used were polyglycine, (Pro-Gly-Gly)8, (Pro-
Gly)12, (Pro-Pro-Pro-Gly)6 and Poly-L-proline. Only (Pro-Pro-Gly)8 showed any interaction 
with Hsp47 demonstrating that the presence of Gly at every third residue is important for 
substrate recognition. This demonstrated that the simplest collagen model peptide (Pro-Pro-
Gly)n could be used as a binding substrate for Hsp47 [88]. 
 
Koide and coworkers also found that most of the Pro-Pro-Gly sequences were converted to 
Pro-Hyp-Gly in the procollagen biosynthetic pathway. This conversion in the Yaa position 
due to P4-H prevents the binding of Hsp47 before the formation of the triple helix. This 
inconsistency encouraged Koide and coworkers to identify Hsp47-binding sequences other 
than (Pro-Pro-Gly)n. Various collagen model peptides were used which led to the discovery of 
Xaa-Arg-Gly triplets as an Hsp47-binding sequence. The Pro-Arg-Gly had a much greater 
affinity for Hsp47 than the previously identified (Pro-Pro-Gly)n sequence. Fluorescent 
quenching–based binding assays revealed Hsp47 binding affinities for the triplets Pro-Arg-
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Gly and Xaa-Arg-Gly were similar. These findings confirmed that Xaa-Arg-Gly triplets were 
dominant binding sites for Hsp47. Further studies showed that Hsp47 bound to (Pro-Pro-Gly)n 
triplet at a temperature of 4 oC, however, significant binding was not observed at 25 oC. This 
demonstrated that Hsp47 binding was temperature dependant and is further evidence for the 
importance of triple – helical conformation of the substrates [91]. 
 
Collagen mimic peptides (PPG)10, consisting of 10 repeating units of Pro-Pro-Gly, that can 
exist in both monomeric and trimeric states that resemble those of collagen have been used to 
study binding affinities of Hsp47 for its substrate. It has been demonstrated that Hsp47 binds 
preferentially to the triple helical form of collagen rather than the monomeric form [88]. It has 
also been shown that the binding of Hsp47 to the monomeric state is much weaker than the 
binding to triple helical collagen. Bulleid and coworkers have used newly synthesised 
procollagen α-chains to demonstrate that Hsp47 interacts with correctly folded, triple helical 
procollagen in comparison to the monomeric procollagen chains [78]. These results suggest 
that Hsp47 binds the triple helical form of collagen in vivo rather than the monomeric form. In 
contrast to this, P4-H interacts with the monomeric but not the triple helical form of collagen. 
The findings that Hsp47 binds cooperatively to triple helical type I collagen [92] and that the 
binding of Hsp47 to single stranded (PPG)10 was non co-operative and had a low affinity, 
indicate that high affinity co-operative binding of Hsp47 requires the presence of triple helical 
procollagen. 
 
Koide and coworkers also demonstrated that binding of Hsp47 to the Pro-Arg-Gly triplet was 
not disrupted by high ionic strength buffer implying that a hydrophobic interaction was 
mainly responsible for the Hsp47-collagen interaction. Thus it was suggested that the 
hydrophobic cleft of the Hsp47 directly interacted with a hydrophobic region formed on the 
Arg side chain [89-91]. 
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The Importance of Hydroxylation 
Hydroxylated collagen chains have been observed to have increased Hsp47 binding. This 
could be because binding of the chaperone to the triple helix requires hydroxylation or 
because triple helix formation requires hydroxylation and Hsp47-collagen binding only occurs 
once the triple helix has formed. Denaturation of the hydroxylated triple helix by an increase 
in temperature revealed that Hsp47 did not associate with denatured, single stranded collagen 
molecules. However, high amounts of Hsp47 were detected on reformation of the triple helix. 
This suggests that high affinity binding of Hsp47 depends upon the structure of the triple 
helix and not the extent of hydroxylation. Progressive hydroxylation of procollagen on the 
other hand, may cause dissociation of Hsp47. This is thought to be due to Hsp47 having a 
preference for proline rather than 4-hydroxyproline at the Y position [88-90]. The above 
results suggest that hydroxylation reduces the binding affinity of Hsp47 to procollagen and 
that the binding is dependant on the triple helical structure of procollagen. This is unusual as 
hydroxylation is required for the formation of the triple helix. This implies that Hsp47 may 
have a role in preventing the denaturation of the triple helix by binding to unhydroxylated 
regions of the triple helix and stabilising them. Consequently, dissociation of Hsp47 from the 
collagen triple helix follows the hydroxylation of the proline residues [88]. 
 
The Knockout Mouse 
The essential role of Hsp47 in collagen biosynthesis was not proven until the establishment of 
Hsp47 knockout mice [93]. Hsp47 -/- mice were shown to secrete type I collagen molecules 
that were immature and partially processed, which resulted in embryonic death due to the 
formation of defective and discontinuous basement membranes. This led to the understanding 
that the molecular chaperone, Hsp47 was a requirement for the complete processing of type I 
collagen and that correctly processed and functional collagen cannot be produced without 
Hsp47. Subsequently, the precise role of Hsp47 in collagen biosynthesis was elucidated. 
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Recently, with the use of Hsp47 knockout mice, it was proved that Hsp47 is vital for the 
processing of type IV procollagen [94]. It was also discovered that knockout of Hsp47 
instigates a delay in collagen secretion. This suggests that the ER possesses a quality control 
mechanism by which progression of procollagen through the secretory pathway is delayed in 
the absence of Hsp47. Thus, it is thought that Hsp47 facilitates the folding of procollagen so 
that it is in its correctly folded conformation in the ER. 
 
Unlike most molecular chaperones that stabilise intermediates in order to favour the formation 
of a stable folded state, Hsp47 binds to the fully folded triple helical form of procollagen that 
has already reached the final stage of the folding pathway. A reason for this could be that 
Hsp47 is involved in preventing the thermal denaturation of the triple helix. Hsp47 may have 
a role in binding to and stabilising unstable regions, such as those resulting from the uneven 
distribution of hydroxyproline residues, during the movement of procollagen from the ER to 
the Golgi body [95]. This is consistent with the fact that heat shock results in the induction of 
Hsp47 expression and Hsp47 binds preferentially to the unhydroxylated form of triple helical 
procollagen [86, 95]. 
 
It has also been seen that Hsp47 inhibits the fibril formation in vitro, with complete inhibition 
requiring a 1:1 ratio of collagen:Hsp47 [96]. Hence, it may be that binding of Hsp47 to 
procollagen in the ER could be to prevent the formation of insoluble collagen fibres. 
However, this is unlikely to be the lone function of Hsp47, as it would not explain the 
observed secretion of immature collagen in the knockout mice. 
 
In general, current findings and evidence support that Hsp47 is essential for the processing 
and folding of collagen. Although a number of roles have been proposed, a specific role is yet 
to be confirmed. It may be that Hsp47 has many roles, such as, aiding the formation of the 
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procollagen triple helix in the ER, preventing dissociation of the procollagen triple helix from 
the ER, precluding the unwinding of regions of the triple helix and preventing premature 
collagen aggregation in the ER. Further research is required to determine which, if any of the 
above is correct. 
 
 
1.8 The pH dependant conformational switch mechanism 
An unusual feature of Hsp47 is its pH-dependant interaction with procollagen/collagen. El-
Thaher and coworkers have shown that the pH-dependant binding and release of 
procollagen/collagen coincides with the pH-driven trans-conformational changes in Hsp47 
indicating that these conformational changes alter the binding affinity of the chaperone for its 
substrate. The use of CD and fluorescence spectra to examine changes in secondary and 
tertiary structure revealed three structural states. The Alkali state (above pH 6.4) consisted of 
25% and 36% α-helix and β-sheet, respectively. The Intermediate state (pH 6.2) comprised of 
15% α-helix and 51% β-sheet and the transition from the Alkali to the Intermediate state 
showed marked changes in secondary structure. The Acid state (below pH 5.7) contained 11% 
and 57% α-helix and β-sheet, respectively. Therefore a pronounced decrease in α-helical 
character and a substantial increase in β-sheet content are characteristic of the transition from 
the Alkali to Intermediate to Acid states [97] (summarised in Table 1.1 below). 
State α-helix character (%) β-sheet character (%) 
Alkali 25 36 
Intermediate 15 51 
Acid 11 57 
 
Table 1.1. Summarizing the secondary structure composition of the Alkali, Intermediate and 
Acid states. The transition from the Alkali to the Acid state is associated with a decrease in α-helix 
and an increase in β-sheet character. 
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The protonation and deprotonation of histidines may be the initial trigger driving the 
conformational changes in Hsp47. Mature recombinant mouse Hsp47 (mrmHsp47) contains 
fourteen histidines and its overexpression in E. coli allowed El-Thaher and coworkers to use 
this for structural studies. It is thought that the transformation from the Alkali to the 
Intermediate state results from the formation of new electrostatic interactions following 
histidine protonation. Titration curves of CD intensities (at 220 nm and 289 nm) as a function 
of pH demonstrated points of inflection at approximately 6.2, the pKa of the imidazole group 
of histidines [97]. They also found that the double mutant H197Q:H198N and a H335L 
mutant resulted in aberrant collagen binding activity. The H335L mutant remained bound to 
collagen even at pH 6.1 whereas the double mutant (H197Q:H198N) abolished collagen 
binding properties completely (Yokota and Nagata, unpublished). 
 
The above findings, along with previous evidence of Hsp47-collagen binding above pH 6.3 
but release at or below pH 6.3, is accounted for by the pronounced effect of pH on the 
secondary and tertiary structure of Hsp47. The three state theory explained above can be used 
to illustrate the correlation between the binding and release of Hsp47 from 
procollagen/collagen and the pH-induced structural changes observed in mrmHsp47, such that 
only in the Alkali state can Hsp47 bind its substrate and not in the Intermediate or Acid state. 
The work by El-Thaher and coworkers supports this hypothesis as protein purification was 
done using a collagen-sepharose column at pH 8.0. Subsequently, the protein was eluted at 
pH 5.8 after which it was stored at pH 8.0, restoring its collagen binding ability [97]. 
 
Dafforn and coworkers also observed this pH-dependency when the binding of Hsp47 to a 
collagen mimic peptide (PPG)10 was reduced following a drop in pH from 7.0 to 6.0. This 
reduction in pH is thought to induce a conformational change, leading to a 1000-fold decrease 
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in the binding affinity of Hsp47 for collagen, resulting in dissociation of Hsp47 and 
impairment of biological activity [87]. 
 
 
1.9 Hsp47 as a member of the Serine Protease Inhibitor Superfamily 
1.9.1 Introduction 
Serine protease inhibitors (serpins) belong to a family of proteolytic enzymes whose members 
are the enzymes of protein digestion. The serpins are known to bind and unfold serine 
proteases, many of which act as triggers for a number of molecular pathways, including 
immune activation and fibrinolysis [98]. It is the unique hypermorphic molecular mechanism 
of serpin function that provides specificity and irreversibility and has rendered serpins as the 
major serine protease inhibitors in the majority of higher organisms [99]. Inhibition of their 
cognate proteases involves a striking conformational transition after which the serpin itself 
becomes inactive. This highly flexible nature of the structure however, makes serpins prone to 
disadvantageous mutations and structural changes that can cause disease [100, 101]. 
 
1.9.2 Identification of the Serpin Superfamily 
The term ‘serpin’ superfamily first came about in 1985 as many of the members were serine 
protease inhibitors [102]. Previously, it had been observed that there was 30 – 50% sequence 
homology between α1-antitrypsin (α1-AT), chick ovalbumin and antithrombin III [103]. 
Currently, over eight hundred proteins in the sequence databases are assigned to the serpin 
superfamily with serpins being present in viruses, higher eukaryotes and prokaryotes. They 
are however yet to be found in yeasts [104]. 
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Sequence comparisons have enabled the serpin superfamily to be classified into clades 
(Figure 1.9) and 10 orphan sequences [105], with similar sequenced serpins placed in the 
same clade. There are sixteen clades in total, eight of which are assigned to the extracellular 
serpins. An example is clade a, which is formed by α1-AT-like serpins such as ACT, 
thyroxine binding-globulin (TBG) and angiotensinogen (ANGT). This group of serpins has a 
broad range of functions, but are mainly associated with inhibition of serine proteases. 
However, some are non-inhibitory. These include cortisol binding globulin (CBG), TBG 
[106], ANGT and the uterine milk protein (UTMP). As antithrombin (clade c) and 
neuroplasmin (clade i) cluster close to the insect/ intracellular/ PAI-1 section of the 
phylogenetic tree, it implies that these groups diverged reasonably early and that intra- and 
extracellular serpins may be linked by antithrombin or neuroserpin [4]. 
 
Intracellular protease inhibitors such as PI-6 and PI-8 (proteinase inhibitor-6 and -8, 
respectively) are in clade b along with the other intracellular serpins or ov-serpins [104]. The 
intracellular serpin subfamily is the ancestor of the extracellular serpins and they function by 
modifying the behaviour of cells. For example, megsin, enhances maturation of 
megakaryocytes from bone marrow cells [107] and PAI-2 has the capability of inhibiting 
tumour necrosis factor-α (TNF) – induced apoptosis [108]. However, the functions of many of 
the serpins in this clade are yet to be identified. The one exception to this is the storage 
protein ovalbumin, where there is evidence of a conformational transition in ovalbumin 
during embryo development [109]. 
 
Hsp47 was identified as a serpin by virtue of sequence homology [99] and is another example 
of a non-inhibitory serpin, which has adapted a role as a collagen-specific molecular 
chaperone [110]. 
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Figure 1.9. A phylogenetic tree demonstrating the relationship between the serpin superfamily. 
a-p represent the 16 clades; clade a-antitrypsin-like serpins, clade b-intracellular serpins, clade c-
antithrombin, clade d-heparin cofactor II, clade e-PAI-1, clade f-capsin, clade g-C1 inhibitor, clade h-
Hsp47, clade i-neuroserpin, clade j-horseshoe crab, clade k-insect, clade l-nematode, clade m-blood 
fluke, clade n-viral serpin 1/2, clade o-viral serpin 3, clade p-plants. The 10 orphans (at the bottom of 
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the tree) represent serpins that failed to group with a clade and include the Aedes aegypti factor Xa 
inhibitor and Acp76A (the accessory gland protein). 
 
1.9.3 Serpin Folding 
Studies on serpin protein folding have involved kinetic and equilibrium measurements. Bruch 
and coworkers investigated the unfolding pathways of α1-AT, antichymotrypsin (ACT), 
antithrombin and C1 inhibitor using circular dichroism (CD) [111]. A stable intermediate was 
observed for each of these serpins, implying that they shared similar unfolding pathways, 
comprising at least one stable intermediate. 
 
The unfolding pathway of α1-AT was probed further by James and coworkers using intrinsic 
tryptophan fluorescence and cysteine labelling [112]. Of the two tryptophan residues (W194 
and W238 found on the A and B β-sheets, respectively) in α1-AT, the majority of the intrinsic 
fluorescence signal is thought to be due to W194 [113]. James and coworkers observed 
ordered unfolding of the different regions in the protein. Early exposure of P3’Cys and C313 
were indicative of early movement in the RCL and opening of β-sheet A and subsequent 
exposure of W194. Opening of the A β-sheet and movement of strand 1 in β-sheet C (s1C) are 
linked to the formation of a stable intermediate [112]. Helix F (hF) of this intermediate 
species has been shown to be unfolded, implying that this helix may be involved in the 
unfolding of α1-AT [114]. Subsequently, the A and C β-sheets of α1-AT are disrupted, prior to 
unfolding of β-sheet B and exposure of C232 [112]. This suggests that the B β-sheet is the 
most resistant region of α1-AT. Figure 1.13 illustrates the basic serpin fold. Similarly, the 
unfolding pathway of PAI-1 also exhibits a folding intermediate and β-sheets B and C are 
more resistant to denaturation than β-sheet A [115].  
 
Powell and coworkers measured changes in tryptophan fluorescence lifetimes and quenching 
to investigate the kinetics of folding and unfolding of α1-AT [116]. Denaturation results were 
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more complex than general globular proteins, with curves demonstrating the presence of 
multiple equilibrium intermediates in the presence of denaturant. They found the folding 
process to be rapid (Figure 1.10), involving a series of intermediates (Xi) that lead to a more 
compact intermediate (I) [117]. Internalisation of tryptophan residues and formation of 
quenching interactions allowed progression from the intermediate to the native (N) state. 
 U X1 
. . . Xi I N’ N, 
Fast Fast Slow Slow 
[116] 
Figure 1.10. Proposed kinetic pathway of α1-AT. Folding of recombinant AT (r-AT) involves rapid 
collapse to a compact intermediate that folds more slowly to the native state. Rapid folding occurs 
through a series of intermediates (Xi) to a compact intermediate (I). Final packing of tryptophan 
residues forms the native (N) conformation. 
 
This model suggests that the two-phase decrease in fluorescence is a result of consecutive 
reactions. 
 
Further understanding of the folding/unfolding pathway of α1-AT was provided by Kim and 
coworkers. They used intrinsic tryptophan fluorescence and extrinsic 1-anilino-8-naphthalene 
sulphonate (ANS) fluorescence [118]. The α1-AT sequence comprises of two tryptophanyl 
residues; W194, which is conserved amongst the serpin protein superfamily and W238, 
substitution of which did not alter the kinetic parameters. Hence, the major changes in 
tryptophan fluorescence in the folding pathway of α1-AT are due to the environment 
surrounding W194. Refolding experiments revealed three kinetic phases. An initial fast phase 
that produced a small increase in fluorescence was followed by a slow decrease in 
fluorescence and a final third phase that was accompanied by a further slow decrease in 
fluorescence. A further, very slow phase (conversion from IN to A), thought to be due to 
aggregation, was observed. Kim and coworkers proposed a folding pathway that was initiated 
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with the folding of the unfolded protein (U) to a molten globule-like state (I). Compactisation 
of I forms a native-like intermediate (IN). Further internalisation of hydrophobic regions 
yields IN’. IN, the active intermediate, undergoes kinetic competition and can proceed to either 
the native protein (N) or aggregation (A) (Figure 1.11). 
I’ 
• • • I IN IN’ N 
A 
U 
  [118] 
Figure 1.11.  A proposed folding pathway of α1-AT. The first step involves conversion of the 
unfolded protein (U) to a molten globule-like state (I). This fast, folding phase is limited by cis-trans 
isomerisation. Folding of the molten globule-like state forms a native-like intermediate (IN), either 
directly or via a more compact intermediate (I’). Further internalisation of hydrophobic residues forms 
IN’. At high protein concentrations, IN is aggregation prone and can result in aggregate formation (A). 
Trp 194 is located at the top of s3A, internalisation of which may be the final folding step in the 
closure of the A β-sheet, yielding native state (N) formation [118].  
 
Dafforn and coworkers investigated in detail, the process by which polymer formation occurs 
in the α1-AT folding pathway, using intrinsic tryptophan fluorescence and extrinsic probe, 8-
anilino-1-naphthalene sulphonic acid (ANSA) [119]. In agreement with Kim and coworkers, 
polymerisation of α1-AT was found to require the formation of an intermediate species [119]. 
Dafforn and coworkers proposed that destabilisation of the native state, accompanied by a 
conformational change, results in the formation of a polymerogenic monomeric state (M*) 
which can lead to polymer (P) formation. The polymerisation process was thought to be a 
two-step process (Figure 1.12) that was dependent upon the concentration of M* and 
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therefore k1. At a high concentration of protein, the process was saturated thus non-specific 
aggregation was thought to compete with polymerisation. 
M*  +   M* P 
L 
k1 k2
M  +  M 
                  
          [119] 
Figure 1.12. A proposed model for the polymerisation of α1-AT. A conformational change in the 
α1-AT monomer (M) produces a polymerogenic intermediate (M*). Self-association of M* yields 
polymer (P). Progression of M* via a side pathway leads to the latent (L) conformation. Polymer 
formation is thought to be a two-step process; therefore the conversion from M to P (k2) is dependent 
on the concentration of M* and hence the conversion of M to M* (k1) [119]. 
 
1.9.4 Serpin Structure 
The serpin superfamily consists of single domain proteins that are usually 350-400 amino 
acids in length. They have a highly conserved secondary structure which comprises of nine α-
helices (A-I) surrounding a core of three β-sheets (A-C) and a 26-34 amino acid reactive 
centre loop (RCL) [120], which acts as bait for target proteases as it contains the protease 
recognition site (Figure 1.13). The central β-sheet is also known as the A-sheet and can exist 
in two forms. The first is the metastable, 5-stranded form that results from normal folding. 
The second is the 6-stranded hyperstable form, which is the result of proteolytic cleavage or 
part denaturation of the protein. Changes in conformation of the RCL, β-sheet A and β-sheet 
C permit serpins to undergo major structural rearrangements [121]. 
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Figure 1.13. The basic serpin fold. Illustrating the positioning of the α-helices (in purple), β-sheets (β 
-sheet A comprises the green β strands, β-sheet B the blue β strands and β-sheet C the pink β strands) 
and the RCL (pink). 
 
Table 1.2 below shows the serpins used to model the mHsp47 structure. 
PDB  
Identifier 
Sequence Identity 
to mHsp47 
Sequence Homology 
to mHsp47 
Resolution 
of structure 
RMSD from Hsp47 
model (C-alpha) 
1by7 28 % 51 % 2.00 Å 1.36 Å 
1ova 26 % 47 % 1.95 Å 1.45 Å 
1qlp 28 % 49 % 2.00 Å 1.67 Å 
Table 1.2. Summarising the statistical parameters of the model structure of mHsp47. The model 
is based on PAI-2 (1by7), ovalbumin (1ova) and α1-AT (1qlp). The sequence identities (over 20 %) for 
each of the named serpins with mHsp47 indicate a good correlation. 
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In addition to motion of the RCL, the conformational transition from the stressed to relaxed 
serpin state is associated with rearrangement of rigid segments within the serpin [101, 122, 
123]. These include the breach, shutter and distal clusters (Figure 1.14). 
Distal hinge 
Gate region Proximal hinge 
3
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s
2
A
s
1
B
s
Shutter region 
s2B
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s
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Figure 1.14. The domains of a serpin shown on a model structure of native Hsp47. The helices are 
shown in purple, the green strands make up β-sheet A, blue stands form the B β-sheet and pink strands 
represent β-sheet C. 
 
1.9.4.1 The Breach Region 
This domain consists of the top of strand 3 of β-sheet A (s3A), s5A, s2B, s3B and s4B and is 
located at the top of the A-sheet [101]. It is the region where the RCL initially inserts into the 
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serpin during the inhibitory process. Conservation of the residues within this region provides 
an indication of its importance in serpin structure [124] and mutations at several of these 
positions cause hyperstability [125]. Point mutations that perturb the conformation of the A-
sheet render it prone to aberrant loop insertions and are the most common cause of 
serinopathies. For example, in the Z-mutant of α1-AT, replacement of the negatively charged 
Glu342 by a positively charged Lys residue disrupts the salt bridge with Lys290. This salt 
bridge is normally responsible for the narrow opening of the top of the cleft of the A-sheet. 
Replacement of the Glu by the Lys results in a charge repulsion between the two Lys residues 
which instigates widening of the breach region, leaving it susceptible to insertion of an RCL 
from a second molecule. The result is polymerisation and can cause diseases such as liver 
cirrhosis and emphysema [126]. Another example is a thermolabile variant of antithrombin in 
which the highly conserved Phe229, a residue deeply buried in the breach cluster, is replaced 
by a Leu residue [127]. As the side chain of Leu is more branched than that of Phe, a small 
internal cavity is formed that enforces a steric clash between residues neighbouring the hinge 
region of the RCL. Such deviations initiate conformational changes that destabilise the 
variant, which then has a tendency for spontaneous polymerisation at increased body 
temperature [127]. As the breach region is at the position of RCL insertion, it is thought to be 
responsible for the regulation of insertion of the polypeptide loop into the A-sheet. Thus, it 
may determine whether the serpin acts as an inhibitor or a substrate [122]. 
 
1.9.4.2 The Shutter Region 
The shutter domain consists of part of s6B, the N-terminal part of helix B and the central parts 
of s5A and s3A. The fragments are located at the core of the serpin and interconnected by a 
cluster of hydrogen bonds. A shutter-like structure results and is responsible for controlling 
the opening of the A-sheet [101], so that aberrant loop insertion into the lower part of the cleft 
is prevented. Protease inhibition is accompanied by the formation of a novel set of hydrogen 
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bonds along the upper half of the cleft, breaking the hydrogen bridge between s3A and s5A. 
This instigates a conformational transition in the entire shutter region, including the 
translocation of helices B and F, which in turn forms an opening for the incoming loop 
(Figures 1.13 and 1.14). In native α1-AT, the shutter region consists of a triad of polar 
residues, Asn186, His334 and Ser56. In cleaved α1-AT, there is a shift in the side chain of 
Asn186 and it forms a new hydrogen bond to Ser56 [101]. The shutter domain, like the 
breach, is vital for controlling the conformational change in serpin structure; therefore 85% of 
residues in the shutter domain are conserved in known serpin structures. The naturally 
occurring α1-AT Siiyama (Ser53Phe) and α1-AT Mmalton (Phe52 deletion) mutants are in this 
region and lead to polymerisation and disease [128, 129]. 
 
1.9.4.3 The Hinge Domains 
The Proximal Hinge 
The proximal hinge domain comprises of residues P8-P15 on the N-terminal of the RCL. 
Studying variants with mutations in this region provided evidence for the necessity of the 
mobility of the RCL for inhibitory activity [123, 130]. Antithrombin variants, Cambridge-I 
(mutation of P10 Ala to Pro) [131], Cambridge-II (mutation of P14 Ala to Ser) [130] and 
Hamilton (mutation of P12 Ala to Thr) [132] have been characterised. Despite having a 
normal association rate with proteases, the variant inhibitor-protease complexes are less stable 
than those of their WT counterparts [133]. It is the locking of the serpin and protease, rather 
than their docking that appears to be affected by mutations in the proximal hinge region [134]. 
The majority of variants remain susceptible to cleavage at P1-P1’ and become protease 
substrate, the outcome of which is loss of inhibitory activity [123]. Great variability has been 
seen in the characteristics of individual examples of variants with mutations in the proximal 
hinge. The consequence of a mutation at the P14 position (Val432Glu) in C1-inhibitor is 
conversion from an inhibitor to a substrate, which results in hereditary angioneurotic oedema 
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[135]. By comparison, a mutation at P10 from alanine to threonine results in a complete loss 
of inhibitory activity, causing the formation of polymers in the plasma [136]. Furthermore, 
mutation of the same residue in antithrombin causes only a minor loss of inhibitory activity 
[130]. Residues P10, P12 and P14 are proposed to be the most critical positions within the 
proximal hinge domain as mutation at other residues do not appear to affect the inhibitory 
characteristics of the serpin [137]. Moreover, the mutation of residues P10, P12 and P14 to 
threonine in leukocyte elastase inhibitor led to a loss of inhibitory activity [138]. 
 
The Distal Hinge Domain 
The distal hinge region is formed by s1C and the turn connecting it to s4B [123]. The 
transition from the native to an alternative conformation is accompanied by a rearrangement 
of the distal hinge [139, 140]. This is supported by studies of antithrombin, which revealed 
extensive movement in this domain as a consequence of transition from the active to latent 
conformation [123] (Figure 1.15). 
 
a    b
 
[123]  
Figure 1.15. The native and latent forms of antithrombin. The distal hinge region (pink) adopts a 
different conformation, depending upon the conformation of the RCL. Such that, in active 
antithrombin (a), strand s1C is ordered, whereas in the latent form of the protein (b) this strand is 
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disordered. s1C is pink, the remainder of the C-sheet is light blue, sheet B is dark blue and the C-
terminus is coloured green. The black spheres represent mutations that result in loss of inhibitory 
activity of the serpin. The yellow spheres are Cα atoms of cysteine residues that form a disulphide 
bond between the gate region and the C-terminus [123]. 
 
A loop, also described as a ‘gate’, formed by s3C and s4C and the turn connecting these 
strands has been shown to hinder the movement of s1C [139]. In PAI-1, this ‘gate’ is flexible, 
permitting spontaneous conversion to the latent form, however, in antithrombin; it is 
constrained by a disulphide bridge (Cys 247-Cys 430). Mutation of Cys 430 results in a loss 
of inhibitory activity of antithrombin. Thus, the hinge is considered as being the s3C and s4C 
gate and the C-terminal sequence that fixes its position, as well as the mobile hinge formed by 
s1C and the turn connecting it to s4B [123]. Stability of the distal hinge domain plays an 
essential role in protease inhibition as variants of antithrombin, C1-inhibitor and α1-AT with 
mutations at s1C, the turn connecting it to s4B and the C-terminal sequence are dysfunctional 
[141]. 
 
Consequently, there appears to be a role for each of the domains. The breach is the initial 
point of insertion of the RCL and it consists of many conserved residues, mutations of which 
result in hyperstability of the molecule [125]. Therefore, the breach domain is thought of as 
being the first line of defence against unwanted conformational changes. The transition from 
the stressed to the relaxed state is fundamental for protease inhibition, and the breach, 
together with the shutter domain, is responsible for regulating the associated conformational 
changes [101]. The shutter region is known to control the rest of the serpin molecule as it 
contains critical hinge regions between the major fragments. Hence, it is essential that this 
domain is accurately packed [101]. The proximal and distal hinge domains are associated with 
conformational transitions and are once again vital for inhibitory function as mutations in this 
region lead to a defect in inhibitory activity [123, 141]. 
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1.9.5 Serpin Function 
The highly flexible RCL is the central component for the activity of an inhibitory serpin [142] 
(Hsp47 however, is not thought to be inhibitory). It acts as a pseudosubstrate that is 
specifically recognised and cleaved by the serine proteases. The interaction of the flexible 
loop region with active site of the proteases allows serpins to form covalent complexes with 
their corresponding serine proteases. The release of the serpin from the complex requires 
cleavage of its polypeptide chain by the protease in the middle of the serpin loop region, 
degrading the serpin molecule. Following cleavage, the RCL inserts itself as a β strand into 
the A-sheet. The result is conversion of the A-sheet from a parallel, metastable conformation 
to an anti-parallel, hyperstable form [99]. This zipping of the flexible loop into a groove on 
the side of the serpin results in the translocation of the protease from one side of the molecule 
to the other, over a distance of 70 Ǻ. This pulls the active site of the protease out of shape, 
disrupting approximately 40% of the protease structure, ultimately resulting in removal of the 
conserved serine residue from the catalytic triad. The protease remains covalently trapped on 
the serpin as an acyl enzyme. Complete irreversible inhibition is the consequence of the loss 
of catalytic activity of the serine protease. This mechanism has led to serpins being referred to 
as ‘molecular mousetraps’ [99, 143]. 
 
The Serpin Mechanism of Action 
Serpins use an irreversible suicide mechanism to inhibit serine proteases (Figure 1.16) [143]. 
The kinetic trapping involves acylation of the serine hydroxyl at the active site of the 
protease, followed by deacylation and ultimately complete proteolysis of the serpin, leading to 
dramatic conformational transitions [144]. The branched pathway of inhibition is initiated by 
the formation of a noncovalent Michaelis-like docking complex (EI) by the protease 
interacting with residues flanking the reactive site P1-P1’ (scissile) bond [143]. Both the 
highly flexible nature and conformation of the RCL are retained upon binding of the loop to 
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the protease [144, 145]. The covalent bond is formed between the serine-195 at the active site 
of the protease and the P1 residue of the serpin [144, 146]. The serpin is then cleaved between 
the P1 and P1’ residues at the scissile bond and a covalent acyl-enzyme complex (EI#) is 
formed [146]. Following removal of the restraint, the RCL starts to insert into the A-sheet, 
transporting the bound protease with it. Translocation of the protease by 70 Ǻ following 
complete loop insertion distorts its active site resulting in removal of the P1 side chain from 
the S1 pocket. The precise length of the RCL insertion results in compression of the protease 
against the base of the serpin which instigates protease distortion and hence inactivation 
[121]. Due to the dramatic conformational change caused by insertion of the loop at strand 4 
in the A-sheet, the protease finds itself at the opposite end of the molecule [147]. This results 
in the formation a loop-inserted covalent complex (EI+) [121]. The dramatic conformational 
change was first observed by Loebermann and coworkers for α1-AT. They interpreted 
electron density maps and found residues adjacent to the cleaved peptide bond to be 
approximately 64 Ǻ apart [148]. The formation of the (EI+) complex begets a 37% structural 
loss in the protease [149]. Huntington and coworkers solved the crystal structure of the PI-2–
trypsin complex and found the structure of trypsin to be distorted by approximately 40% 
[121]. Distortion of the protease active site prevents deacylation and the protease in released 
from the complex, leaving cleaved, inactive serpin (I*) and free, active protease (E) [150]. 
Furthermore, as the trapping of the protease in kinetic, the serpin-protease complex eventually 
breaks down. The stability of the serpin-protease complex determines the rate of breakdown 
once the acyl-enzyme intermediate has formed. Thus, the half-lives of the covalent complexes 
vary from minutes to months [151]. 
 
The rates of RCL insertion and deacylation determine whether the serpin will act as an 
inhibitor or a substrate. If deacylation is faster than insertion the serpin will act as a substrate 
and so will dissociate from the protease once it has been cleaved. Conversely, if insertion of 
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the RCL is faster than the rate of deacylation, the serpin will act as an inhibitor and form a 
covalent complex with the protease [122]. Thus, the ratio of (EI+): (I*) + (E) depends upon 
the rate of hydrolysis (k3) in relation to loop insertion (k4) (Figure 1.14) [121]. 
 
 
[121] 
Figure 1.16. The branched pathway, suicide substrate inhibition mechanism of a serpin. A 
peptide in the exposed RCL of the serpin (I) is recognised by the protease (E) and an initial non-
covalent Michaelis complex (EI) is formed. Progression through the pathway involves conversion of 
the initial non-covalent complex into a covalent acyl enzyme intermediate (EI#). Cleavage of the 
scissile bond allows the insertion of the RCL into the A-sheet which involves concomitant protease 
translocation because of the ester linkage between the serpin and its cognate protease. This forms a 
covalently trapped serpin-protease complex (EI+). Dissociation of the serpin-protease pair yields 
cleaved, inactive serpin (I*) and active protease (E). Rate constants, k3 and k4 represent the rate of 
hydrolysis and insertion, respectively and determine the stoichiometry of inhibition. 
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1.9.6 Serpin conformations 
The ability to undergo dramatic conformational changes due to high flexibility enables serpins 
to adopt a variety of conformations (Figure 1.17) and perform their inhibitory functions. 
 
It will be seen in the results section that understanding these transitions in Hsp47 are 
important in understanding the activity of mutant Hsp47. In the past this part of Hsp47 
function has been ignored. 
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(b)    Cleaved state – hyperstable  
 Tm: 100 oC 
(a)     Native state – metastable  
 Tm: 40-70 oC 
(c)    Latent state – hyperstable  
 Tm: 70->100 oC 
 
Figure 1.17. Possible conformations of a serpin. (a) Model structure of native Hsp47. The native 
state is the biologically active conformation and one in which the serpin is least stable (melting 
between 40 and 70 oC). (b) Cleaved α1-AT structure. The cleaved state results from insertion of the 
RCL into the A-sheet following cleavage by the protease. This increases the stability of the serpin 
which has a melting point of approximately 100 oC. (c) Latent PAI-1 structure. The latent state results 
from insertion of the RCL into the A-sheet without cleavage. Insertion of the RCL enhances the 
stability of the latent conformation, which has a melting temperature between 70 and 100 oC. 
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1.9.6.1 The Native Conformation 
The native state has been defined as the biologically active conformation [120] or stressed 
serpin state. The transition from the native to the cleaved or latent (relaxed) forms is required 
for protease inhibition to occur. This change in transition is due to the metastability of the 
native serpin fold resulting in it possessing thermodynamic characteristics that allow the 
conversion from the native state, meaning that the active (native) form of the protein is not the 
most stable [21]. This contradicts a fundamental rule of folding, whereby the active form of 
the protein is the most energetically favourable [7]. As it consists of only 5 β-strands in the A-
sheet, it lacks the full complement of strands, reducing the structural stability of this 
conformation. This state shows characteristics of a mesostable protein, which is denatured 
between temperatures of 40 and 70 oC [152]. 
 
1.9.6.2 The Cleaved Conformation 
The cleaved conformation is an inactive state. Adoption of the cleaved conformation involves 
insertion of the RCL (residues N-terminal to the cleaved bond) as strand 4 into the A-sheet, 
resulting in a 6-stranded, hyperstable A-sheet. This requires movement of the first three 
strands of the A-sheet and an F helix [120, 153]. Bruch and coworkers used far UV-CD 
(circular dichroism) and near UV-CD to demonstrate that the rearrangement is associated with 
a change in secondary structure [111]. Cleavage of the RCL drives the transition from the 
stressed state to the relaxed state [101, 102]. The cleaved form can arise via two methods; the 
first is by breakdown of the serpin-protease complex following trapping of the cognate 
protease and the second is following non-specific cleavage by non-cognate proteases. The 
ability to develop into the cleaved state is a characteristic feature of inhibitory but not non-
inhibitory serpins [154, 155]. The non-inhibitory serpin ovalbumin, for example, does not 
show a conformational transition or an increase in stability upon cleavage [111]. Cleavage of 
the RCL in inhibitory serpins is irreversible and results in a loss of inhibitory function but 
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greatly increases the conformational stability of the serpin in this state [156]. The cleaved 
conformation is hyperthermophilic as it does not denature at temperatures below 100 oC as 
well as being more resistant to chemical denaturation with protein unfolding requiring more 
than 6 M guanidinium HCl [152]. 
 
1.9.6.3 The Latent Conformation 
As with the cleaved conformation, this conformation is inactive. Formation of the uncleaved, 
latent state involves conversion of the high energy, stressed state into an alternative lower 
energy, relaxed state, whereby the intact RCL is inserted into the A-sheet without cleavage 
[120]. In contrast to the cleaved conformation, in addition to the movement of the strands in 
the A-sheet and an α-helix, formation of the latent conformation requires the movement of 
s1C. The latent state was first discovered for plasminogen activator inhibtor-1 (PAI-1) which 
takes up this conformation spontaneously [139]. The intact RCL of PAI-1 inserts itself into 
the strand 4 position of the A-sheet but only up to residue P3, however. Complete RCL 
insertion requires movement of s1C away from the rest of β-sheet C, resulting in this β-sheet 
consisting of only 3 strands [157]. Antithrombin is another example of a serpin which 
spontaneously adopts the latent conformation [158]. The conformational stability of this state 
is intermediate between that of the native and cleaved conformations. It is more stable than 
the native but less stable than the cleaved conformer. Latent PAI-1, for example, denatures at 
temperatures of approximately 70 oC (although it can be as high as 90 oC) whereas the native 
form has a melting temperature of approximately 50 oC and the cleaved conformer denatures 
at temperatures in excess of 100 oC [152]. The spontaneity of adoption of the latent 
conformation by PAI-1 is thought to be part of a control mechanism by the serpin so that it 
circulates in the inactive form, only becoming active upon interaction with vitronectin [159]. 
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Studies on the latent form of antithrombin (L-antithrombin) have implied a two-step process; 
a rapid initial transition whereby the RCL in partially inserted into the A-sheet and s1C is 
displaced from β-sheet C, and a slower second phase involving complete loop insertion [160]. 
This proposal was due to the effect of citrate on latent state formation. At 60 oC, in the 
absence of citrate, antithrombin (like other serpins) rapidly polymerises. The presence of 
citrate however, inhibits polymer formation, resulting in the slow formation of L-
antithrombin. As the formation of L-antithrombin was slow and increased with time, it 
implied that preventing polymer formation allowed the time required for the slow conversion 
to the latent state.                                                                        
  
The prevention of the spontaneous conversion from the native to latent conformation is 
thought possible by two means. Firstly, the interactions of the A-sheet may prevent loop 
insertion and secondly, the interactions in the C sheet may prevent the insertion of s1C into 
the A-sheet [161]. Extension of the RCL by a flexible linker, (Gly-Gly-Ser)n, resulted in loop 
insertion into the central β-sheet, thereby demonstrating that interactions of the A-sheet alone 
do not provide enough strength to prevent insertion of the reactive centre loop [162]. It was 
therefore proposed that interactions of the B/C barrel are critical for the prevention of loop 
insertion into the A-sheet. A number of mutations were made to destabilise native interactions 
of α1-AT. Substitutions such as V364A and F366A of s1C promoted conversion into the 
stable, latent conformation. It is therefore likely that conversion of the native into the latent 
state is obstructed by holding s1C in the barrel [161]. 
 
1.9.6.4 The Polymers 
Serpin polymerisation occurs when the RCL of one serpin interacts with a β-sheet of another 
serpin. The initial insertion of the loop into the β-sheet of a second serpin molecule results in 
dimerisation. Repetition of this results in oligomerisation into polymer conformations [87]. 
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Most of the polymers have greater conformational stability compared to that of the native 
form [162]. Polymer types identified thus far include the s4A linked polymer (Figure 1.18a), 
the C-sheet linked polymer (Figure 1.18b), the s7A linked polymer (Figure 1.18c) and the 
cleaved RCL linked polymer as well as polymers resulting from inter- and intramolecular 
disulphide bonds [163-168]. The resulting polymers possess pathogenicity and are associated 
with a range of conformational diseases. In such situations, mutations in the serpin variant 
cause a defect in movement of the RCL and the opening of the A-sheet. The result is polymer 
formation. Mutants of α1-AT, neuroserpin and α1-antichymotrypsin polymerise and have been 
linked to diseases such as liver cirrhosis, emphysema and dementia [87, 123, 169].  
s4A linkage C-Sheet linkage s7A linkage 
a                   b             c
 
        [170] 
Figure 1.18. Possible polymer conformations of the serpin superfamily. (a) A s4A linkage 
resulting from the insertion of the RCL of one serpin into the strand 4 position of the A-sheet of a 
second serpin. (b) The C sheet linkage is formed when the RCL of one serpin molecule forms a β-
strand in the C-sheet of a second. (c) The s7A linkage, which results from insertion of the loop into the 
strand 7 position of the A-sheet of an adjacent serpin. 
 
The s4A Linked Polymer 
As suggested by the name, these polymers arise following self-association of the RCL of a 
serpin into the strand 4 position of a second serpin molecule (Figure 1.18a) [126]. The 
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accumulation of the disease causing Z-variant of α1-AT (Glu342Lys) in hepatocytes was 
studied by Lomas and coworkers. They discovered that the heating of monomeric α1-AT 
resulted in the formation of non-covalently linked polymers. The resulting polymers, when 
visualised by electron microscopy had a ‘beads-on-a-string’ appearance [126, 171] (Figure 
1.19). Consequently, it was believed that this insertion is the cause of accumulation of Z 
variant α1-AT in the liver [126]. Other rare mutations such as Mmalton (F52 deleted) and Siiyama 
(S53F), have been described to follow a similar pattern of events that ultimately lead to 
inclusions in the liver [172]. The affected residues were proposed to be vital for the opening 
of the A-sheet, following cleavage of the RCL [173]. Lomas and coworkers therefore 
hypothesised that the above variants would also undergo spontaneous loop-sheet 
polymerisation [126]. Electron microscopy confirmed the presence of polymers and 
moreover, these polymers had the distinct ‘beads-on-a-string’ morphology with occasional 
self-terminating circular necklaces [174]. Furthermore, Sivasothy and coworkers have used 
Fluorescent Resonance Energy Transfer (FRET) to demonstrate the distances between 
monomeric units in polymeric α1-AT and confirmed that RCL-s4A linkages were responsible 
for polymer formation [175]. The s4A linkage is the polymeric conformation that is most 
important in serpin related disorders. The stability of this oligomer is similar to that of the 
latent and cleaved conformers [152]. 
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  [171] 
Figure 1.19. Electron micrograph of the antitrypsin Siiyama variant. The appearance was identical 
to that of Z antitrypsin with the presence of circlets or ‘beads-on-a-string’ morphology [171]. 
 
Recently, Huntington and coworkers investigated the molecular basis of serpin 
polymerisation by protein crystallography [174]. They used the previously reported self-
terminating antithrombin dimer as a prototype [176] and observed an extensive domain swap 
that involved the insertion of strands 4 and 5 of the central β-sheet of one monomer into β-
sheet A of another monomer (Figure 1.20). A similar domain-swapping observation for the 
prototypical serpin α1-AT implied that this intermolecular linkage was not only confined to 
antithrombin but could be applied to serpins in general [174].  
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 Figure 1.20. A model of the linear serpin dimer. RCL is coloured yellow. Balls indicate AspN 
cleavage sites found in antithrombin (magenta) and α1-AT (cyan) polymers. The antithrombin dimer 
was linearised by breaking of intermolecular contacts in order to produce a dimer capable of further 
polymerisation. Cleavage by the metalloprotease AspN allowed the unravelling of helix I that was 
required to create a flexible between folded regions. The yellow ball represents the Leu303Cys 
substitution used to further investigate the effect of unravelling helix I on polymerisation of α1-AT 
[174]. 
 
The C-Sheet Linked Polymer 
C-sheet polymerisation involves a ‘head-to head’ association of two serpins whereby the RCL 
of one forms a β-strand in the C-sheet of the second [152]. The RCL of one protein inserts as 
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strand 1 into β-sheet C of the second and requires over-insertion of the loop with s1C 
subsequently peeling away from the C-sheet [177]. C-sheet polymers have been observed for 
AT where the native and latent states of the protein resulted in dimer formation [158]. 
Furthermore, it is believed that in addition to forming A-sheet polymers, α1-AT can also form 
C-sheet polymers, depending upon the buffer conditions [164]. The weak interactions in this 
polymer type, namely hydrogen bonds between the 2 β-strands, dissociation of C-sheet dimers 
can take place using chemical denaturants [152]. This distinguishes between the s4A and C-
sheet polymers, which are stable to high temperatures and concentrations of denaturants.  
 
 
The s7A Linked Polymer 
Formation of s7A polymers involves insertion of the RCL of one serpin at the end of the A-
sheet, as strand 7 of another (Figure 1.18c). This conformation was first observed for native 
PAI-1 when its crystals revealed polymer contacts in the structure [178]. Acid-induced 
polymerisation studies of PAI-1 indicate that these polymers may be present in solution [166]. 
As of yet, PAI-1 is the only serpin known to adopt this conformation. 
 
The Cleaved Polymer 
Formation of the RCL-cleaved serpin polymer involves cleavage of the serpin at the P7-P6 
position of the RCL, which produces a free peptide end that inserts into the A-sheet at the 
strand 4 position [165] (Figure 1.21) . Self-insertion of residues P14-P7 of the cleaved RCL 
precedes insertion of P6-P3 into another molecule that is partially occupied by P14-P7 of its 
own RCL. Cleaved polymers were first identified by Mast and coworkers using electron 
microscopy and were thought to have a ‘beads-on-a-string’ type appearance [126, 179]. As 
with the cleaved monomeric conformation, the cleaved polymer is hyperstable, thereby 
having similar thermal denaturation characteristics [179]. Differentiation of the cleaved 
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polymer from the other polymers can be done using SDS-PAGE where it is the only one that 
migrates to the same position as the cleaved, monomeric form of the protein [152]. Analysis 
of native PAGE and electron microscopy results for cleaved polymers revealed that they were 
structurally similar to serpin polymers associated with disease [165].  
 
 
[165] 
Figure 1.21. A model of the polymer conformation of cleaved α1-AT. The polymer is formed by the 
repeated insertion on residues P6-P3 of the RCL inserting into the A-sheet of a neighbouring α1-AT 
molecule. 
 
 
1.10 The Location of Key Histidines in Hsp47 
As described previously (section 1.8), the reversible pH dependent conformational changes in 
Hsp47 are driven and regulated by histidine residues in the serpin structure [87, 97, 180]. It is 
proposed that a change in the charge of at least one of these histidines is responsible for 
triggering the conformational change as the reduced binding affinity of Hsp47 for its substrate 
occurs between pH 6.0 and 7.0, close to the pKa of histidine [97]. Dafforn and coworkers used 
the highly conserved serpin scaffold to construct a molecular model of mouse Hsp47 [87]. 
Upon examination, three histidine clusters were identified (Figure 1.22), each one being 
located in a serpin domain known to be involved in the transition from the metastable, 
stressed state to the relaxed state [120]. The breach cluster comprises of H197 and H198 
 57
(s3A-s4C) and H220 (s3C) and is found below the hinge region at the top of the A-sheet. As 
mentioned earlier, histidines 197 and 198 were probed by El-Thaher and coworkers [97], 
however they focused on the conformational transition of Hsp47 in relation to collagen 
binding and did not study the effect of the mutations on serpin conformation. Furthermore, the 
variants in this study differ from those made by El-Thaher and coworkers (explained in 
sections 1.9.8 and 1.9.9). Residues H255 and H256 (s3B-hG) form the gate cluster and lie 
adjacent to the gate region towards the end of the C-sheet. Finally, the shutter cluster consists 
of H302 and H335 and is found at the base of the A-sheet, neighbouring the shutter region 
[181]. The positioning of the histidine clusters in regions concerned with the conformational 
dynamics of serpins implies that they have an involvement in the pH-dependent 
conformational switch of Hsp47 [87]. With the exception of H255, which is conventionally 
substituted with tyrosine or asparagine, each of these histidines is conserved within the Hsp47 
family. Only H335, however, is also conserved in the serpin superfamily. These histidines are 
thus likely to be involved in maintaining the serpin fold [181]. 
 
(a) 
H335
H297
H368 
H302
H255 & H256
H220
H191
H197 & H198
H244
H90
H135
H140
H197 & H198 H220
H368
H302
H297
H335 
H140
H90
H135
H244
H191 H255 & H256
(b) 
 
Figure 1.22. Models illustrating the positions of the histidine residues in Hsp47. Image (b) is a 
180o rotation of image (a). 
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Observed Conformations of Hsp47 
Monomeric Hsp47 is thought to form trimers by the insertion of the RCL of one molecule as 
strand 4 in the A-sheet. Dafforn and coworkers used extensive biophysical analyses to model 
the structure of the serpin polymer [87]. They proposed a ring structure (Figure 1.23), such as 
that seen in the Siiyama mutant of α1-AT [171]. It is thought that such ring structures are 
sterically constrained, yielding only a few possible configurations of trimeric Hsp47. A 
proposed model suggests that the A-sheet of each Hsp47 monomer be pointing towards the 
centre of the ring and the helices that pack behind the A-sheet be exposed to solvent [87]. 
This includes the proposed collagen binding cleft between helices hA and hG/hH [182], 
leaving it plausible that trimeric Hsp47 has three binding sites for three collagen peptides 
[87]. 
 
[87] 
Figure 1.23. Model of a closed trimer of Hsp47. Trimer formation is a result of individual 
monomers (coloured red, green and yellow) being linked by insertion of the RCL of one monomer into 
the A-sheet of another, resulting in a 6-stranded A-sheet. The proposed binding cleft (between helices 
hA and hG/hH) contains a (PPG)10 peptide (shown in white). 
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1.11 Objectives 
To date, studies of the substrate specific chaperone, Hsp47, have focused mainly on its 
specificity for collagen and the role of the glycoprotein in fibrotic disease. As a consequence, 
the function and mechanism of action of the protein are not well understood. This may be 
partly due to low expression levels of the protein and the tendency of the protein to aggregate 
following purification thereby making the purification procedure rather difficult. In order to 
overcome these limitations, the Hsp47 gene needs to be cloned into a stable plasmid that 
would yield a clone which produced consistent expression of the protein. Subsequently, a 
purification procedure comprising of a minimal number of steps would be required to obtain 
good yields of pure, soluble Hsp47. In addition to this, attempting to purify Hsp47 from 
different organisms could be a valuable strategy to increase the yields of pure Hsp47 for 
biophysical and conformational studies. 
 
Although it has been shown that Hsp47, like the other members of its superfamily is 
conformationally mobile, regions of particular importance are yet to be discovered. 
Identification of histidine residues involved in the trans-conformational changes of Hsp47 is 
required to better understand the pH-dependent conformational switch mechanism associated 
with binding and release of collagen. A closer look at the locations of the histidines and 
comparison to mobile domains of other serpins should allow key histidines to be recognised. 
While in some ways Hsp47 possesses properties that are characteristic of a serpin, in other 
ways it is an unusual member of the inhibitory superfamily. For example, albeit that a number 
of serpins form oligomers, the existence of only two distinct forms (in this case a monomer 
and a trimer) of a serpin is not the norm. Antithrombin is the only other serpin that is reported 
to form a discrete set of oligomers [158, 183]. It would therefore be interesting to investigate 
the possibility of the existence of other serpin conformations for Hsp47. 
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1.12 Aims 
1.12.1 Cloning and Purification of Mus musculus, Xenopus laevis and Danio rerio Hsp47 
(mHsp47, xHsp47 and zHsp47, respectively) 
The genes for wild type (WT) Mus musculus (mouse), Xenopus laevis (frog) and Danio rerio 
(zebra fish) Hsp47 were cloned into different vectors in order to discover a stable construct 
that produced large quantities of protein for structural characterisation studies. The difference 
in the protein sequence of each of the above organisms may be advantageous as it could affect 
protein properties, such as solubility and stability. 
 
1.12.2 Cloning and Purification of mHsp47 Mutants 
Mutants of mHsp47 were designed using site-directed mutagenesis in an attempt to identify 
the any key histidines. As with WT Hsp47, Hsp47 variants were cloned into a stable plasmid 
and purified from the E. coli expression system in order to obtain good yields of pure, soluble 
protein. 
 
1.12.3 Biophysical Analyses of mHsp47 Mutants 
Circular dichroism (CD) and analytical ultracentrifugation (AUC) were used to determine the 
secondary structure composition and oligomerisation state of each of the mutants. Any 
differences or similarities between the mutants were established and results previously 
obtained for WT mHsp47 were used for comparison. 
 
1.12.4 Probing the pH-Dependent Conformational Change 
pH titrations were carried out in order to distinguish the pH at which conformational 
transition of the serpin occurs. These involved minute additions of phosphoric acid to reduce 
the pH from 8.0 to 4.0, whilst constantly measuring the change in secondary structure. The 
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point of inflexion acquired for each mutant was compared and the pH at which Hsp47 
dissociated from collagen was determined in each case. 
 
1.12.5 Effect of Mutants on Collagen Fibrillisation 
A collagen molecule undergoes many conformational changes prior to its materialization as 
the major component of connective tissues. The assembly of three procollagen chains with all 
peptide bonds being in the trans conformation allows the formation of a triple helical collagen 
molecule in the ER. Along with the many other suggestions for roles of Hsp47 in collagen 
biosynthesis, it has been proposed that Hsp47 may prevent the aggregation of collagen in the 
ER [96]. To investigate this further, the effect, if any on collagen fibre formation was 
measured by reducing the pH and monitoring the change in absorbance of the solution. The 
results for WT mHsp47 were compared to that of each of the mutants so as to investigate the 
effect of the mutation(s). 
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CHAPTER 2: Materials and Methods 
 
2.1 Materials 
Molecular Biology reagents/Plasmid expression vectors 
Taq DNA Polymerase, all restriction endonulceases and T4 DNA ligase was purchased from 
New England Biolabs (NEB) (Hitchin, UK). dNTPs used for PCR were purchased from 
Bioline (London, UK). All primers were custom synthesised by Alta-Biosciences (University 
of Birmingham, UK). The sequence of each of the primers is shown in the Appendices 
(Chapter 9, Appendix A). The vectors used in this study were pET101/D-TOPO® (Figure 
2.1), pET102/D-TOPO® (Figure 2.2), pET-32 Xa/LIC (Figure 2.3), PTYB12 (Figure 2.4) and 
pCR®T7/NT-TOPO® (Figure 2.5). The TOPO® vectors were purchased from Invitrogen 
(Paisley, UK), pET-32 Xa/LIC from Novagen (Nottingham, UK) and pTYB12 from NEB. 
Molecular biology ‘kits’ for the purification of PCR amplified and restriction endonuclease 
digested cDNA were MinEluteTM PCR Purification Kit and QiaQuick® PCR purification kits 
from Qiagen (Crawley, UK). Extraction of DNA from agarose gel slices used the QIAquick® 
Gel Extraction Kit (Qiagen). QIAprep® Spin Miniprep Kits, also from Qiagen, were used for 
isolation and purification of plasmid DNA from bacterial suspensions. Agarose, DNA loading 
buffer and Hyperladder IV were purchased from Bioline (London, UK). 
 
Protein Purification reagents 
Electrocompetent Top10 Cells were purchased from Sigma-Aldrich (Dorset, UK) and BL21 
Star DE3 Chemically Competent Cells were purchased from Invitrogen. Liquid broth 
contained peptone and yeast extract both of which were purchased from Merck (Feltham, UK) 
and sodium chloride from Fischer Scientific (Leicestershire, UK). Agar was from Oxoid 
(Basingstoke, UK). Antibiotics used were ampicillin and chloramphenicol and these were 
purchased from Sigma. IPTG was from Bioline (London, UK). All reagents for SDS-PAGE 
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gels were purchased from Sigma-Aldrich as were DNase, RNase and lysozyme. SDS protein 
molecular weight marker was from NEB. Western blotting reagents included Anti-Hsp47 
Mouse Monoclonal antibody from Stressgen Bioreagents (Cambridge, UK), Anti-mouse Ig, 
horseradish peroxidase linked whole antibody (from sheep) GPR purchased from GE 
Healthcare (Buckinghamshire, UK) and ECL western blotting reagents from Amersham 
(Buckinghamshire, UK). The Impact Expression system and chitin-affinity beads were 
purchased from NEB whilst Ni-NTA was from Qiagen. Lysis buffers contained imidazole, 
triton, β-mercaptoethanol from Sigma-Aldrich and Tris-HCl from Fischer Scientific. 
Glutathione, HEPES and DTT were purchased from Sigma, NaH2PO4 from BDH Laboratory 
Supplies (Poole, UK), urea from Fischer Scientific and polyethylene glycol 6,000 from Fluka 
(Buchs, Switzerland). Silver staining used thiosulphate and silver nitrate from Sigma, 
formaldehyde and sodium carbonate from BDH Laboratory Supplies and acetic acid from 
Fischer Scientific. Cleavage of fusion tags was attempted with thrombin, enterokinase and 
Factor Xa, all of which were purchased from Invitrogen. 
 
Protein Characterisation reagents 
Gel filtration used a Superdex HiLoad 16/60 column from GE Healthcare. Molecular weight 
markers; blue dextran, ferritin, immunoglobulin G, bovine serum albumin, ovalbumin, 
myoglobin, ribonuclease A and Vitamin B12 were acquired from Sigma-Aldrich. Phosphoric 
acid was purchased from Fisons (Surrey, UK). Sephadex resin was from Sigma-Aldrich and 
the calf Achilles tendons were from a local butcher (Kenilworth, UK). 
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2.2 Methods 
The Hsp47 gene from Xenopus laevis (frog), Danio rerio (zebrafish) and Mus musculus 
(mouse) was amplified using PCR for cloning into vectors with different characteristics in 
order to obtain pure, soluble protein. Vectors used were pET101/D-TOPO® (Figure 2.1), 
pET102/D-TOPO® (Figure 2.2), pET-32 Xa/LIC (Figure 2.3), PTYB12 (Figure 2.4) and 
pCR®T7/NT-TOPO® (Figure 2.5). A summary of the vectors and important features is shown 
in Table 2.1. 
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ctors used. Table 2.1. Summary of ve
Vector Antibiotic(s) Promoter N-terminal tag C-terminal tag Cleavage 
pET101/D-TOPO® Ampicillin T7   6xHis   
pET102/D-TOPO® Ampicillin T7 HP-thioredoxin 6xHis Enterokinase cleaves N-terminal tags. 
pET-32 Xa/LIC Ampicillin T7 HP-thioredoxin 
S.tag 
His tag 
6xHis Thrombin cleaves HP-thioredoxin & 
S.tag. 
Factor Xa cleaves all N-terminal tags. 
PTYB12 Ampicillin 
Tetracycline 
T7 Self-cleavable 
intein tag 
 Presence of DTT 
pCR®T7/NT-TOPO® Ampicillin 
Chloramphenicol 
(for expression in 
pLysS cells) 
T7 6xHis  Enterokinase 
 
 
 
 
 
 
 
 
  
T7 promoter:  bases 209-225 
T7 promoter priming site: bases 209-228 
lac operator (lacO): bases 228-252 
Ribosome binding site (RBS): bases 282-288, 292-296 
TOPO® cloning site (directional): bases 297-310 
V5 epitope: bases 333-374 
Polyhistidine (6xHis) region: bases 384-401 
T7 reverse priming site: bases 455-474 
T7 transcription termination region: bases 416-544 
bla promoter: bases 845-943 
Ampicillin (bla) resistance gene (ORF): bases 944-1804 
pBR322 origin: bases 1949-2622 
ROP ORF: bases 2990-3181 (complementary strand) 
lacI ORF: bases 4493-5584 (complementary strand) 
 
(www.invitrogen.com) 
Figure 2.1. Vector map of pET101/D-TOPO®. Transcription is initiated from a T7 promoter in cells 
that produce T7 RNA polymerase. A Lac operator controls this promoter; consequently protein 
expression is induced on the addition of IPTG. The vector encodes a C-terminal His tag for high 
affinity purification of the protein on Nickel-NTA resin.   
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 T7 promoter:  bases 209-225 
T7 promoter priming site: bases 209-228 
lac operator (lacO): bases 228-252 
Ribosome binding site (RBS): bases 282-288 
His-patch (HP) thioredoxin ORF: bases 298-627 
TrxFus forward priming site: bases 607-674 
Overhang: bases 675-678 
TOPO® recognition site 1: bases 670-674 
V5 epitope: bases 700-741 
Polyhistidine (6xHis) region: bases 751-768 
T7 reverse priming site: bases 822-841 
T7 transcription termination region: bases 783-911 
bla promoter: bases 1407-1505 
Ampicillin (bla) resistance gene (ORF): bases 1506-2366 
pBR322 origin: bases 2511-3184 
ROP ORF: bases 3552-3743 (complementary strand) 
lacI ORF: bases 5055-6146 (complementary strand) 
 
 
        (www.invitrogen.com) 
Figure 2.2. Vector map of pET102/D-TOPO®. Transcription is initiated from a T7 promoter in cells 
that produce T7 RNA polymerase. A Lac operator controls this promoter; consequently protein 
expression is induced on the addition of IPTG. The vector encodes a C-terminal His tag for high 
affinity purification of the protein on Nickel-NTA resin.   
 
This vector also comprises a His tag on the C-terminus. As well as this it also contains a His-
Patch thioredoxin (HP-thioredoxin), which is known to enhance the expression of 
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recombinant proteins, increase translational efficiency and solubility. It is termed ‘His-Patch 
thioredoxin’ because in this vector, the thioredoxin has been mutated so that it contains a 
metal binding domain. The mutation is of glutamate32 and glutamine64 to histidine residues. 
Folding of the His-Patch thioredoxin causes the two histidines to interact with a native 
histidine, forming a ‘patch,’ which has a high affinity for divalent ions (such as Ni2+). Thus 
HP-thioredoxin proteins can be purified using metal chelating resins such as Ni-NTA. The 
positioning of the ATG initiating sequence, a certain distance from the ribosome binding site 
(RBS), maximises translation in this vector. There is also an enterokinase (EK) cleavage site 
on this vector which when cleaved removes the N-terminal His tag from the recombinant 
fusion protein. Furthermore, the pET101/D-TOPO® and pET102/D-TOPO® vectors both 
possess an ampicillin resistant gene.  
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      (Adapted from www.emdbiosciences.com) 
lacI 
Ampicillin 
pBR322 ori 
f1 origin 
pET-32 Xa/LIC 
     5926 bp 
trxA 
MCS 
Bpu1102 (80) 
Xho I (158) 
Ava I (158) 
Eag I (166) 
Not I (166) 
Hind III 
(173) 
Sal I (179) 
Sac I (190) 
EcoRI (192) 
BamH I (198) 
EcoR V (206) 
Nco I (211) 
BseR I (235) 
PinA I (257) 
Kpn I (264) 
BgI II (267) 
Nsp V (294) 
T7 promoter: bases 790-806 
T7 transcription start: base 789 
HP-Thioredoxin tag coding sequence: bases 392-718 
His tag coding sequence: bases 353-370 
S tag coding sequence: bases 275-319 
Multiple cloning sites (MCS) (BseR I-Xho I): bases 158-225 
His tag coding sequence: bases 140-157 
T7 terminator: bases 26-72 
lacI coding sequence: bases 1197-2276 
pBR322 origin: base 3710 
Ampicillin (bla) resistance gene coding region: bases 4471-5328 
f1 origin: 5460-5915 
 
Figure 2.3. Vector map of pET-32 Xa/LIC. 
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The pET-32 Xa/LIC vector contains an N-terminal His tag and a HP-thioredoxin, separated 
by an S tag. The Xa/LIC vector possesses a Factor Xa (fXa) cleavage site, which when 
cleaved allows the removal of all the vector encoded sequences from the N-terminus of the 
purified protein. LIC (ligation-induced cloning) enables PCR products to be cloned without 
the need for digestion or ligation. LIC uses the 3’ to 5’ exonuclease activity of T4 DNA 
polymerase to create overhangs in the Xa/LIC vector. The building of 5’ extensions into 
primers can be used to create complementary overhangs in the PCR product. Purification of 
the PCR product removes dNTPs and the original template plasmid. T4 DNA polymerase, in 
the presence of dGTP can then be used to generate overhangs that are compatible to the 
vector. When mixed with the vector the sticky ends form a suitable vector-insert complex that 
can be transformed without dissociation. Ligases within the E. coli then ligate the insert into 
the vector. 
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 (Adapted from www.addgene.org) 
lacI 
Ampicillin 
f1 origin 
pBR322 ori 
MCS 
pTYB12 
7417 bp 
rop 
tet 
tet 
Pst I (6567) 
Sma I(6556) 
Xho I (6548) 
EcoR I (6542) 
Not I (6535) 
Sal I (6527) 
Nru I (6523) 
Spe I (6515) 
Nde I (6510) 
Sac II (6391) 
Pml I (6380) 
Stu I (6355) 
Bst BI (6326) 
Nco I (5956) 
Msc I (5955) 
Nhe  I (5792) 
T7 promoter: bases 4840-4858 
Ampicillin (bla) resistance gene coding region: bases 140-1000 
f1 origin: bases 1538-1232 
pBR322 ori: bases 1650-2269 
rop ORF: bases 2814-2623 
Tetracycline (tet) resistance gene coding region (312-612): bases 3010-3309 
lacI ORF: bases 4462-3371 
Tetracycline (tet) resistance gene coding region (636-888): bases 4554-4805 
lac operator (lacO): bases 
Ribosome binding site (RBS): bases 4903-4919 
T7 terminal primer: bases 6642-6624 
T7 transcription termination region: bases 6582-6710  
 
Figure 2.4. Vector map of pTYB12. 
 
pTYB vectors are fusion vectors in which the C- or N- terminal is fused to an intein tag. 
pTYB12 is an N-terminal fusion vector in which the intein tag is fused to the N-terminus. As 
with the TOPO® vectors, gene expression in pTYB vectors is controlled by the T7 promoter 
and lacI gene. This vector does not contain a thioredoxin or His tag, therefore Hsp47 would 
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be obtained without the need to cleave unwanted tags as the chitin binding domain (CBD) 
(described in section 2.2.10) and intein  tags are self cleaved and do not require a protease.  
 
 
 
         
T7 promoter:  bases 20-36 
T7 promoter priming site: bases 20-39 
Ribosome binding site (RBS): bases 87-90 
Polyhistidine (6xHis) region: bases 112-129 
XpressTM epitope: bases 169-192 
TOPO® Cloning site: bases 204-205 
T7 reverse priming site: bases 207-289 
T7 transcription termination region: bases 231-360 
f1 origin: bases 845-943 
Ampicillin resistance gene (ORF): bases 1017-1877 
pUC origin: bases 2022-2695 
         (www.invitrogen.com) 
Figure 2.5. Vector map of pCR®T7/NT-TOPO®. Transcription is initiated by the T7 promoter which 
is controlled by the lac operator, thus protein expression is induced by IPTG. The vector also encodes 
a 6xHis tag, which allows affinity purification using Nickel-NTA resin. 
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2.2.1 PCR 
Primers (described in Chapter 11, Appendix A) were used to perform a PCR to amplify the 
required gene. A scale up (x 10) of the PCR procedure from ChampionTM pET Directional 
TOPO® Expression Instruction Manual was used. Hsp47 cDNA was used as the template. All 
components except Taq polymerase were mixed. The Taq polymerase was added at the end as 
this commences the reaction. Five repeats were done so that the unsuccessful PCR reactions 
could be discarded and successful ones used for further studies. The PCR cycle was: 
1. 95 oC for 5 minutes – this allowed separation of the strands 
2. 95 oC for 30 seconds 
3. x oC for 30 seconds – for annealing     25 cycles 
4. 75 oC for 2 minutes – for elongation to occur 
5. 75 oC for 10 minutes 
 
In Step 3, varying temperatures were used for optimisation of the annealing temperature. This 
is denoted by ‘x’ in the PCR cycle above. The time period for the annealing reaction was also 
varied depending on the primers and vector in the experiment. An annealing temperature of 
30 seconds was optimal for most PCRs that were performed.  
 
The PCR products were loaded onto 1% agarose gel (50 ml of 1 x TAE, 0.5 g agarose).  
Agarose Gel Electrophoresis 
50 x TAE buffer composition was as follows: 
Component and final 
concentration Amount added per litre 
2 M Tris base 242 g 
1 M acetate 57.1 ml of glacial acetic acid 
100 mM EDTA 200 ml of 0.5 M (pH 8.0) 
Water to make 1 litre 
 
Table 2.2. Composition of 50 x TAE buffer. 
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The gel contained 0.4 mg/ml ethidium bromide. Ethidium bromide is fluorescent when in 
DNA so bands on the gel (indicating presence of DNA) monitored the presence of successful 
PCR product. The gel was run for 40 min at 80 V. 5 μl of HyperLadder I was loaded 
alongside the samples, this is a molecular weight marker, which is particularly useful for 
quantifying and determining the size of the DNA.  
 
Hsp47 PCR products were purified using either a QIAquick© Gel Extraction Kit or 
QIAquick© PCR Purification kit. 
 
QIAquick© Gel Extraction Procedure 
A sterile scalpel was used to excise the DNA fragment from the agarose gel. Subsequently, 
the slice was weighed in a tube and 3 volumes of Buffer QG was added to 1 volume of gel 
(100 mg ~ 100 μl). The mixture was incubated at 50 oC until the gel slice had completely 
dissolved. The tube was vortexed every 2-3 minutes during incubation to help dissolve gel. 
Once the gel slice had completely dissolved, the colour of the mixture was checked and was 
yellow. A QIAquick spin column was placed in a provided 2 ml collection tube. To bind 
DNA, the sample was applied to the QIAquick column and centrifuged for 1 minute. The 
flow-through was discarded and the QIAquick column was placed back in the same collection 
tube. The column was washed by adding 0.75 ml of Buffer PE and centrifugation for 1 
minute. The flow-through was discarded and the QIAquick column centrifuged for an 
additional 1 minute at 13, 000 rotations per minute (rpm). The QIAquick column was placed 
into a clean 1.5 ml microcentrifuge tube. DNA was eluted by the addition of 50 μl Buffer EB 
(10 mM Tris-HCl, pH 8.5) to the centre of the QIAquick membrane followed by 
centrifugation for 1 minute. 
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QIAquick PCR Purification Procedure 
5 volumes of Buffer PB were added to 1 volume of the PCR sample and mixed. A QIAquick 
spin column was placed in a provided 2 ml collection tube. To bind DNA, the sample was 
applied to the QIAquick column and centrifuged for 30-60 seconds. The flow-through was 
discarded and the QIAquick column placed back into the same tube. To wash, 0.75 ml Buffer 
PE was added to the QIAquick column and centrifuged for 30-60 seconds. The flow-through 
was discarded and the QIAquick column placed back in the same tube. The column was 
centrifuged for an additional 1 minute. The QIAquick column was placed in a clean 1.5 ml 
microcentrifuge tube. To elute DNA, 50 μl Buffer EB (10 mM Tris-HCl, pH 8.5) were added 
to the center of the QIAquick membrane and the column centrifuged for 1 minute. 
 
2.2.2 Insertion of Genes into Vectors 
Cloning into pET101/D-TOPO® and pET102/D-TOPO® Vectors 
Cloning into the TOPO® vectors followed the Invitrogen ChampionTM pET Directional 
TOPO® Expression Kit Version G 2004 protocol. Directional TOPO® cloning enables cloning 
of blunt-ended PCR products in a 5’ to 3’ orientation directly into an expression vector using 
a five minute ligation reaction, eliminating the need for subcloning steps. Directional TOPO® 
cloning vectors contain a single-stranded GTGG overhang on the 5’ end and a blunt end on 
the 3’ end. The four-nucleotide overhang invades the double-stranded DNA of the PCR 
product and anneals to the CACC sequence placed in the 5’ primer. Subsequently, ligation of 
the PCR product in the correct orientation is done by Topoisomerase I (Figure 2.6 below). 
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CCC TT 
GGGAAGTGG 
P
TOPO 
TOPO 
P
AAGGG 
TT CCC 
3’ phosphate 
+  CACC 
GTGG PCR product 
Topoisomerase I recognition 
Directional TOPO® cloning vector Blunt-ended PCR product. 
(Designed with CACC at  
The 5’ end) 
5 minutes at room temperature 
CCC TT 
GGGAA GTGG 
 PCR product CACC AAGGG TT CCC 
TOPO 
TOPO 
GTGG 
Completion of ligation 
Topoisomerase I 
is released 
Extra GTGG is released 
 
Figure 2.6. The mechanism of Directional TOPO® Cloning. 
 
Cloning into the pET-32 Xa/LIC Vector 
This was done using the Novagen Xa/LIC Cloning Kits User Protocol TB184. Ligation 
independent cloning (LIC) allows directional cloning of PCR products without the 
requirement for restriction enzyme digestion or ligation reactions. The Xa/LIC vectors 
possess a Factor Xa cleavage site, which allows vector encoded sequences to be removed 
from the purified protein. As all the Xa/LIC vectors possess the same Xa/LIC cloning site, 
Xa/LIC treated target inserts can be annealed to Xa/LIC vectors in a 5-minute reaction. 
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LIC uses the 3’ to 5’ exonuclease activity of T4 DNA Polymerase to create specific single 
stranded overhangs in the Xa/LIC vectors. The building of appropriate 5’ extensions into 
primers creates PCR products with complementary overhangs. Purification of the PCR 
product to remove dNTPs and subsequent treatment with T4 DNA Polymerase in the presence 
of dGTP generates specific vector compatible overhangs. Cloning the LIC method is highly 
efficient as annealing produces only the desired product.  
Procedure 
Assembly of the components in Table 2.3 below into a sterile microcentrifuge tube and 
incubation on ice. 
 
20 -Final Volume 
4.6 -Sterile Water 
0.4 5000 U/mlT4 DNA polymerase 
1 100 mMDTT solution 
2 25 mMdGTP solution 
2 10 xT4 DNA polymerase buffer
10 20 nMPurified PCR product 
Volume (μl) Concentration Component  
 
 
 
 
 
 
 
Table 2.3. The reaction mix for treatment of the insert with T4 DNA Polymerase prior to 
ligation into pET-32 Xa/LIC. 
 
The reaction was started by addition of the enzyme and mixed with the pipette tip. The 
mixture was incubated at 22 oC for 30 minutes. The enzyme was inactivated by incubation at 
75 oC for 20 minutes. The prepared insert could now be annealed into the Xa/LIC vector. 
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Cloning into the pTYB12 Vector 
Cloning directly into pTYB12 
Following PCR, the amplified DNA insert along with the pTYB12 vector was digested with 
Bsm I and EcoR I restriction enzymes in order to produce compatible sticky ends for the 
insertion of the Hsp47 gene into the vector.  
 
Cloning into pTYB12 via the shuttle vector pET-32 Xa/LIC 
The successfully amplified Hsp47 gene was cloned firstly into the pET-32 Xa/LIC shuttle 
vector, following the same protocol as above. Subsequently, the insert was cut out of the 
Xa/LIC vector using restriction enzymes (EcoR I and Nde I) and cloned into pTYB12, which 
had previously been cleaved using the same restriction enzymes. This method allowed the 
sequences at either end of the insert to be known, ensuring ligation into the pTYB12 vector. 
Following the cutting of the Hsp47 insert from the pET-32 Xa/LIC vector, the DNA was run 
on a 2% agarose gel and purified using the Novagen Xa/LIC Cloning Kits User Protocol 
TB184. 
 
Cloning into pCR®T7/ NT-TOPO® 
Cloning of the mHsp47 gene into pCR®T7/NT-TOPO® was carried out by Dr. Taka and Dr. 
Olerenshaw at Imperial College London. mHsp47 cDNA was amplified by PCR using a 5’ 
primer with a Hind III restriction site and a 3’ primer with an Nde I restriction site, 
respectively. Subsequently, the Hsp47 gene was cloned into the pCR®T7/NT-TOPO® vector 
containing the equivalent restriction sites. Mutations were introduced using a QuickChange 
Site Directed Mutagenesis Kit (Stratagene). Each construct was sequenced to confirm that the 
correct mutation had been incorporated. Transformation of the plasmids into E. coli BL21 star 
(DE3) pLysS cells allowed expression of the protein. In addition to the advantages of BL21 
star (DE3) competent cells (described in section 2.2.5), the BL21 star (DE3) pLysS strain 
 79
produces T7 lysosyme to reduce basal level expression of the gene of interest, thereby 
preventing leaky protein expression. In addition to the ampicillin resistance conferred by 
BL21 star (DE3) cells, pLysS strains confer resistance to chloramphenicol (CamR). 
 
2.2.3 Ligation  
Ligation into the TOPO® Vectors 
Directional TOPO© cloning was used to ligate the PCR product into the appropriate TOPO® 
vectors. A 1:1 molar ratio of PCR Product: TOPO® vector was used in the ligation mix (Table 
2.4) as this was thought to give the highest cloning efficiency.  
 
Ligation Mix 
 
 
 
 
 
 
 
 
1.0 1.0 15-20 ng/μl TOPO Vector 
3.6 3.5 - Sterile Water 
1.0 1.0 1.2 M NaCl 
0.06 M MgCl2 
Salt Solution 
0.4 0.5 x PCR Product 
Volume for ligation 
of Xenopus laevis 
Hsp47 (μl) 
Volume for ligation of 
Danio rerio Hsp47 
(μl)
Concentration 
of Stock 
Ligation Mix 
Component 
Table 2.4. Components of ligation mixes for cloning into TOPO® Vectors. 
 
 
Ligation mixes were incubated at room temperature for 5 minutes after being mixed gently. 
They were then placed on ice. 
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Ligation into pET-32 Xa/LIC 
The LIC (ligation-independent cloning) system involves the treatment of the PCR product 
with T4 DNA Polymerase to produce compatible sticky ends for the ligation into the Xa/LIC 
cloning site (Figure 2.7).  
5’ G G T A T T G A G G G T C G C A T G…insert…T A A G G C T C T A A C T C T C C T C T 3’ 
start stop 
3’ C C A T A A C T C  C C A G C G T A C…insert.. A T  T C C G A G AT  T G AG A G GA GA 5’ 
sense 
anti-sense 
T4 DNA polymerase + dGTP 
sense 
anti-sense 
5’ G G T A T T G A G G G T C G C A T G…insert…T A A G G                                   3’ 
3’                                              G C G T A C…insert…A T T C C G A G AT  T G AG A G GA G A 5’ 
 
Xa/LIC vector
+ 
 C T  C T A A C TC T  C CT  C T 
Iefjief 
jhj 
jjh
Xa/LIC overhangs 
T C C  
  AG G C C A T A A C T C C C A 
bj
Figure 2.7. The mechanism of Xa/LIC cloning using T4 DNA polymerase. Amplification of the 
PCR insert with primers including the 5’ LIC extensions and subsequent treatment with T4 DNA 
Polymerase in the presence of dGTP produced overhangs that were compatible to those of the Xa/LIC 
vector.  
 
Following treatment of the insert with T4 DNA Polymerase (components described in section 
2.2.2 above), the vector and the Xa/LIC insert were annealed. 
 
Annealing the Vector and Xa/LIC Insert 
A 2:1 molar ratio of PCR Product: Xa/LIC vector (0.01 pmol/μl) was used in the ligation mix 
to anneal the T4 DNA polymerase treated insert to the pET-32 Xa/LIC vector.  
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The procedure was as follows: 
The following components were assembled in a sterile microcentrifuge tube: 
Component Concentration Volume (μl) 
Xa/LIC Vector 1 μg 1 
T4 DNA Polymerase treated Xa/LIC insert 0.02 pmol 2 
EDTA 25 mM 1 
TOTAL VOLUME - 4 
 
The mix was incubated at 22 oC for 5 minutes prior to the addition of 1 μl of EDTA (25 mM). 
The resulting mix was incubated at 22 oC for a further 5 minutes. 
 
 Ligation into pTYB12 
Ligation directly into pTYB12 
Before the PCR product could be inserted into the pTYB12 vector, both the insert and vector 
had to be digested with the same restriction enzymes in order to generate complimentary 
sticky ends for ligation. Digestion mixes (Table 2.5) had a final volume of 60 μl. 
 
Digestion Mix 
Component Stock Concentration Volume (μl) 
Hsp47 insert/pTYB12 vector 40 ng/μl 40 
EcoR I restriction enzyme 20, 000 units/ml 3 
Nde I restriction enzyme 20, 000 units/ml 3 
Buffer at pH 7.5 containing: 
Tris Acetate,   
Potassium Acetate,  
Magnesium Acetate, 
  Dithiothreitol 
 
20 mM 
50 mM 
10 mM   
1 mM 
 
 
6 
Sterile water - 8 
Table 2.5. Components of digestion mix for the production of complementary sticky ends. 
 
The digested inserts and vector were separated on a 1% agarose gel and purified using the 
QIAquick© Gel Extraction Kit. Subsequently, the insert and pTYB12 vector were ligated 
(mixes shown in Tables 2.6 and 2.7) using QuickTM and standard T4 ligase. 
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QuickTM Ligation 
50 ng of vector was mixed with a 3-fold molar excess of insert (Table 2.6). The final volume 
was made up to 10 µl with sterile water. Next, 10 µl of 2 x Quick Ligation Reaction Buffer 
was added and the reaction mixed. Subsequently 1 µl of Quick T4 DNA Ligase was added 
and the components mixed thoroughly. This was followed by brief centrifugation and 
incubation at room temperature for 5 minutes. The reaction was then chilled on ice and used 
to transform E. coli. 
Component Concentration Volume (μl) 
Hsp47 Insert 8 ng/μl 0.9 
pTYB12 vector 8 ng/μl 2 
Sterile water - 7.1 
FINAL VOLUME - 10 
Table 2.6. Quick ligation mix. The volume of insert and vector required was done by estimating their 
concentration following clean up.  
 
Overnight Ligation 
The components of the ligation mix (Table 2.7) were combined and the reaction was left at 16 
oC overnight. 
Component Concentration Volume (μl) 
Reaction Buffer (pH 8.0):
Tri-HCl 
MgCl2 
NAD 
Dithiothreitol 
BSA 
 
30 mM 
4 mM 
26 μM 
1 mM 
50 μg/ml 
 
 
0.5 
Ligase 10, 000 units/ml 0.2 
pTYB12 8 ng/μl 2 
Hsp47 Insert 8 ng/μl 0.3 
Sterile Water - 2 
FINAL VOLUME - 5 
Table 2.7. Overnight ligation mixes. 
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Ligation into pTYB12 via pET-32 Xa/LIC as a shuttle vector 
The Hsp47 insert was ligated first into the pET-32 Xa/LIC vector as described above. It was 
then cut out of the LIC vector using restriction enzymes, identical to those used for cutting 
pTYB12. This produced complementary sticky ends that would ligate easily. Ligation of the 
complementary insert and vector followed the overnight ligation procedure described above. 
 
2.2.4 Transformation of One Shot® Top10 Chemically Component E. coli 
Cells 
The ligation mixes were used to transform One Shot® Top10 Chemically Component E. coli 
cells. This makes the cells excellent hosts for the recombinant plasmids and allows the 
reproduction, characterisation, propagation and maintenance of the plasmid. The Top10 cells 
do not contain the T7 RNA polymerase so expression of the gene should not occur in the 
absence of the inducer. 
 
Transformation procedure 
3 μl of the TOPO® Cloning reaction from Performing the TOPO® Cloning Reaction were 
added to a vial of One Shot® TOP10 Chemically Competent E. coli cells and mixed gently by 
inversion. The mixture was incubated on ice for between 5 to 30 minutes. The cells were then 
heat-shocked for 30 seconds at 42 oC without shaking. The tubes were immediately 
transferred to ice. 250 μl of S.O.C. medium (0.5% Yeast extract, 2% Tryptone, 10 mM NaCl, 
2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM Glucose) were then added to the tubes. 
The tubes were capped tightly and shaken (200 rpm) in an incubator at 37 oC for an hour. On 
completion of the transformation, the sample was spread on liquid broth (LB) agar (10 g 
Tryptone, 5 g Yeast extract, 10 g NaCl and 15 g Agar in 1 liter de-ionised water) plates 
containing the appropriate antibiotic at the appropriate concentration (see table 2.8 below). 
The plates were incubated overnight at 37 oC.  
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          Vector     Antibiotic    Concentration (μg/ml) 
pET101/D-TOPO®    Ampicillin             100 
pET102/D-TOPO®    Ampicillin             100 
pET-32 Xa/LIC    Ampicillin             100 
   Ampicillin             100 pTYB12 
  Tetracycline              20 
   Ampicillin             100 pCR®T7/NT-TOPO® 
    Chloramphenicol              34 
Table 2.8. Table showing the different vectors used in this in this study and the corresponding 
antibiotic(s) and concentrations. 
 
Growth of 5 ml Cultures and Purification of Plasmid DNA 
5 ml cultures of LB medium containing the appropriate antibiotics were inoculated with 
selected colonies produced on the LB ampicillin plates by the cloning procedures described 
previously (Section 2.2.4). The cultures were left to grow overnight at 37 oC with shaking at 
200 rpm. The following day the cells were harvested by centrifugation at 13,000 rpm using a 
bench top centrifuge.  
 
Isolation of the plasmid involved following a QIAprep® Spin Miniprep Kit (described below). 
 
QIAprep® Spin Miniprep Kit  
Pelleted bacterial cells were resuspend in 250 μl Buffer P1 and transferred to a 
microcentrifuge tube. 250 μl Buffer P2 were added and the tube was gently inverted 4-6 
times. 350 μl Buffer N3 was added and the tube inverted immediately but gently 4-6 times. 
The mixture was centrifuged for 10 minutes at 13, 000 rpm in a table-top centrifuge. The 
supernatant from Step 4 was applied to the QIAprep spin column by decanting or pipetting 
prior to centrifugation for 30-60 seconds. The QIAprep spin column was washed by adding 
0.5 ml Buffer PB and centrifuging for 30-60 seconds. The flow-through was discarded. The 
QIAprep spin column was washed by adding 0.75 ml Buffer PE and centrifuging for 30-60 
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seconds. The flow-through was discarded and centrifuged for an additional 1 minute to 
remove residual wash buffer. The QIAprep column was placed in a clean 1.5 ml 
microcentrifuge tube. To elute DNA, 50 μl Buffer EB (10 mM Tris-Cl, pH 8.5) were added, 
left to stand for 1 minute and centrifuged for 1 minute. 
 
The presence of plasmid was confirmed by separating 2 μl samples of the miniprep eluate on 
a 1% agarose gel. PCRs (where the miniprep eluate is used as the template in a PCR reaction) 
were also performed to ensure that the gene was present in the plasmid. 
 
The genes within the plasmid were sequenced using ABI PRISM® BigDyeTM Terminator v3.0 
Ready Reaction Cycle Sequencing Kit. 
   
2.2.5 Transformation of BL21 star (DE3) One Shot Cells 
Recombinant plasmids containing the correctly sequenced genes were used to transform BL21 
star (DE3) One Shot E. coli Cells. These competent cells contain the λ DE3 lysogen which 
carries the gene for T7 RNA polymerase under the control of the lac UV5 promoter. This 
allows for high levels of protein expression that is induced by IPTG. These strains carry a 
mutated rne gene which encodes a truncated RNase enzyme that lacks the ability to degrade 
mRNA, resulting in an increase in mRNA stability. The (DE3) and pLysS strains do not 
contain the lon protease. They are also deficient in the outer membrane protease, OmpT. The 
lack of these proteases reduces degradation of heterologous proteins expressed in the strains. 
 
One 50 μl vial of BL21 star (DE3) One Shot E.coli Cells was used per transformation. 1 μl of 
the recombinant plasmid was added to a vial, which was incubated on ice for 30 minutes. The 
cells were then heat shocked at 42 oC for 30 seconds and recovered by the addition of 250 μl 
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of S.O.C medium. The transformation reaction was incubated at 37 oC for 30 minutes with 
shaking prior to plating on a LB ampicillin plate, which was incubated at 37 oC overnight.  
 
Successful transformation into BL21 star (DE3) competent cells yields a construct that is 
ready for protein expression experiments. 
 
2.2.6 Determination of Protein Expression Levels 
Colonies from the successful transformants were selected and used to inoculate 5 ml of LB 
medium containing the required antibiotic(s) (see Table 2.7). These cultures were incubated at 
37 oC overnight with shaking at 200 rpm. The following day, 1 ml from the overnight samples 
was diluted to 3 ml with LB media containing appropriate antibiotics. From the resulting 3 
ml, 1 ml was retained as the uninduced sample. 2 μl IPTG (1 M) was added to the remaining 2 
ml of culture to induce the protein expression. The samples were then incubated at 37 oC for a 
further 4 hours. Subsequently, 1 ml of the induced samples was harvested by centrifugation at 
13,000 rpm for 1 minute using a desktop microcentrifuge along with the 1 ml uninduced 
sample retained earlier. The pellet resulting from spin was resuspended in 20 μl of SDS 
loading buffer. Samples were then boiled for 5 minutes and SDS-PAGE (described in section 
2.2.12) was used for the analysis.  
 
2.2.7 Purification of the Protein expressed in TOPO® and Xa/LIC vectors 
E. coli colonies that had been shown to be expressing protein were used to inoculate 5 mls of 
LB containing 100 μg/ ml ampicillin. Following confirmation of successfully expressing cells, 
4 ml out of the 5 ml overnight culture was used to secondary inoculate 1 litre of LB medium 
containing ampicillin (100 μg/ ml). The cells were left to grow at 37 oC until an OD600nm of 
approximately 0.6 was reached, at which point protein expression was induced by the addition 
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of 1 ml IPTG (1 M). The cells were then incubated overnight at 16 oC with shaking at 200 
rpm. 
 
The following day cells were harvested by centrifugation at 6000 x g for 10 minutes using a 
F10-6 x 500 rotor in a Beckman J2-2 Lite centrifuge. The pellet resulting from the spin was 
resuspended in 50 ml Tris-HCl buffer (100 mM Tris, 150 mM NaCl), pH 8.0. After the 
addition of 10 μg/ ml lysozyme, 10 μg/ ml DNase and 5 μg/ ml RNase, the cells were lysed by 
sonication which involved 20-second pulses followed by 20 second intervals for 4 minutes. 
The cell lysate produced was then centrifuged at 15,000 rpm for 10 minutes in a Beckman J2-
2 Lite Centrifuge. Centrifugation produced a pellet (cell debris) and supernatant (crude 
lysate).  
 
The presence of a His tag at the N-terminal of the protein enabled the use of nickel-
nitrilotriacetic acid (Ni-NTA) metal affinity chromatography (section 2.2.7.1 below) to purify 
the protein. Prior to the application of the supernatant, the Ni-NTA resin was equilibrated 
with Tris-HCl buffer (100 mM Tris, 150 mM NaCl), pH 8.0. Once the supernatant had been 
applied to the resin, supernatant-resin interactions were allowed to occur with occasional 
turning. 
  
The supernatant-resin mix was centrifuged at 3,200 rpm for 1 minute using a Sorvall RT 
6000B centrifuge in a Sorvall H1000B swing out rotor and the supernatant removed. This 
fraction was defined as flow-through (FT) and would comprise of protein that did not bind the 
Ni-NTA beads. The column was then washed with 40 ml Tris-HCl buffer, pH 8.0 (100mM 
Tris, 150 mM NaCl) to remove any unwanted material. After spinning at 3,200 rpm for 1 
minute, the supernatant was removed and the step was repeated with a further 40 ml of Tris-
HCl buffer. Washing the column with 40 ml of low Imidazole-Tris buffer (20 mM Imidazole, 
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100 mM Tris, 150 mM NaCl, pH 8.0) eluted any partially bound protein. Centrifugation at 
3,200 rpm for 1 minute was followed by removal of the supernatant. This step was repeated. 
A high concentration of imidazole releases the His tags from the resin, permitting the elution 
of the His tagged protein. Therefore, 10 ml of high imidazole-containing Tris-HCl buffer (100 
mM Tris, 150 mM NaCl, 250 mM imidazole, pH 8.0) was added to the resin in order to elute 
the protein. The column was centrifuged at 3,200 rpm for 1 minute and the supernatant 
retained. 
 
Cell debris, crude lysate, flow-through, wash, elution and resin fractions were analysed by 
SDS-PAGE.  
 
2.2.7.1 Ni-NTA Chromatography 
Constructs comprising HP-thioredoxin or histidine tags can be purified using Ni-NTA affinity 
chromatography. Ni-NTA is a tetradentate chelating adsorbent that is thought to overcome 
leaching. NTA occupies four of the six ligand binding sites in the coordination sphere of the 
nickel ion, leaving two sites free for interaction with the 6xHis tag (Figure 2.8).    
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Figure 2.8. The interaction between the 6xHis tag and Ni-NTA. 
 
Non-specific binding is reduced by low concentrations (10-20 mM) of imidazole, which 
reduces the potential for binding background contaminants. The imidazole rings in the 
 89
histidine residues of the 6xHis tag bind to the nickel ions, immobilised by the NTA groups, on 
the matrix. The binding of imidazole to the nickel ions disrupts the binding of dispersed 
histidines residues in non-tagged background proteins. Low imidazole concentrations 
prevents non-specific, low affinity binding of background proteins while still allowing string 
binding of 6xHis tagged proteins to the Ni-NTA matrix. 
 
Endogenous proteins with histidine residues that interact with the Ni-NTA groups can be 
washed out of the matrix with stringent wash conditions such as an increase in imidazole 
concentration (10-50 mM). 
 
A further increase in the imidazole concentration (100-250 mM) instigates the dissociation of 
6xHis tagged proteins from the Ni-NTA as they can no longer compete for the binding sites 
on the Ni-NTA resin. 
 
 
2.2.8 Purifying Hsp47 from Insoluble Intracellular Aggregates 
Unfolding the protein 
In some cases Hsp47 was retained in E. coli as inclusion bodies. To purify the protein from 
these inclusion bodies involved unfolding and refolding before purification could be 
attempted. As before (section 2.2.7), a large culture (1-6 L) E. coli was established, the cells 
were spun, pellet resuspended in 100 mM Tris buffer pH 8.0 containing 150 mM NaCl and 
sonicated. As the protein was to be purified using the insoluble fraction, a temperature of 37 
oC was used even after induction. In the previous culture, the temperature was lowered to 
prevent aggregation of the protein. After sonication, the sample was spun again at 3,200 rpm 
using a JA20 (fixed angle) rotor and a Beckmann J2-21 centrifuge. The pellet was 
resuspended in 100 mM Tris at pH 8.0 containing 0.1% Triton to wash away the membrane, 
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spun again at 3,200 rpm (again using the JA20 rotor and Beckmann J2-21 centrifuge) and the 
supernatant resulting form the spin was discarded. The pellet was resuspended in 40 ml buffer 
containing 100 mM Tris-HCl, 100 mM NaH2PO4 and 8 M urea at pH 8.0 (urea was added to 
unfold the protein). The resulting solution was added to 20 ml of a Ni-NTA resin in a 50 ml 
Falcon tube for purification and as before, unbound, bound, wash and elution fractions were 
collected for analysis on SDS-PAGE.  
 
The only difference to the previous purification protocol being the inclusion of urea in the 
wash and elution buffers. Wash buffer at pH 6.3 contained 8 M urea, 100 mM NaH2PO4 and 
10 mM Tris-HCl. Elution buffer at pH 4.5 contained 8 M urea, 100 mM NaH2PO4 and 10 mM 
Tris-HCl.  
 
Optimisation of Refolding Hsp47 
Refolding of Hsp47 was attempted using dialysis where 1 ml of the eluted protein was placed 
into dialysis tubing, which acted as a membrane, allowing the passage of water molecules. 
Four different dialysis tubes containing 1 ml of the protein were set up and each one placed in 
a buffer solution of different urea concentrations for varied times so that the optimum 
conditions for refolding could be distinguished. The urea concentrations used were 6 M, 4 M, 
2 M and 0 M urea. As mentioned above, the protein solution resulting from the purification 
contained 8M urea, thus placing it in buffer with different urea concentrations would allow 
the urea to migrate from a high concentration to a low concentration, leaving pure Hsp47 in 
the dialysis tubing. The buffer solution consisted of: 100 mM Tris-HCl at pH 8.0 
          250 mM NaCl 
             5 mM Glutathione 
             6 M/4 M/ 2 M/ 0 M urea 
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Four dialysis experiments were set up: 
(i) At time (t) = 0 hour, the protein (sample 1) was placed in buffer containing 6 M 
urea. At t = 2 hours, the tube containing the protein was moved into the buffer 
containing 4 M urea and at t = 4 hours, the protein was placed in 2 M urea. After 6 
hours the protein was placed in the 0M urea buffer and left to dialyse overnight. 
(ii) At t = 0 hour the protein (sample 2) was placed in the 4 M urea buffer, it was then 
moved to the buffer containing 2 M urea at t = 2 hours. Then at t = 4 hours the 
protein was placed in the 0 M urea buffer and left to dialyse overnight. 
(iii) At t = 0 hour, the protein (sample 3) was placed in 2 M urea and at t = 2 hours, it 
was placed in the buffer solution of 0 M urea and left to dialyse overnight. 
(iv) The 8 M urea protein (sample 4) solution was placed in 0 M urea buffer solution 
and left to dialyse until the following day. 
 
The above method is known as step-wise dialysis. The change in urea concentration allowed 
the urea to slowly diffuse out of the protein, leaving pure folded Hsp47.  
 
The following day the solutions in each of the four dialysis tubes were spun at 16,000 x g to 
separate the soluble and insoluble fractions. The supernatant included soluble Hsp47 whilst 
the pellet after spinning contained any remaining insoluble Hsp47. Protein loading buffer was 
added to each of the samples prior to them being boiled and SDS-PAGE was used to identify 
whether the unfolding and refolding was successful. 
 
2.2.9 Cleavage of the Thioredoxin Tag 
The pET-32 Xa/LIC construct contained both Factor Xa and Thrombin cleavage sites (Figure 
2.9). 
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 Thioredoxin Tag His. tag S. tag Hsp47 
Thrombin Factor Xa 
T7 Promoter His Tag 
      
Figure 2.9. Position of Thrombin and Factor Xa cleavage sites on the pET-32 Xa/LIC construct. 
An initial cleavage of the fusion tags was attempted using thrombin and factor Xa separately.  
 
Cleavage with Thrombin 
Cleavage with thrombin used a stock of 2 mg of thrombin in 1 ml water (37 units/ mg). 0.5 ml 
of the thrombin solution was added to 0.5 ml of protein solution, which was incubated at 4 oC. 
At specific time points (0 hours, 0.5 hours, 1 hour, 2 hours, 4 hours and overnight), 100 µl 
samples were taken and boiled after the addition of 20 µl of SDS protein loading buffer to 
denature the enzyme and stop the cleavage reaction. Samples were analysed by SDS-PAGE. 
 
Cleavage with Factor Xa (fXa) 
Cleavage with fXa involved the addition 10 µl of the enzyme to 200 µl of protein solution at 
room temperature. Again, samples were taken at regular intervals to monitor the cleavage 
over time. This would give an indication of the optimum time for the cleavage. As above, the 
samples were denatured by the addition of SDS loading buffer and boiling and analysed by 
SDS PAGE. 
 
Cleavage where both Factor Xa and Thrombin sites were present 
Cleavage was repeated, in which four different experiments were set up (Table 2.9). The first 
experiment included a control in which neither Factor Xa or thrombin was added, a second 
experiment was set up in which cleavage of the protein was with thrombin. The third 
 93
experiment involved cleavage of the protein using Factor Xa and a fourth experiment was set 
up in which a mixture of Factor Xa and thrombin were used to try to cleave the fusion tags.  
Volume (μl) Component Concentration 
Experiment 1 Experiment 2 Experiment 3 Experiment 4
Protein ~1 mg/ml 200 200 200 50 
Thrombin 50 U 40 0 40 0 
Factor Xa 400 U 0 20 20 0 
Sterile water - 20 40 0 10 
 
Table 2.9. Reaction mix components of Thrombin and Factor Xa Cleavage Assays.  
 
The cleavages were left to occur overnight at 4 oC and the samples analysed by SDS-PAGE. 
 
2.2.10 Purification of protein expressed in pTYB12 
The Intein Mediated Purification with an Affinity Chitin-binding Tag (IMPACT) expression 
system was used to express and purify the protein in E. coli. IMPACT uses the self-cleavage 
of an intein (a protein splicing element) (Figure 2.10) to separate the target protein from the 
affinity tag. IMPACT allows the purification of a native recombinant protein tag without the 
use of a protease. A target protein is fused to a self-cleavable intein tag in which a chitin-
binding domain allows affinity purification of the fusion precursor on a chitin column.  
 
The absence of any other fusion tags makes this advantageous for cloning into as it allows 
single-column purification and release of the fusion tag without the use of proteases.     
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Figure 2.10. Purification of protein expressed 
by pTYB12. The Hsp47 gene was cloned into the 
multi-cloning sites (MCS). A chitin binding 
domain and an intein tag are encoded upstream of 
the cloned gene and these features enhance the 
purification steps. When using pTYB12 vector 
system, the target protein is expressed with an 
intein tag and can be purified by a chitin column. 
The intein tag binds target protein to the column. 
Cleavage of intein tag, induced by adding DTT, 
will release the desired protein. 
 
 
 
 
Following confirmation that cells were successfully expressing Hsp47, a 5 ml overnight 
culture was used to secondary inoculate 1 litre of LB medium containing ampicillin (100 μg/ 
ml). The cells were left to grow at 37 oC until an OD600nm of approximately 0.6 was reached, 
at which point expression was induced by the addition of 1 ml IPTG (1 M). The cells were 
then incubated overnight at 16 oC with shaking at 200 rpm. Cells were harvested by 
centrifugation at 6,000 x g for 10 minutes using a F10-6 x 500 rotor in a Beckman J2-2 Lite 
centrifuge. The pellet resulting from the spin was resuspended in 50 ml cell lysis buffer (20 
mM Tris-HCl, 500 mM NaCl, 0.1% Triton). 50 µl DNase and 50 µl RNase were added to the 
suspension, which was then incubated at 20 oC with shaking at 200 rpm for 30 minutes. 
Lysozyme was not added to the suspension as it is known to bind and digest chitin. Cell lysis 
was by French Press rather than sonication. The resulting crude lysate was centrifuged at 
20,000 x g for 30 minutes to pellet cell debris. The supernatant (cell extract) was collected 
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and the pellet discarded. 40 µl of the cell extract was retained for analysis by SDS-PAGE. The 
clarified cell extract was loaded onto a chitin column at a flow rate of 1 ml/minute. The flow-
through was collected for analysis by SDS-PAGE. The chitin column was then washed with 
10 bed volumes of column buffer (20 mM HEPES, 500 mM NaCl, 0.1% Triton). Due to the 
high affinity of the Chitin Binding Domain (CBD) for the chitin beads, a higher flow rate of 2 
ml/minute and stringent wash conditions were used. The target protein is released from the 
chitin column when the chitin-bound intein tag undergoes self-cleavage in the presence of 
DTT. Therefore induction of on-column cleavage was done by quickly flushing the column 
with 3 bed volumes of Cleavage Buffer (20 mM Tris-HCl (pH 8.0), 500 mM NaCl, 50 mM 
DTT). This allowed even distribution of thiols throughout the column. Following the quick 
flush the column flow was stopped and the column left at 4 oC overnight. The target protein 
was eluted off the column using Cleavage Buffer without DTT. 1 ml fractions were collected 
for 3 column volumes and fractions were analysed by SDS-PAGE. The cleavage efficiency 
was assessed by removing some chitin resin from the column for analysis by SDS-PAGE. 
 
2.2.11 Purification of mHsp47 in pCR®T7/NT-TOPO® (adapted from [87]) 
Colonies expressing Hsp47 were used for primary inoculation of 5 ml LB containing the 
appropriate antibiotics (100 μg/ml ampicillin and 34 μg/ml chloramphenicol). The culture was 
incubated overnight at 37 oC with shaking at 200 rpm. Subsequently, the culture was used for 
secondary inoculation of 1 litre LB media containing 100 μg/ml ampicillin and 34 μg/ml 
chloramphenicol. The culture was grown at 37 oC until an OD600nm of 0.6 was reached, 
whereupon protein expression was induced by the addition of 1 mM IPTG. Consequently, the 
temperature was reduced to 20 oC and the cells incubated overnight at 200 rpm. The cells 
were harvested by centrifugation at 6,000 x g for 15 minutes at 4 oC using a F10-6 x 500 rotor 
in a Beckman J2-2 Lite centrifuge. The resultant pellets were resuspended in 50 ml of 50 mM 
Tris-HCl, pH 7.5, containing 0.5 M NaCl, 0.02% Triton-X-100 and 3 mM β-mercaptoethanol. 
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10 μg/ml lysozyme, 10 μg/ml DNase and 5 μg/ml RNase was added to the resuspension prior 
to cell lysis using a French press at 11400 psi. Cell debris was removed by centrifugation at 
20,000 x g for 30 minutes at 4 oC in a Beckman Lite centrifuge. The resulting cell lysate 
(approximately 50 ml) was loaded onto a 15 ml gelatin-agarose column using a Pharmacia 
ActaPrime HPLC. The column had been pre-equilibrated with 3 column volumes of 50 mM 
Tris-HCl, pH 7.5, containing 0.5 M NaCl. The flow-through was collected for analysis using 
SDS-PAGE. The column was washed with 50 mM Tris-HCl, pH 7.5, containing 0.3 M NaCl 
to remove any impure or weakly binding protein. This was continued until the absorbance 
reached base levels and the wash fraction was collected for SDS-PAGE analysis. A 0.3 M 
phosphate buffer pH gradient (from pH 9.0 to pH 3.0) was used to elute the bound Hsp47 
from the gelatin beads. Elution fractions of 1 ml were collected for analysis and data on the 
pH, absorbance and salt concentration was collected through-out the purification procedure. 
Following elution, the pH of the protein was restored by the addition of 50 mM Tris-HCl, pH 
8.0 to each of the elution fractions. Fractions were analysed SDS-PAGE and those containing 
Hsp47 were dialysed against 50 mM Tris-HCl, pH 8.0 overnight. Fractions were then snap-
frozen in liquid nitrogen prior to storage at -70 oC. 
 
2.2.12 Detection of Hsp47 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
The SDS-polyacrylamide gels comprised of 10% resolving (30% acrylamide, 1.5 M Tris-HCl 
(pH 8.8), 10% SDS, 10% ammonium persulphate and 0.04% TEMED) and 5% stacking (30% 
acrylamide, 1.0 M Tris-HCl (pH 6.8), 10% SDS, 10% APS and 0.04% TEMED) gels. 
Samples for analysis were boiled for 10 minutes at 100 oC in 5 x SDS loading buffer. The 
procedure followed was that of Roskams and Rodgers 2002 [184]. Gels were run for 40 
minutes at 200 volts (V) and 400 milliamps (mA) in SDS running buffer (25 mM Tris-HCl, 
192 mM Glycine and 0.1% SDS) using a Biorad mini protean III apparatus. New England 
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Biolabs Broad Range Pre-stained markers were used as molecular weight markers. Coomassie 
Brilliant Blue (CBB) staining was used for visualisation of protein bands. 
 
Visualisation by CBB 
The CBB stain was made by dissolving 0.25 g of R-250 CBB in 90 ml of methanol: water 
(1:1 v/v) and 10 ml glacial acetic acid. The solution was filtered through a Whatman #1 filter 
paper to remove particulate matter. The gels were stained for a minimum of 4 hours in 5 
volumes of coomassie prior to destaining. Destain contained 5:4:1 ratio of methanol: water: 
acetic acid and was continuously changed until distinct bands were visible on the gels. 
 
Visualisation by Western Blot 
This is a more sensitive technique (can detect ng of protein) for the detection of protein in a 
gel. Once the gel was run in the normal way (described above), it was transferred to 
nitrocellulose using a Biorad transfer apparatus (see manufacturers instructions). This time the 
transfer was run for 60 minutes at 80 V. Ponceau stain (2 g of Ponceau S, 30 g of 
trichloracetic acid and 30 g of sulfosalicyclic acid in 100 ml of water) was then added to the 
nitrocellulose for a couple of seconds to visualise the transferred bands. The nitrocellulose 
blot was then washed for 60 minutes with PBST (8 mg/ml NaCl, 0.2 mg/ml KCl, 1.44 mg/ml 
Na2HPO4O, 0.24 mg/ml KH2PO4O and 0.5 μl/ml tween) + 5% milk, this removed any stain 
that was not due to presence of protein. The blot was then washed for another 60 minutes, this 
time with PBST + 0.5% milk + 1:10000 anti-mouse Hsp47. The anti-mouse Hsp47 is an 
Hsp47-specific antibody that should bind to any Hsp47 present on the gel. The gel was then 
washed with 1 x PBST for five minutes. This was repeated three times, to remove any 
unbound antibody. It was then washed for a further 60 minutes with PBST + 0.5% milk + 
1:1000 anti mouse-HRP (horse radish peroxidase) conjugate. This binds to the anti-Hsp47 
antibody that was used to wash the gel with previously. This antibody catalyses the 
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conversion of substrate to products, giving off light in the process. It is this light that is used 
to visualise the presence of protein. Before visualisation, however, the gel was washed three 
times with 1 x PBST for 5 minutes to remove any unbound antibody. A light sensitive film 
was used to photograph the gel. 
 
Visualisation by Silver Stain 
The silver stain method is much more sensitive than the normally used coomassie blue 
staining technique. Therefore minimal amounts of protein can be detected. The silver stain 
method required 4 solutions:  
 
Starter solution – 37.5 mg/ 500 ml thiosulphate 
Solution I – 0.3 g AgNO3 + 67 µl of 38% formaldehyde in 80 ml water 
Solution II – 10 g Na2CO3 + 113 µl of 38% formaldehyde in 80 ml water 
Stopper solution – 10% acetic acid 
 
Gloves were worn at all times to reduce contamination from human protein. The silver stain 
procedure started with washing the gel with water. This was repeated three times. Starter 
solution was added for 1 minute. The gel was washed with water three times. Solution I was 
added and left for 20 minutes with shaking. The gel was washed three times with water. 
Solution II was added and the bands visualised. It took about 15 minutes for the bands to 
become clearly visible. Solution II was then poured off and stopper solution added. 
 
Protein Concentration Determination 
The absorbance of the eluted protein was measured at 280 nm using a spectrophotometer. A 
10 mm quartz cuvette was used and absorbance spectra from 220 nm to 300 nm were 
collected. 
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Determining protein concentration using the Beer-Lambert Law requires the use of the 
following equation: A280= εCl 
A280 = Absorbance at 280 nm  
ε = Molar extinction coefficient (M-1 cm-1)  
C = Protein concentration (M) 
l = Pathlength (cm) 
 
Each protein has a unique extinction coefficient that depends on the number of tryptophan and 
tyrosine residues and the number of disulphide bonds within the protein. mHsp47 has a molar 
extinction coefficient of 42400 M-1 cm-1. 
 
Conversion of the calculated concentration in M to mg/ml can be done by multiplying the 
concentration (M) by the molecular weight of the protein. In the case of Hsp47 it is 47,000 
Da. 
 
2.2.13 Characterisation of Purified Hsp47 
2.2.13.1 Circular Dichroism  
CD Spectra 
CD spectroscopy measures the difference in absorbance of left- and right- handed circularly 
polarised light by chiral molecules. Chiral molecules can exist as two isomers that have low 
degrees of symmetry. Proteins consist of many chiral subunits thus producing CD signals. 
The CD signals that arise from proteins are a result of cysteine, tryptophan, tyrosine and 
phenylalanine residues and peptide bonds. The CD spectra between 260-180 nm is specific 
for peptide bond conformation and allows identification of different secondary structures, 
such as alpha helices, beta sheets, random coils and turns.  
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CD measurements were performed on a Jasco J815 spectropolarimeter using a 
thermostatically controlled 0.2 cm pathlength quartz cuvette. Far UV spectra were recorded 
from 190 to 300 nm at a constant temperature of 25 oC. Each spectrum was an average of 16 
accumulations and the signal was averaged over 15 seconds. 
 
Thermal melts 
CD measurements were performed on a Jasco J815 spectropolarimeter using a 
thermostatically controlled 0.2 cm pathlength quartz cuvette. The change in dichroic signal 
was monitored at a wavelength of 222 nm while the temperature was increased from 20 to 90 
oC at a constant rate of 1 oC/min. 
 
As Tris-HCl is an unsuitable buffer for CD measurements, samples were dialysed against the 
elution phosphate buffer, pH 8.0 and all CD measurements were performed immediately after 
protein elution from the column. A buffer only background CD trace was measured at the 
beginning of each CD spectra measurement and this was removed from the trace of each 
sample. 
 
2.2.13.2 Gel Filtration Chromatography 
Gel filtration chromatography (also known as size exclusion chromatography) separates 
molecules according to size using porous particles. Small molecules can enter the pores of the 
particles so have a longer path before they are eluted. Larger molecules however, cannot enter 
the porous particles, thus have a shorter path length and shorter transit time. Size exclusion 
columns are generally used to determine the molecular weight (Mr) of a molecule. 
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 (www./chem-ed/sep/lc/size-exc.htm) 
Figure 2.11. A schematic diagram of a size exclusion chromatography column.  
 
Molecules that are smaller than the size of the pore are retained and elute last whereas larger 
molecules cannot enter the porous particles and are eluted first. 
 
Gel filtration experiments were carried out using a Superdex 200 HiLoad 16/60 column with a 
bed volume of 120 ml. The flow rate was 1 ml per minute and the pressure limit was 0.3 MPa. 
The column was equilibrated with Tris-HCl buffer (pH 8.0) prior to the loading of 2 ml of 
protein onto the column. The absorbance of the column eluate was recorded at 280 nm. A 
solution of molecular weight markers, comprising of blue dextran (2000 kDa), ferritin (440 
kDa), immunoglobulin G (160 kDa), bovine serum albumin (67 kDa), ovalbumin (45 kDa), 
myoglobulin (16.7 kDa), ribonuclease A (13 kDa) and vitamin B12 (1.355 kDa) was also run 
through the column. Data from these MW markers was used to plot a calibration curve, which 
was then used to perform linear regression in order to establish the MW of the elution peaks.  
 
2.2.13.3 Analytical Ultracentrifugation (AUC) 
This technique allows characterisation of key sample properties of biomolecules in their 
native state under biologically relevant solution conditions. The experiments are performed in 
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free solution, thus there are no complications caused by interactions with matrices or surfaces 
that can obscure interpretation. 
 
Sedimentation velocity experiments allow interpretation of the entire time-course of 
sedimentation of a sample. It is a hydrodynamic technique that provides information about the 
shape and molecular mass of the macromolecules in addition to their size distribution. An 
initially uniform solution is placed in a cell and a moving boundary is formed on application 
of a strong centrifugal force which causes rapid sedimentation of solute towards the cell 
bottom. This results in a depletion of solute near the meniscus and the formation of a sharp 
boundary between the depleted region and the uniform concentration of sedimenting solute 
(the plateau). A series of scans are recorded at regular intervals to determine the rate of 
movement and broadening of the boundary as a function of time. The rate of movement of the 
boundary is measured to determine sedimentation coefficients, which depend directly on the 
mass of the particles in the sample. 
 
Following elution of protein from the gelatin column, all samples were dialysed against 50 
mM Tris-HCl, pH 8.0 prior to analysis by AUC. Sedimentation velocity measurements of 
Hsp47 samples were made using a Beckman (Paolo Alto, US) proteomelab XLI analytical 
ultracentrifuge. Samples were run using two sector cells in an Xti rotor. Samples were 
centrifuged at 40,000 rpm for 8 hours at 4 oC. The protein content in the cell was measured by 
continuously monitoring the protein absorbance at 280 nm. SEDFIT 
(sedfitsedphat.nibib.nih.gov) was used to analyse the data and obtain a sedimentation 
distribution. All results were corrected to the viscosity and density of Hsp47. 
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2.2.13.4 pH Titrations 
pH titrations were carried out on a Jasco J815 connected to an autotitrator. A stirred, 
thermostatically controlled 1 cm quartz cuvette was used. All mHsp47 constructs were studied 
at a final protein concentration of 0.15 mg/ml in phosphate buffer, pH 8.0 at 25 oC. The pH 
was then progressively decreased to approximately pH 4.0 by the addition of 2.5 μl of 1.52 M 
phosphoric acid. The change in dichroic signal was measured at 222 nm with an emission slit 
width of 3 nm. Spectra for each variant were measured before and after the titration to identify 
any structural variation following a reduction in the pH. 
 
2.2.13.5 Collagen Fibrillisation Assay 
Collagen used in this study was isolated from fresh calf Achilles tendons. First, the tendons 
were rinsed with acetone to remove the fatty deposits. Subsequently, the collagen was 
extracted by stirring with 0.5 M acetic acid at 4 oC for 48 hours and then salting out with 
sodium chloride. The sample was further dialysed against deionised water at 4 oC for 48 
hours. The collagen was then freeze-dried and kept in the refrigerator.  
 
Before use, collagen from calf Achilles tendons was dissolved in 75 mM sodium citrate pH 
3.6-4.0 to a final concentration of 1 mg/ml. This solution was brought to a pH of 7.0 and to a 
final protein concentration of 0.2 mg/ml by the addition of 20 mM sodium phosphate buffer, 
pH 7.4, containing 50 mM NaCl. The protocol used for collagen fiber formation was similar 
to that described by Williams and coworkers [185]. Turbidity measurements were made at 
313 nm in a spectrophotometer over a period of 320 minutes at a constant temperature of 34 
oC, which was maintained by a controlled water bath. A 1 cm quartz cuvette was used. 
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 2.2.13.6 Collagen Binding Assay 
A collagen-binding assay was performed to determine whether Xenopus laevis and Danio 
rerio Hsp47 bound to collagen immobilised on agarose beads. A control resin, containing no 
collagen was used to determine non-specific binding.  
 
Preparation of resin 
The collagen resin was prepared by spinning 500 μl of resin at 14,000 x g in a centrifuge for 1 
minute. The supernatant was discarded and the pellet resuspended in 1 ml Tris-HCl at pH 8.0; 
this was repeated three times. Finally, the resulting beads were resuspended in 500 μl of Tris 
pH 8.0 to complete the preparation of the collagen resin. 
 
The control resin was prepared by resuspending sephadex in Tris-HCl buffer at pH 8.0. The 
solution was spun until all the sephadex had resuspended and could now be used for the 
binding assay. 
 
The binding assay procedure  
0.5 ml of the Hsp47 was thawed and spun at 14,000 x g for 15 minutes in order to remove any 
aggregated insoluble protein. The supernatant resulting from the spin was transferred to a 
fresh tube and stored on ice. A mix containing 50 μl Hsp47, 50 μl collagen agarose beads and 
50 μl Tris-HCl pH 8.0 buffer (100 mM Tris-HCl, 150 mM NaCl) was incubated on ice for 5 
minutes whilst turning. It was then spun for 1 minute at 14,000 x g, the supernatant was 
retained in a microcentrifuge tube for analysis on SDS-PAGE whilst the beads were 
resuspended in 1 ml Tris buffer (100 mM Tris-HCl, 150 mM NaCl, pH 8.0). The samples 
were then spun at 14,000 x g for 1 minute and the supernatant discarded. The beads were 
resuspended in the Tris buffer and spun twice more. After the final spin, the supernatant was 
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discarded and 50 μl of loading buffer added to the resin remaining in the microcentrifuge tube 
and the previously retained supernatant sample. The samples were then boiled and run on 
SDS-PAGE. 
 
The same procedure was used to perform the binding assay using the control resin, however 
instead of collagen-agarose beads; the pre-prepared sephadex resin was used. 
 
2.2.13.7 Electron Microscopy 
Transmission electron microscopy (TEM) was used to visualise collagen samples pre- and 
post-fibrillisation. This allowed the comparison of the surface features and the size and shape 
of collagen fibres before and after fibrillisation and furthermore, in the absence and presence 
of Hsp47. 
 
TEM permits determination of the topography and morphology of a sample. It involves 
transmitting a beam of electrons through an ultra thin specimen using a positive electrical 
potential. Focussing of the beam is by a magnetic lens. Interaction of electrons with the 
specimen forms an image that is magnified onto an imaging device, such a fluorescent screen. 
Thus, the interactions and effects are detected and transformed into an image. 
 
Negative staining was used as a contrast enhancement method that allows the specimen to 
appear translucent against a dark background. 
 
Negative Staining Protocol 
A carbon coated grid was discharged just before use to increase hydrophilicity. 5 µl of sample 
was placed on the grid and left to dry for 30 seconds. The grid was blotted with filter paper. 
30 µl of 2% uranyl acetate stain were pippetted onto the grid and immediately blotted using 
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filter paper. This was repeated for a further four drops of uranyl acetate ensuring that drying 
between drops was prevented. A further 30 µl of uranyl acetate were pipetted onto the grid 
and this time was allowed to soak for 20 seconds prior to blotting. This was repeated for a 
further 30 µl of uranyl acetate. The grid was allowed to dry for a few minutes before imaging. 
 
Imaging used a JEOL 2011 microscope running at 200 KV with a La6B filament. A defocus 
of 3-6 microns was used to improve the visual performance.  
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CHAPTER 3: Purification and Characterisation of Xenopus laevis and 
Danio rerio Hsp47 
 
3.1 Introduction 
Work done previously on Hsp47 has focused mainly on murine Hsp47. However, this form is 
relatively insoluble and unstable in solution making it difficult to work with. Therefore, an 
alternative strategy using Xenopus laevis and Danio rerio Hsp47 was developed. 
Consequently, the Danio rerio and Xenopus laevis gene for Hsp47 was used to try to purify 
larger quantities of protein that would allow more detailed structural studies from which 
molecular information could be elucidated. This has the advantage of maintaining function 
while altering DNA sequence. It was hoped that these new sequences would express better 
and/or produce a more stable protein. 
 
Earlier studies used the E. coli strain DH1 with λhind- prophage for the cloning and 
overexpression of the mature mouse Hsp47 [186]. The same group attempted to clone the 
cDNA of Hsp47 into the HB101 strain with pRH1 or pCNR1 plasmids. This proved 
unsuccessful as it yielded low levels of expression [187]. To overcome this problem, the 
pKS26 vector, possessing a PL promoter for high expression levels, was selected. This 
plasmid allowed overexpression of Hsp47 to 40-50% of the total protein in the cell. Following 
the transformation of DH1 cells, expression of recombinant Hsp47 involved growing of the 
plasmid overnight at 37 oC in LB containing ampicillin. This overnight culture was used to 
inoculate a culture at 1% (v/v). The cells were heat induced at 42 oC, after reaching an 
OD600nm of 0.5-0.8, by increasing the temperature in the incubator. The cells were grown at 
this temperature for a further 1 hour and 30 minutes. Western blot analysis using a 
monoclonal antibody to Hsp47 confirmed expression of the protein [187]. Hsp47 studies in 
our lab however, have found that Hsp47 is a rather unstable and fragile protein and such an 
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increase in temperature results in the majority of the protein being insoluble and present in 
inclusion bodies or aggregates. Furthermore, even a reduction in temperature following 
induction with IPTG resulted in very small amounts of soluble protein. 
 
It was therefore decided that the Hsp47 gene from different organisms would be used to 
attempt to obtain larger amounts of pure, soluble protein. As the sequence for both Xenopus 
laevis and Danio rerio Hsp47 is slightly different to that of Mus musculus Hsp47, these 
organisms were considered favourable for the above objective. Amino acid sequences from 
Genbank were used to calculate the sequence identities between various organisms. Xenopus 
laevis has 73% and 70% sequence homology with Mus musculus and Danio rerio, 
respectively. Most of the sequence identity was focused at the centre of the sequence and at a 
few carboxyl terminal regions. This sequence identity is in part due to three key features that 
are conserved between Hsp47 from most species; a hydrophobic leader sequence, two 
potential glycosylation sites and the ER-retention signal. 
 
Furthermore, Xenopus laevis is a poikilothermic vertebrate and Danio rerio is an ectothermic 
vertebrate in comparison to the mammalian endotherm, Mus musculus. As these organisms 
differ in the controlling of their body temperature it was thought that there may also be a 
difference in the stability and solubility of Hsp47 between ectothermic and endothermic 
organisms.  
 
Some of the work detailed in this chapter was done in our lab prior to the start of this study. It 
is important to present all the work that was carried out in order to tell the complete story. 
Those experiments and results that did not involve me have been clearly stated. 
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This chapter will detail the outcome of cloning, expression and purification of Xenopus laevis 
and Danio rerio Hsp47 for each of the vectors used (for vector maps see Figures 2.1-2.4). 
 
 
3.2 Results 
3.2.1 Cloning into the vectors 
The gene for Hsp47 from Xenopus laevis and Danio rerio was cloned into four different 
vectors, each possessing different tags that should aid purification (described in section 2.1). 
 
3.2.1.1 Cloning the Xenopus laevis Hsp47 gene into pET102/D-TOPO® 
PCR was carried out to introduce specific terminal sequences into the gene to allow cloning 
into the D-TOPO® vector (results shown in Figure 3.1 below). Subsequently, samples that 
showed the correct amplimer (1, 300 base pairs (bp)) were combined and purified to remove 
any impurities from the amplified genes. 
 
400 
1, 000 
1, 500 
10, 000 
1, 300 bp 
Band size (bp) 
 1  2   3  4 
Lane 1: PCR sample 1 
Lane 2: PCR sample 2 
Lane 3: PCR sample 3 
Lane 4: DNA Hyperladder I 
Figure 3.1. PCR result for Xenopus laevis Hsp47 gene. Lanes 1-3 showed bands at ~1, 300 bp, the 
size of the Hsp47 gene, illustrating successful PCR reactions. 
 
Following purification, the amplimer was ligated into the pET102/D-TOPO® and transformed 
into Top10 cells. Colonies resulting from the overnight incubation of the transformation mix 
on LB agar plates (supplemented with 100 mg/ml ampicillin) were used to inoculate 5 ml LB 
comprising 100 mg/ml ampicillin. The presence of the correct size of plasmid DNA was 
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checked by performing mini-preps on the transformants (results not shown). Samples that 
revealed a band at 7615 bp (6315 bp for vector + 1300 for Hsp47 insert) were identified as 
successfully cloned constructs and were used to transform BL21 Star (DE3) One Shot Cells. 
The presence of insert was confirmed by DNA sequencing. 
 
3.2.1.2 Cloning the Xenopus laevis Hsp47 gene into pET-32 Xa/LIC 
Using the same protocol as for the pET102/D-TOPO®  vector amplification of the Hsp47 gene 
was performed so that it could be used for insertion into the pET-32 Xa/LIC vector. Results 
from the PCR are illustrated in Figure 3.2 below. 
 
1            2 
10, 000 
1, 500 
1, 000 
Band size (bp) 
1, 300 bp 400 
Lane 1: DNA Hyperladder I 
Lane 2: Xenopus laevis Hsp47     
PCR sample 
 
Figure 3.2. Results for PCR of Xenopus laevis Hsp47 gene. Successful amplification of the protein 
gene was illustrated by a single band at 1, 300 bp. 
 
Following purification of the DNA product, the target insert was treated with T4 DNA 
polymerase before annealing the vector and the Xa/LIC insert. Analysis of the mini-prep 
(shown in Figure 3.3 below) revealed that the pET-32 Xa/LIC vector had successfully taken 
up the Hsp47 gene. 
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Band size (bp) 
    1   2   3   4   5   6   7 
10, 000 
1, 500 
400 
Lane 1: DNA Hyperladder I 
Lane 2: Mini prep 1 
Lane 3: Mini prep 2 
Lane 4: Mini prep 3 
Lane 5: Mini prep 4 
Lane 6: Mini prep 5 
Lane 7: Mini prep 6 
~ 7226 bp (5926 bp vector + 1300 bp insert)  
Figure 3.3. Results for mini-preps of pET-32 Xa/LIC containing Xenopus laevis Hsp47 insert. 
The presence of bands at ~7226 bp indicates insertion of the gene into the vector. 
One of the above plasmids was used to transform Top10 E. coli cells. 
 
3.2.1.3 Cloning into pTYB12 
The gene for Xenopus laevis Hsp47 and Danio rerio Hsp47 was amplified by PCR. The 
annealing time was increased to 45 seconds as the previously used annealing time of 30 
seconds did not produce any PCR product. An annealing temperature of 40 oC in the PCR 
cycle produced successful gene amplification (Figure 3.4) for both the Danio rerio and 
Xenopus laevis Hsp47. 
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~ 1, 300 bp 
 1     2     3 
Lane 1: DNA Hyperladder I 
Lane 2: PCR 1 
Lane 3: PCR 2 
1, 000 
1, 500 
 
Figure 3.4. A 1% agarose gel of PCR results for (a) Danio rerio Hsp47 and (b) Xenopus laevis 
Hsp47. 
 
The successful PCR reactions for each species were pooled, run on a gel and the band excised 
using QIAprep® MinElute Gel Extraction Kit. Presence of purified PCR product was checked 
by running the samples on a 1% agarose gel (results not shown). The purified Danio rerio 
Hsp47 gene was cloned into pET101/D-TOPO®, pET102/D-TOPO®, pET-32 Xa/LIC and 
pTYB12 and Xenopus laevis Hsp47 was inserted into pET102/D-TOPO®, pET-32 Xa/LIC 
and pTYB12. Consequently, successfully clones were used to transform BL21 star (DE3) One 
Shot Cells prior to protein expression determination (method described in section 2.8). 
 
Previous to this study, the Hsp47 gene from Danio rerio had been successfully cloned into 
pET102/D-TOPO® and pET-32 Xa/LIC and these constructs were used for the 
characterisation of Danio rerio. 
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3.2.2 Expression of the protein from the Vectors 
3.2.2.1 Expression of Hsp47 from Xenopus laevis 
from pET102/D-TOPO® 
The optimum expression conditions for Xenopus laevis Hsp47 from pET102/D-TOPO® were 
distinguished by growing expression cultures at different temperatures. Samples were taken at 
1 hour intervals for 5 hours and the turbidity measured. These samples were analysed by 
SDS-PAGE. 
 
Analysis of the samples using SDS-PAGE and coomassie brilliant blue staining showed that 
no Hsp47 was present in the culture grown at 15 oC, as there were no distinct bands for Hsp47 
(Figure 3.5). 
 
Hsp47 
1        2        3       4        5       6         7 
Lanes 
47.5
32.5 
 
16.5
kDa
Lane 1: Pre-induction sample 
Lane 2: 1 hour post-induction 
Lane 3: 2 hours post-induction 62
83
175
Lane 4: 3 hours post-induction 
Lane 5: 4 hours post-induction 
Lane 6: 5 hours post-induction 
Lane 7: Protein molecular weight 
markers 
 
Figure 3.5. SDS-PAGE of Xenopus laevis Hsp47 expression at 15 oC. The lack of a distinct 47 kDa 
band following induction implied that Hsp47 was not being expressed. 
 
An incubation temperature of 20 oC produced results (Figure 3.6) different to those given by 
an incubation temperature of 15 oC. Protein expression occurred but it was not enhanced by 
induction with IPTG. Western blot analysis was used to confirm that the protein was Hsp47. 
 114
                 Lanes 
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          83 
 Lane 1: Protein molecular 
weight markers 
Lane 2: Pre-induction sample 
Lane 3: 1 hour post-induction 
Lane 4: 2 hours post-induction 
Lane 5: 3 hours post-induction 
Lane 6: 4 hours post-induction 
Lane 7: 5 hours post-induction 
 
 kDa   62 
 
47.5 
 
 
32.5 
 
 
 
   
 
Hsp47 
 
Figure 3.6. SDS-PAGE of Xenopus laevis Hsp47 expression at 20 oC. The gel illustrates that the 
intensity of the bands corresponding to Hsp47 is very similar pre- and post-induction. This implies that 
protein expression was not enhanced by induction with IPTG. 
 
Subsequently, the protein culture was incubated at 25 oC. The turbidity of the culture was 
monitored by taking a 1 ml sample from the culture and measuring its absorbance. Once an 
OD600nm of 0.6 was reached, the culture was induced with IPTG. The absorbance was 
monitored thereafter until a plateau was reached, indicating that cells could be harvested. The 
absorbance measurements were used to plot a growth curve (Figure 3.7) to illustrate the 
absorbance after induction. 
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Figure 3.7. A growth curve of a protein culture at 25 oC. There was a steady increase in absorbance 
that continued after induction, followed by a deceleration phase. 
 
Analysis of the gel for the culture at 25 oC demonstrated that there was no Hsp47 present in 
the pre-induced sample (as expected) and the amount of Hsp47 produced post-induction 
gradually increased with time (Figure 3.8).  
 
 Lanes 
        1       2        3       4        5       6        7       8 
 
 
 
 
 
 
Figure 3.8. SDS-PAGE analysis of Xenopus laevis Hsp47 expression at an incubation 
temperature of 25 oC. The results reveal that the expression of the protein ~47 kDa increased with 
time. 
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The size of the major protein band in the post-induced samples (lanes 4-8) represents Hsp47 
with a HP-thioredoxin tag. A Western blot (not shown) confirmed that the bands represented 
Hsp47. The Hsp47 band became more distinct at 3 hours, indicating an increase in protein 
expression; therefore this was decided as the optimum time for induction. 
 
Once the optimum incubation conditions had been established these conditions were used to 
check the expression of Hsp47 Xenopus laevis in pET102/D-TOPO®. SDS-PAGE (Figure 
3.9) revealed that a large band appeared for all the 5 ml cultures that were induced, 
confirming that over expression of the protein was taking place. 
 
 
 
 
 
 
 
 
 
                    Lanes 
         1          2        3         4         5        6         7 
                               
 
                Hsp47 control    Hsp47 + intein tag 
                   175 
 
                     62 
   
47.5 
 
 
              32.5 
 
 
16.5 
kDa 
Lane 1: Hsp47 control marker 
Lane 2: Protein molecular       
weight markers 
Lane 3: Induced sample 1 
Lane 4: Induced sample 2 
Lane 5: Induced sample 3 
Lane 6: Induced sample 4 
Lane 7: Pre-induction 
Figure 3.9. SDS-PAGE of Xenopus laevis Hsp47 expression by pET102/D-TOPO®. The bands at 
~62 kDa represented Hsp47 with an attached 16 kDa HP-thioredoxin tag. Induced samples 1-4 are 
repeats of the same expression experiment to ensure reproducibility of protein expression.  
 
The uninduced and induced samples contained a protein with a molecular weight of 
approximately 62 kDa. Presence of protein in the uninduced fraction is due to leaky 
expression. This was consistent with the combined molecular weight of Hsp47 and the HP-
thioredoxin tag (16 kDa) in the vector. The additional mass reduced protein mobility, 
resulting in slower movement along the gel. Due do the large size of the band, it was 
 117
estimated that approximately 70% of the protein being expressed was Hsp47. The enhanced 
protein expression was thought to be due to the presence of the HP thioredoxin. 
 
from pET-32 Xa/LIC  
The attempted cleavage of the thioredoxin using enterokinase was unsuccessful and so the 
gene was cloned into pET-32 Xa/LIC. This vector comprises a thrombin and factor Xa sites 
for the cleavage of the thioredoxin tag. It was thought that the presence of two possible 
cleavage sites would increase the chance of successfully removing the fusion tag. 
 
Successful recombinants of vector containing insert were used to transform BL21 star (DE3) 
One Shot Cells. Presence of multiple colonies indicated that the transformation was 
successful. 
 
As before, overnight cultures were grown and induced, cells were harvested and centrifuged. 
SDS-PAGE (Figure 3.10) was used to analyse the samples.  
83 
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Lane 1:   Protein molecular weight marker 
Lane 2:   Hsp47 control marker 
Lane 3:   Expression culture 1 - induced 
Lane 4:   Expression culture 2 - induced 
Lane 5:   Expression culture 3 - induced 
Lane 6:   Expression culture 4 - induced 
Lane 7:   Expression culture 1 - uninduced 
Lane 8:   Expression culture 2 - uninduced 
Lane 9:   Expression culture 3 - uninduced 
Lane 10: Expression culture 4 - uninduced 
Hsp47 
kDa 
 
Figure 3.10. SDS-PAGE of Xenopus laevis Hsp47 expression in pET-32 Xa/LIC. The protein 
bands at ~62 kDa represent Hsp47 with a thioredoxin tag. These bands are not present in the 
uninduced samples (lanes 7-10) but are clearly visible in the induced samples (lanes 3-6). Expression 
cultures 1-4 represent repeats that were performed under similar conditions to ensure reproducibility. 
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SDS-PAGE analysis revealed that the induced samples showed successful expression of 
Hsp47 whereas the uninduced samples did not show this expression. A Western blot 
confirmed that the over-expressed bands corresponded to Hsp47. The increased molecular 
weight was due to the presence of the HP-thioredoxin in the construct. 
 
from pTYB12 
5 ml overnight cultures of colonies from the transformations were set up. The following day a 
1 ml sample was diluted to 3 ml and left to grow until an OD600nm of approximately 0.6 was 
reached. 1 mM IPTG was then added to induce protein expression and the culture was 
induced for a further 4 hours at 37 oC. After this period the cells were harvested by 
centrifugation and analysed by SDS-PAGE (Figure 3.11). 
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Lane 1: Protein molecular weight marker 
Lane 2: Expression culture 1 - uninduced  
Lane 3: Expression culture 2 - uninduced 
Lane 4: Expression culture 3 - uninduced 
Lane 5: Expression culture 4 - uninduced 
Lane 6: Expression culture 5 - uninduced 
Lane 1: Protein molecular weight marker 
Lane 2: Expression culture 1 - induced   
Lane 3: Expression culture 2 - induced 
Lane 4: Expression culture 3 - induced 
Lane 5: Expression culture 4 - induced 
Lane 6: Expression culture 5 - induced 
 
Figure 3.11. SDS-PAGE of Xenopus laevis Hsp47 expression by pTYB12. The molecular weight of 
Hsp47 with an intein tag (55 kDa) was 102 kDa. (a) The uninduced samples did not show distinct 
bands at ~100 kDa. However, expression cultures 2, 3 and 5 (lanes 3, 4 and 6, respectively) revealed 
faint bands at this position. (b) The induced fractions were not distinctly different from the uninduced 
fractions. Closer examination of the gels revealed that the induced fraction of expression culture 1 
produced a band at ~100 kDa, which was absent in the uninduced fraction. The ~100 kDa band in 
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expression culture 5 was more concentrated than the ~100 kDa band of the uninduced fraction of 
expression culture 5. Expression cultures 1-5 represent experiments that were performed under similar 
conditions to monitor the reproducibility of protein expression.  
 
The gels demonstrated a very subtle change in protein concentration between the uninduced 
and induced fractions. Only a very slight difference could be seen between the pre- and post-
induced samples of expression cultures 1 and 5. A Western blot was performed and a band 
was seen at the 47 kDa position, confirming that the protein band did in fact correspond to 
Hsp47.  
 
In spite of low basal and induced expression levels, cultures that showed successful 
expression of Hsp47 will be used for protein purification as low induced expression levels are 
a common factor in protein expression. 
  
In summary, the results from the expression experiments demonstrated that Xenopus laevis 
Hsp47 was successfully expressed in pET102/D-TOPO®, pET-32 Xa/LIC and pTYB12 and 
the protein was soluble in all constructs. The expression of the protein cloned into pET101/D-
TOPO® however was unsuccessful. 
 
3.2.2.2 Expression of Danio rerio Hsp47 
from pET101/D-TOPO® 
The recombinant plasmid was used to transform BL21 star (DE3) One Shot Cells (as 
described in section 2.7). Subsequently the expression of Hsp47 in the transformed cells to 
was tested (as described in section 2.9). These cultures however, failed to express protein and 
so were not studied further. 
 
 
 120
from pET102/D-TOPO® 
As before, transformation of the BL21 star (DE3) One Shot Cells was followed by assessing 
the expression level of the protein. The results of the SDS-PAGE showed that thioredoxin 
tagged Hsp47 was being expressed.  
 
from pET-32 Xa/LIC 
The Hsp47 gene from Danio rerio was successfully cloned into the pET-32 Xa/LIC vector 
and the construct used to transform BL21 star (DE3) One Shot Cells. Successful 
transformations enabled expression levels to be determined. Samples analysed by SDS-PAGE 
revealed that expression of the protein was taking place after induction by IPTG. 
 
Cloning of Danio rerio Hsp47 into pET101/D-TOPO®, pET102/D-TOPO®, pET-32 Xa/LIC 
were performed in our lab prior to this study but did not involve me. From this point onwards, 
all work, whether Xenopus laevis or Danio rerio Hsp47 was performed by me. 
 
from pTYB12 
Expression of Hsp47 was checked following successful transformation into BL21 star (DE3) 
One Shot Cells. This involved inoculation of a culture of LB containing ampicillin followed 
by induction of protein expression with IPTG (see section 2.8). Samples were collected pre- 
and post- induction to determine whether Hsp47 was being produced. 
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Lane 7: Expression culture 3 - uninduced 
Lane 8: Expression culture 3 - induced 
 
Figure 3.12. SDS-PAGE of Danio rerio Hsp47 expression in pTYB12. Lanes 3, 5 and 7 show 
uninduced fractions whilst lanes 4, 6 and 8 represent induced fractions. Expression cultures 1-3 are 
repeats of the expression experiment under similar conditions to check the reproducibility of protein 
expression under the specified conditions. 
 
The SDS-PAGE results revealed that the pre- and post- induction samples showed similar 
levels of protein expression as the bands that appear in the induced fractions (lanes 4, 6 and 8) 
were also present in the uninduced fractions (lanes 3, 5 and 7). The size of Hsp47 with the 
intein tag (55 kDa) is approximately 100 kDa. A Western blot was carried out to determine 
whether the bands at ~100 kDa represented Hsp47 (Figure 3.13). The results however were 
negative, showing no bands with a molecular weight of 100 kDa, suggesting that Hsp47 was 
not being produced by this construct.  
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 Lane 1: Xenopus laevis Hsp47 in pTYB12 
Lane 2: Danio rerio Hsp47 in pTYB12 
  1             2  
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47.5 
83 
62 
Hsp47 + intein 
kDa 
Hsp47 alone 
Figure 3.13. A Western blot of Danio rerio and Xenopus laevis Hsp47 in pTYB12. The bands at 47 
kDa in lanes 1 and 2 denote that both Xenopus laevis and Danio rerio expressed Hsp47 without the 
intein tag. Only Xenopus laevis however, produced a band at ~100 kDa, representing Hsp47 with 
attached intein tag (lane 1). 
 
The absence of a band at ~100 kDa (Hsp47 + intein) and the presence of a band at 47 kDa 
(Hsp47 - intein) in the Danio rerio sample suggested that the construct was not expressing 
intein tagged Hsp47 but was expressing non-tagged Hsp47. 
 
3.2.3 Protein Purification 
Purification of Hsp47 from pET102/D-TOPO® and pET-32 Xa/LIC involved Ni-NTA 
immobilised on beads whilst protein produced by the pTYB12 construct involved purification 
using chitin resin.  
 
3.2.3.1 Purification of Hsp47 from Xenopus laevis 
in pET102/D-TOPO® 
As the construct cloned into the pET102/D-TOPO® vector resulted in substantial expression 
of protein, it was used to attempt to purify the Hsp47. The presence of both HP-thioredoxin 
and a C-terminal His tag allowed purification using Ni-NTA affinity chromatography. 
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Samples were collected throughout protein purification for analysis on SDS-PAGE (Figure 
3.14).  
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kDa 
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Figure 3.14. SDS-PAGE for purification of Xenopus laevis Hsp47 in pET102/D-TOPO® 
construct. The presence of a very intense band at ~47 kDa band in lane 2 suggested that the majority 
of the protein being produced was Hsp47. The protein in lanes 3 and 4 implied that of the protein 
being produced, most of this was insoluble. Lanes 6 and 7 demonstrated pure, soluble protein. 
 
The results revealed that although this construct produced large amounts of Hsp47, the 
majority of this was insoluble (Lane 4) and was probably in inclusion bodies. The lack of a 47 
kDa distinct band in lane 5 implied that the majority of the soluble Hsp47 bound to the Ni-
NTA for purification via metal affinity chromatography. The bands at 47 kDa in lanes 6 and 7 
(elution I and II, respectively) illustrated that the purification of the little soluble Hsp47 was 
successful and pure, soluble Xenopus laevis Hsp47 was obtained. The fractions of pure 
protein were stored at -70 oC for structural and biochemical analysis. 
 
A Western blot (Figure 3.15) was carried out to confirm the findings of the SDS-PAGE. As 
this technique is more sensitive and used antibodies specific for Hsp47, any protein that 
showed up was essentially Hsp47. 
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Figure 3.15. A Western blot of purification of Xenopus laevis Hsp47 in pET102/D-TOPO® 
construct. An over-expressed band at 47 kDa in the cell lysate fraction (lane 1) confirmed that the 
majority of the protein being produced was Hsp47. Lanes 2 and 3 suggest that there was no soluble 
Hsp47 present but a small amount of insoluble protein was produced. The absence of a 47 kDa band in 
lanes 5 implied that no pure Hsp47 was eluted. 
 
The above Western blot was not very clear as there was a lot of background noise and the 
antibody did not seem to react well to the protein. A monoclonal anti-Hsp47 mouse primary 
antibody was used for all Western blots. It may be that the mouse antibody does not react well 
to Hsp47 from other organisms, resulting in reduced sensitivity and therefore compromised 
results. 
 
The results of the Western blot (Figure 3.15) told a different story from the results of the 
SDS-PAGE (Figure 3.14). Similarly, both the SDS-PAGE and Western blot showed that there 
was a large amount of Hsp47 being produced. However, whereas the SDS-PAGE illustrated 
that there was an elution band present at 47 kDa the Western blot did not show a band in this 
fraction, suggesting that this was not the case. Also, the amount of insoluble Hsp47 was 
considerably lower in the Western blot in comparison to the SDS-PAGE. Furthermore, the 
Western blot did not reveal a distinct band in the elution lane (Figure 3.15, lane 5); implying 
that purification of soluble Xenopus laevis Hsp47 using Ni-NTA was unsuccessful. 
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Purification of Hsp47 in the insoluble fraction using pET102/D-TOPO® 
Purification of the protein in the insoluble fraction was attempted in order to increase the 
yields of pure Hsp47.  
 
Unfolding the Hsp47 
In order to obtain a larger amount of soluble Xenopus laevis Hsp47, the insoluble form of the 
protein was unfolded using 8 M urea. It was thought that the His tag may be buried within the 
insoluble protein, unable to interact with the Ni2+ ions of the Ni-NTA resin, thereby 
preventing protein purification. 
 
Unfolding of the protein involved resuspension of the cell debris (insoluble protein) fraction 
in a buffer comprising of 8 M urea. The wash and elution buffers used during protein 
purification by Ni-NTA also contained urea (see section 2.2.8 for a more detailed method). 
 
SDS-PAGE analysis was used to determine protein solubility following protein unfolding. 
Lanes 
1       2      3      4      5      6      7      8      9 
Lane 1: Hsp47 control marker 
Lane 2: Soluble fraction 1 
Lane 3: Soluble fraction 2 
Lane 4: Soluble fraction 3 
Lane 5: Soluble fraction 4 
Lane 6: Insoluble fraction 1 
Lane 7: Insoluble fraction 2 
Lane 8: Insoluble fraction 3 
Lane 9: Insoluble fraction 4 
47 kDa 
  
Figure 3.16. SDS-PAGE of unfolding of insoluble Xenopus laevis Hsp47. The presence of bands at 
47 kDa in lanes 2-5 suggested that some of the insoluble protein had been unfolded and was now 
soluble. The large bands at 47 kDa in lanes 6-9 illustrate that the majority of the protein was still 
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insoluble, however. Fractions 1-4 represent repeats of the unfolding experiment from different 
expression cultures. 
 
The results from the unfolding experiment illustrated that the use of urea in the purification 
buffers converted some of the insoluble material into a soluble form. 
 
Refolding Hsp47 
Dialysis was used to remove the urea from the unfolded protein and consequently allow 
protein refolding. Four experiments were set up to determine the refolding conditions. Each 
experiment consisted of 1 ml of unfolded protein containing 8 M urea being placed into 
buffers of differing urea concentrations for various durations. The protein to be refolded was 
placed in dialysis tubing with a molecular weight cut off of 12,000-14, 000 Da prior to 
dialysis. 
 
The experiments were set up as follows: 
     UREA CONCENTRATION IN BUFFER 
 EXPERIMENT 6M  4M  2M  0M 
 1 
 2 
 3 
 4 
Overnight 
Overnight 
Overnight 
Overnight 2 hours 4 hours 
6 hours 
2 hours 2 hours 2 hours 
Experiment 1, for example, started with dialysis of the protein in 6 M urea for two hours, 
followed by dialysis in 4 M urea for two hours and then 2 two hours in 2 M urea before 
dialysing it in water overnight. 
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SDS-PAGE was used to analyse the protein samples after the dialysis was complete. 
Lanes 
1    2    3    4     5    6    7    8    9   10
83 
Lane 1:        Protein molecular weight marker 
Lane 2:        Hsp47 control marker 
Lanes 3-6:   Soluble protein after refolding 
Lanes 7-10: Insoluble protein after refolding 
62 
47.5 
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32.5 
16.5  
Figure 3.17. SDS-PAGE of refolding of insoluble Xenopus laevis Hsp47. The presence of bands at 
~63 kDa in lanes 3-6 indicates that soluble protein (thioredoxin-tagged Hsp47) was present after the 
refolding experiment. However, the higher intensity bands in lanes 7-10 illustrate that the majority of 
the protein was still insoluble. 
 
in pET-32 Xa/LIC 
Hsp47 produced from this construct was also purified by metal affinity chromatography using 
Ni-NTA. As with the pET102/D-TOPO® vector, fractions were collected during the 
purification procedure for analysis by SDS-PAGE. 
 
Lanes
1     2    3     4     5    6    7     8    9   10
 
Lane 1:   Protein molecular weight marker 
Lane 2:   Hsp47 control marker 
Lane 3:   Induced sample 
Lane 4:   Insoluble protein 
Lane 5:   Soluble protein 
Lane 6:   Unbound fraction 
Lane 7:   Wash fraction 
Lane 8:   Elution fraction I 
Lane 9:   Elution fraction II 
Lane 10: Ni-NTA resin after purification  16.5 
32.5 
47.5 kDa 
62 
83 
Figure 3.18. SDS-PAGE for purification of Xenopus laevis Hsp47 in pET-32 Xa/LIC construct. 
Presence of a band in the induced fraction (lane 3) at 47 kDa suggests that Hsp47 was being produced. 
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The bands in lanes 8 and 9 at ~63 kDa correspond to thioredoxin tagged Hsp47, suggesting that pure 
Hsp47 was obtained. 
 
Analysis of the SDS-PAGE suggested that although the protein expression was small in 
comparison to the pET102/D-TOPO® vector, the majority of the protein was soluble and 
bound to the Ni-NTA resin. This can be seen if Figure 3.18 as there is no distinct band at ~63 
kDa in lane 7. Some of the protein bound more tightly as it remained on the Ni-NTA even 
after protein elution with 250 mM imidazole (lane 10). 
 
in pTYB12 
Protein produced by the pTYB12 construct was purified using a chitin column. A chitin 
binding domain on the self-cleavable intein tag fused to Hsp47 allowed affinity purification of 
the protein. DTT was used for on-column cleavage of the intein tag from the recombinant 
protein (method described in section 2.10). SDS-PAGE was used to analyse the samples 
collected throughout the purification procedure. 
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Figure 3.19. SDS-PAGE for purification of Xenopus laevis Hsp47 in pET-32 Xa/LIC construct. 
(a) The ~102 kDa band in lane 4 represents Hsp47 with an intein fusion tag (55 kDa). Lane 5 
illustrates that there was not much protein present in the flow-through fraction, suggesting that most of 
the protein bound to the chitin column. However, the intensity of the band at 102 kDa in lane 7 implies 
that the majority of the bound protein did not elute from the column. (b) Lanes 5-8 show faint bands at 
47 kDa, corresponding to Hsp47 without the intein fusion tag. The low intensity of the bands, however 
suggest that there was a small amount of intein-free material after cleavage. Elutions fractions 1-11 are 
fractions collected during the on-column cleavage with DTT. 
 
The protein produced by this construct was soluble as illustrated by the 102 kDa band in the 
cell lysate fraction (Figure 3.19(a), lane 4). The absence of distinct bands in the flow-through 
and wash fractions (Figure 3.19(a), lanes 5 and 6, respectively) implied that most of the 
expressed Hsp47 bound to the chitin column. However, much of this was not released upon 
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cleavage of the intein and remained bound to the column (Figure 3.19(a), lane 7). 
Nevertheless, there was some cleaved Hsp47 eluted from the column (Figure 3.19(b), lanes 5-
8) that could be used for further analysis. 
 
3.2.3.2 Purification of Hsp47 from Danio rerio  
in pTYB12   
Purification using this vector was not successful as the protein did not elute from the chitin 
beads. However the protein preparation produced soluble protein which could be used for 
further attempts to purify this protein. A possible explanation for the unsuccessful purification 
may be due to the lack of intein tagged Hsp47 that was produced. Figure 3.13 illustrated that 
there was no Danio rerio intein-Hsp47 being expressed. Without the intein, protein 
purification on chitin resin would not be feasible due to the absence of the CBD. 
 
3.2.4 Fusion tag cleavage 
Cleavage of fusion tags was necessary because collagen-binding assays with fusion tagged 
Hsp47 showed no binding between protein and its substrate. It was therefore hypothesised 
that the His and/or thioredoxin tags may be interfering with the interaction of Hsp47 to 
collagen. 
 
3.2.4.1 Cleaving the Thioredoxin tag from the pET102/D-TOPO® construct 
The pET102/D-TOPO® vector contains an enterokinase (EK) cleavage site (illustrated in 
Figure 3.20) hence EKMaxTM was used to attempt to cleave the thioredoxin from the 
pET102/D-TOPO® construct.  
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 Figure 3.20. Illustrating the position of the EK cleavage site on the pET102/D-TOPO® vector. 
 
Xenopus laevis 
Two cleavage assays were run at 37 oC to determine optimum cleavage conditions. Varying 
EK concentrations and cleavage incubation times were tried in order to cleave the thioredoxin 
tag from the protein. The concentration of EK ranged from 0 μg/ml to 12.8 μg/ml, and two 
cleavage incubation periods of 6 and 24 hours were used.  
 
Due to the minimal amount of pure protein obtained from this vector, detection of the protein 
following the cleavage with EK required the use of the silver stain method for detection of 
protein (Figures 3.21).  
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Figure 3.21. Result of digestion of thioredoxin tagged Xenopus laevis Hsp47 with enterokinase. 
(a) Samples digested for 6 hours with differing amounts of protease. The absence of bands at 47 kDa 
in lanes 4-9 suggest that there was no successfully cleaved Hsp47 present. (b) Samples digested 
overnight with differing amounts of enterokinase. Again, no Hsp47 was visible in any of the fractions 
representing digested protein, implying that that cleavage was unsuccessful. 
 
EKMaxTM is a clone of the catalytic subunit of enterokinase and has a molecular weight of 43 
kDa. The results from the 6 hour and overnight digestions revealed that there was no Hsp47 
present in any of the fractions but EK was present in all the fractions. This suggested that 
there was not enough Hsp47 in comparison to EK or it may have been that there was non-
specific cleavage by the protease, resulting in complete digestion of Hsp47. 
  
Danio rerio 
As with Xenopus laevis, various concentrations of EK were used to try to cleave the 
thioredoxin tag. Two cleavage assays were run at 37 oC, using EK concentrations ranging 
from 0-12.8 μg/ml and reaction times of 6 and 24 hours. The result was digestion of the entire 
protein. This indicated that either the enzyme concentration was too high or the incubation 
period was too long. Consequently, the EK concentration was lowered 100 fold and the 
32.5 
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cleavage incubation time was reduced to 3 hours. However this also proved to be ineffective 
as the SDS-PAGE illustrated one band corresponding to uncleaved thioredoxin tagged Hsp47. 
Another attempt at cleaving the fusion tag involved keeping the time for cleavage at 3 hours 
and varying the enzyme concentration between from the highest concentration where 
complete digestion of the protein occurred to the lowest concentration where no cleavage took 
place. The results revealed that no cleavage occurred at enzyme concentrations lower than 8 
μg/ml and non-specific cleavage occurred at EK concentrations of 8 μg/ml and above. These 
results demonstrate that the failure to cleave the thioredoxin could be due to the tag being 
buried in the protein structure and not fully exposed.  
 
On-column cleavage where the protein was cleaved whilst on the Ni-NTA column was 
attempted. This involved incubation of the column with 8 μg/ml of EK at 37 oC. Elution of the 
protein required 50 mM Tris-HCl buffer, pH 8.0 containing 250 mM imidazole. This attempt 
also proved to be unsuccessful. 
 
The failure to cleave the thioredoxin tag on all attempts indicated that the EK was not 
recognising the cleavage site. 
 
As with Xenopus laevis, all cleavage attempts were unsuccessful so it was decided that the 
uncleaved thioredoxin tagged protein would be used for protein characterisation studies. 
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3.2.4.2 Cleaving the Thioredoxin tag from the pET-32 Xa/LIC construct 
This construct contained both Factor Xa (fXa) and thrombin cleavage sites. 
 
Factor Xa Thrombin 
 
 
Figure 3.22. Protease cleavage sites on pET-32 Xa/LIC. Cleavage with thrombin cleaves the N-
terminal thioredoxin and His tag. Factor Xa cleaves also cleaves the N-terminal S tag in addition to the 
thioredoxin and His tag. 
 
The ability of these proteases to cleave the fusion tag was tested simultaneously. Experiments 
were set up so that the each individual protease and a combination of the two proteases were 
tested for their ability to cleave the thioredoxin tag. 
 
Xenopus laevis 
The initial protein cleavages, one with factor Xa alone and another with only thrombin were 
inconclusive as it was unclear whether the cleavages were successful. Therefore a second set 
of cleavage experiments (described in section 2.9.2) were set up to achieve a more definitive 
result. The results for both experiments are shown below. 
 
 
 
Thioredoxin Tag His. tag S. tag Hsp47 T7 Promoter His Tag 
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  Lanes Lane 1: Protein molecular weight markers 
 
Figure 3.23. SDS-PAGE of attempted cleavage of thioredoxin tag from Xenopus laevis Hsp47 
from pET-32 Xa/LIC using thrombin and factor Xa. The absence of a 47 kDa band in the fractions 
representing cleavage with thrombin (lanes 3-9) suggests that it was unsuccessful. Lanes 10-14, 
however, representing cleavage attempts with factor Xa, revealed bands at 47 kDa implying that 
cleavage of the thioredoxin tag with this protease was successful. 
 
The attempted cleavage of the thioredoxin tag was unsuccessful even when left overnight. 
This is evident from Figure 3.23 as the bands at ~59 kDa (representing Hsp47 with attached 
thioredoxin tag) were present in all the fractions, even when the cleavage was left to occur 
overnight. Furthermore, there were no bands at 47 kDa in any of the fractions, confirming the 
absence of tag-free Hsp47. The cleavage of the thioredoxin tag with factor Xa, on the other 
hand was successful when left from 0-4 hours (Figure 3.23, lanes 10-13, respectively). The 
presence of a 47 kDa band in the fraction representing 0 hour cleavage time suggested that 
cleavage of the tag occurred immediately after the protease was added to the protein solution. 
 
The second cleavage attempt involved four experiments; the first was a control in which no 
proteases were added, the second was an attempted with thrombin only, the third was 
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cleavage with factor Xa alone and the fourth cleavage attempt was with both thrombin and 
factor Xa together. The experiments showed variable success. 
 
Thioredoxin-tagged Hsp47 
 1    2     3     4    5     6     7 
Lanes 
 
Figure 3.24. SDS-PAGE results for second attempted cleavage of the thioredoxin tagged 
Xenopus laevis Hsp47 from pET-32 Xa/LIC. The absence of a 47 kDa band in lane 5 implies that 
cleavage with thrombin was unsuccessful. Cleavage with factor Xa alone and thrombin + factor Xa 
together (lanes 6 and 7, respectively) revealed a band at 47 kDa, implying that cleavage of the 
thioredoxin tag was successful. 
 
As previously, the attempted cleavage with thrombin was unsuccessful as it did not yield a 
band that corresponded to non-tagged Hsp47. The cleavage with factor Xa (Figure 3.24, lane 
6) revealed a band at 47 kDa, suggesting that cleavage of the thioredoxin tag with this 
protease was successful. The cleavage with thrombin and factor Xa also showed a band at 47 
kDa; however this was most probably due to the factor Xa rather than the thrombin as all 
previous cleavage attempts with thrombin were unsuccessful. As well as the 47 kDa band, 
lanes 6 and 7 also illustrated a band at ~59 kDa (corresponding thioredoxin tagged Hsp47) 
which implied that the some tagged protein was also present. 
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Danio rerio 
SDS-PAGE revealed that digestion with thrombin resulted in non-specific cleavage; however 
the cleavage with factor Xa was successful, forming Danio rerio Hsp47 without an N-
terminal fusion tag. 
 
 
3.2.5 Collagen Binding Assays 
The activity of the protein was determined using collagen binding assays. It was thought that 
active Hsp47 should bind to collagen whilst inactive protein should not.  
 
The assay involved thawing 0.5 ml of frozen pure Hsp47 and spinning at 14, 000 x g to 
remove any aggregated insoluble protein. 50 μl of the resulting supernatant was combined 
with 50 μl collagen agarose beads along with 50 μl Tris buffer (100 mM Tris-HCl, 150 mM 
NaCl, pH 8.0) and the mixture incubated on ice for 30 minutes with turning. Any bound 
protein was removed after spinning again at 14, 000 x g for 5 minutes. The column was then 
washed and a sample of the resin beads was retained for SDS-PAGE.  
 
3.2.5.1 Collagen Binding properties of Hsp47 in pET102/D-TOPO® 
Xenopus laevis 
The results for the collagen binding assay (shown in Figure 3.25) in this vector showed that 
the protein did not bind to either the control or collagen resin. 
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 Figure 3.25. SDS-PAGE of collagen binding assay for Xenopus laevis Hsp47 from pET102/D-
TOPO® construct. The presence of ~63 kDa bands in lanes 3 and 4 suggest that the HP thioredoxin 
tagged protein did not bind to either the control or collagen-agarose resin. This is confirmed by the 
absence of any protein in the fractions corresponding to resin samples (lanes 5 and 6). 
 
The result for the collagen binding assay demonstrated that the uncleaved Hsp47 produced by 
the pET102/D-TOPO® construct did not bind to either the control or collagen-agarose resin. 
This could be due to the HP-thioredoxin tag interfering with the binding of the protein to the 
collagen-agarose beads. 
 
Danio rerio 
The thioredoxin tagged Hsp47 had equal binding affinity for the control resin and the 
collagen-agarose beads. This indicates that the protein did not show specificity for collagen. 
This may be due to the N-terminal thioredoxin tag interfering with the collagen binding 
properties of Hsp47. 
 
3.2.5.2 Collagen Binding properties of Hsp47 in pET-32 Xa/LIC 
Xenopus laevis 
The results (Figure 3.26) indicated again that there was no binding of the protein to either the 
collagen or control (sephadex) resin. 
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Figure 3.26. SDS-PAGE of collagen binding assay for Xenopus laevis Hsp47 from pET-32 
Xa/LIC construct. The presence of bands at 47 kDa in both the supernatant fractions (lanes 3 and 5) 
suggested that the protein did not bind to either of the resins. 
 
As with the protein produced by the pET102/D-TOPO® construct, the Hsp47 from the pET-32 
Xa/LIC construct did not bind to either the control (sephadex) resin or the collagen-agarose 
resin, suggesting that the Hsp47 did not bind specifically or non-specifically. 
 
The inability of the protein to bind to either of the resins indicated that the C-terminal His tag 
must be interfering with the binding of the Hsp47 to collagen.  
 
Danio rerio 
Although the N-terminal thioredoxin had been successfully cleaved, the protein failed to bind 
specifically to collagen. This indicated that the C-terminal His tag must be interfering with the 
collagen binding properties of Hsp47. 
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3.2.6 Characterisation of the Protein 
Biophysical analyses were used for the determination of secondary structure composition and 
stability of the protein. Furthermore, the molecular weight and therefore oligomeric state of 
the protein could be calculated. 
 
As described in the previous section, the protein failed to bind collagen. Therefore CD was 
considered a useful technique to determine whether the lack of substrate binding was due to 
the fold or stability of the protein. 
 
 
3.2.6.1 Using Xenopus laevis Thioredoxin tagged Hsp47 from pET-32 Xa/LIC 
CD Results 
This involved two experiments that allowed the conformation of the protein to be determined. 
The first involved determination of secondary structure composition by measuring the change 
in CD signal over a wavelength range. The different secondary structures are identifiable 
according to the peaks produced between 180-260nm. Minima at 208 and 222 nm denote the 
presence of α-helices and a minimum at 216 nm represents β-sheet presence. Folded proteins 
also produce a positive signal between 190-200 nm. 
 
Xenopus laevis Hsp47 produced a spectrum (Figure 3.27) that represented a protein that was 
neither fully folded nor unfolded, but a protein that was partly folded. The minimum at 216 
nm, representing β-sheet was not evident and of the minima representing α-helical presence, 
only the minimum at 208 nm was clearly visible. Moreover, the signal at 200 nm was at -10 
mdeg, implying that was not fully folded. 
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Figure 3.27. CD spectrum of purified thioredoxin tagged Xenopus laevis Hsp47. The spectrum 
does not represent a fully folded protein due to the negative signal at 200 nm. A minimum at 208 nm 
denotes the presence of α-helices and a minimum at 216 nm implies presence of β-sheet character. 
  
The second experiment measured the effect of temperature on the protein conformation 
(Figure 3.28) to distinguish its melting point which would in turn allow determination of 
protein stability. It also allowed identification of whether the protein was in the stressed or 
relaxed state. The active monomer form of Hsp47 is known to be mesostable (unfolds at 
approximately 80 oC) whereas the oligomeric (inactive) forms unfold at greater than 100 oC. 
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Figure 3.28. Thermal denaturation curve (at 222 nm) for thioredoxin tagged Xenopus laevis 
Hsp47 from pET102/D-TOPO® construct. There is a transition with a midpoint of 42 oC. This 
gradual loss of structure implies the unfolding of material. 
 
Although slow denaturation of protein was evident from heating of the sample, the transition 
observed was not sharp. Hsp47 usually unfolds with a sharp transition, which represents a 
distinct loss of secondary structure rather than a gradual decline in the secondary structure 
composition. 
 
Taken together, the results from the circular dichroism experiments suggest that neither the 
spectrum nor the denaturation curve were characteristic of Hsp47. It was therefore thought 
that the protein was largely unfolded, which may have been due to the interference of the 
thioredoxin tag still fused to the Hsp47. The small transition observed during the denaturation 
experiment may be due to the unfolding of the thioredoxin tag rather than Hsp47 as there was 
not very much folded material present at the beginning of the stability experiment (as shown 
by Figure 3.27).  
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Size Exclusion Chromatography Results 
This was used to determine the approximate mass of the purified protein. The position at 
which the Hsp47 was eluted from the column was compared to the positions at which proteins 
of known mass were eluted and the molecular masses of the known proteins used to calculate 
a probable mass of the Hsp47 purified in this project. Figure 3.29 shows the position at which 
the purified Hsp47 eluted in the column. 
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Figure 3.29. Graph to show elution of Xenopus laevis Hsp47 by size exclusion chromatography. 
The peak at 83.35 ml signifies the elution of Hsp47. 
 
A western blot (data not shown) was used to confirm that the protein eluted was Hsp47. 
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A chromatogram for proteins of known masses was used to determine the size of the Xenopus 
laevis Hsp47. 
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Figure 3.30. Elution positions of proteins with known masses. Peak one is due to Ferritin- a 440 
kDa protein, peak two is Ig G- a 160 kDa protein, BSA (67 kDa) produces the third peak, ribonuclease 
A (13 kDa) is responsible for the fourth peak and the fifth peak corresponds to Vitamin B12- which is 
a 1.355 kDa protein. 
 
The positions at which each of the proteins eluted were used to plot a graph of volume vs. 
log10 mass (Figure 3.31) to determine the approximate mass of the purified Hsp47.  
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Figure 3.31. Determination of the mass of Xenopus laevis Hsp47. The masses of the known proteins 
were logged and used to plot a straight-line graph that could be used to get a log mass value for the 
Hsp47 protein. Figure 3.28 showed that the Hsp47 eluted at 83.35ml. This value was used to identify 
the point on the line that corresponded to the protein. Its log10 mass value could then be identified by 
looking at the y-axis value for the point on the line. The log10 mass is approximately 1.48. 
 
The antilog of 1.48 = 30.2, thus the mass of the purified Hsp47 was close to 30.2 kDa. This is 
lower than the known mass for Hsp47 (47 kDa) and the difference was probably due to the 
interactions between the protein and the gel filtration column. This was thought to be the case 
as SDS-PAGE of Xenopus laevis Hsp47 in pET102/D-TOPO® illustrated a band at 47 kDa 
(Figure 3.14). However, we identified that the purified protein was a monomer as the size of 
the protein clearly suggests that it could not be a dimer or otherwise. This was consistent with 
the results from the CD experiments, which identified the protein might be metastable. The 
interaction of the protein with the column may have been due to the partially folded state of 
the Hsp47, as suggested by the spectrum and denaturation analyses (Figures 3.27 and 3.28, 
respectively). 
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3.2.6.2 Using Danio rerio Thioredoxin tagged Hsp47 from pET102/D-TOPO® 
Size exclusion chromatography of Danio rerio Hsp47 was carried out in our lab prior to this 
study. The results from size exclusion chromatography showed that the protein was present in 
the hexameric form whilst the results from CD showed that the protein comprised of both α-
helices and β-sheets. There was very little structural change during the transition from 20 oC 
to 80 oC, suggesting that Danio rerio Hsp47 existed in a hyperstable conformation. 
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Table 3.1. Summary of results for Xenopus laevis and Danio rerio Hsp47. 
Construct contained self-cleavable intein tag 
- 
 
- 
Construct contained self-cleavable intein tag 
- 
 
- 
EK 
- - - * ** PTYB12 
- -  -   ** * pET-32 Xa/LIC 
metastable folded Non-specific - - - ** ** pET102/D-TOPO® 
- - - - - - No expression pET101/D-TOPO® Danio 
rerio 
- - - * ** PTYB12 
hyperstable unfolded     * * pET-32 Xa/LIC 
- -  - - - ** ** pET102/D-TOPO® 
- - - - - - No expression pET101/D-TOPO® Xenopus 
laevis 
Melt 
CD 
Spectra 
Collagen 
binding 
activity Thr + FXa Thrombin  FXa 
Cleavage of His tags 
Insoluble 
Protein Purification 
Soluble 
Vector Organism 
3.3 Discussion 
Heat shock protein 47 is a 47 kDa collagen specific molecular chaperone and is a member of 
the serpin superfamily of proteins. The majority of studies on Hsp47 have focused mainly on 
mouse Hsp47. However, this form of the chaperone is relatively insoluble and unstable in 
solution, making it difficult to work with. 
 
The genes for Danio rerio and Xenopus laevis Hsp47 were cloned into four vectors. 
Subsequently the protein was expressed and purified using various techniques. Following 
successful purification, cleavage of fusion tags was performed and subsequently the protein 
was characterised by CD and size exclusion chromatography. Activity was determined by 
collagen binding assays. 
 
Thus far, this research has focused on the Danio rerio and Xenopus laevis forms of Hsp47. 
Very little data has been published regarding these forms of the protein and it was hoped that 
they would be easier to work with. So far in this project, Danio rerio and Xenopus laevis 
Hsp47 have been successfully cloned, expressed and purified. The thioredoxin tagged form 
has also been characterized using collagen-binding assays, CD and size exclusion 
chromatography. 
 
Cloning of the Hsp47 Gene  
The cloning of Danio rerio Hsp47 into pET101/D-TOPO® was successful as the sequencing 
results indicated that the gene had successfully inserted into the vector, however over-
expression of the protein did not occur. E. coli use the majority of their protein synthesis 
machinery to over-express a protein, thus it is not surprising that expression problems arise 
[188]. One possible explanation for the lack of over-expression could be due to translational 
problems that are a result of Danio rerio having a different codon bias to E. coli. This occurs 
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because E. coli cells have inadequate tRNA to recognise particular codons on the eukaryotic 
gene. This can cause amino acid substitutions and frameshifts, halting translation and 
subsequently preventing over-expression of the protein. There are ways in which this problem 
can be overcome. One such method is the mutation of the codon that is disrupting the 
expression to a codon that is favoured by E. coli. Another method is to reduce the temperature 
during the growth of the culture so that protein expression is slowed and the chance of 
aggregation is reduced. The cloning results of Danio rerio Hsp47 into pET101/D-TOPO® 
suggested that this vector was unsuccessful as an expression vector for Xenopus laevis. 
 
Danio rerio and Xenopus laevis Hsp47 were successfully cloned into pET102/D-TOPO®. The 
recombinant plasmid was transformed into BL21 Star One Shot E. coli cells; subsequently 
soluble thioredoxin-Hsp47 was obtained for both Danio rerio and Xenopus laevis. The 
production of soluble protein was enhanced by the presence of the HP-thioredoxin tag at the 
N-terminus. The presence of a 6xHis tag at the C-terminus enabled the purification of the 
fusion protein using Ni-NTA. Cleavage of the thioredoxin tag using EK was unsuccessful 
albeit that the vector pET102/D-TOPO® encodes a cleavage site for this protease. This is a 
common problem as it has been encountered by groups working on other proteins [189]. It is 
thought that the EK may have been contaminated by other proteases, resulting in the non-
specific cleavages that were seen. A way of overcoming this problem may be the enterokinase 
EKMax. This protease is produced by over-expression in yeast cells and so undergoes post-
translational modifications meaning that is can be expressed without risk of protease 
contamination. This form of the EK is thought to be very specific; therefore the likelihood of 
fusion tag cleavage is greater.  
 
Both Danio rerio and Xenopus laevis Hsp47 was successfully cloned into pET-32 Xa/LIC. 
This vector possesses an N-terminal thioredoxin fusion tag at its N-terminal and a His tag at 
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its C-terminal. Cleavage of the N-terminus thioredoxin can be done using Thrombin or Factor 
Xa as this vector has cleavage sites for both these proteases. Transformation of the 
recombinant plasmid resulted in the production of soluble protein that could be purified using 
Ni-NTA resin. The thioredoxin tag was successfully cleaved using Factor Xa. Cleavage of the 
thioredoxin tag by Factor Xa resulted in the removal of vector encoded sequences from the 
purified protein leaving an N-terminal free of fusion tags. 
 
The cloning of the Danio rerio and Xenopus laevis Hsp47 gene into pTYB12 was also a 
success. Following transformation into BL21 Star One Shot Cells, soluble Xenopus laevis 
Hsp47 was obtained. Danio rerio Hsp47 has proved more difficult to attain and this will the 
primary aim of future work. As of yet only a small amount of pure Xenopus laevis Hsp47 has 
been acquired using the chitin resin and it is hoped that this can be increased once the 
optimum on-column cleavage conditions have been established. 
 
To conclude, it can be said that the pET101/D-TOPO® vector was not suitable for the cloning 
of the Hsp47 gene as expression could not be induced. Although the gene was successfully 
cloned into pET102/D-TOPO®, cleavage of the thioredoxin tag with EK resulted in non-
specific cleavage of the entire protein. Cloning into the pET-32 Xa/LIC was highly successful 
as it yielded pure, soluble protein from which successful thioredoxin fusion tag cleavage was 
enabled using Factor Xa. Cloning into the PTYB12 vector was also successful but produced 
only small amounts of soluble Danio rerio and Xenopus laevis Hsp47. 
 
Molecular Characterisation by Collagen Binding Assay 
Both the thioredoxin tagged (cloned into pET102/D-TOPO®) and non-thioredoxin tagged 
(cloned into pET-32 Xa/LIC) form of the protein failed to bind collagen. Therefore it seems 
likely that C-terminus fusion tags interfere with the collagen-binding site of Danio rerio and 
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Xenopus laevis Hsp47. This implied that the collagen-binding site is likely to be located near 
the C-terminus of the protein. Another possible explanation for the lack of Hsp47-collagen 
binding could be that the incompletely folded protein was inactive.  
 
Molecular Characterisation by CD and Size Exclusion Chromatography 
Hsp47 belongs to the serpin superfamily of proteins. A serpin moves from a metastable, 
native conformation to a hyperstable, cleaved conformation when the cleaved RCL inserts 
itself as a β-strand into the A-sheet (Figure 3.28). CD can be used to observe the changes in 
the stability of the protein, which can in turn identify the conformation of a serpin [152]. 
 152
Native state – metastable 
 Latent state – hyperstable  Cleaved state – hyperstable  
s4A linkage – hyperstable 
 
Figure 3.32. Possible serpin conformations. Denaturation of the native metastable form occurs at 
temperatures between 40 oC and 70 oC. The cleaved form is hyperstable and denatures at temperatures 
exceeding 100 oC. The latent and polymerized forms are also hyperstable and denaturation occurs at 
temperatures between 70 oC and over 100 oC. (Adapted from Gettins, 2002) 
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The CD results for Xenopus laevis Hsp47 showed that the protein (cloned into the pET102/D-
TOPO® vector) had a midpoint melting temperature of 42 oC, indicating that the protein was 
in the monomeric metastable form. The CD spectrum for the protein suggested the presence 
of α-helices and β-sheets; this is characteristic of members of the serpin protein superfamily. 
Results of the size exclusion chromatography were consistent with those obtained by CD, 
identifying the protein as being monomeric. 
 
The results from this study implied that purified Xenopus laevis Hsp47 existed in a partially 
folded, monomeric conformation that denatured upon heating to 80 oC. Due to the gradual 
loss of secondary structure during an increase in temperature and a CD spectrum denoting a 
partially folded protein, it was hypothesized that the thioredoxin tag prevented the correct 
folding of the protein. Furthermore, the prolonged transition upon denaturation was thought to 
be due to the unfolding of the thioredoxin rather than Hsp47. The results from the size 
exclusion experiment also strengthened this proposition as the interaction between Hsp47 and 
the column could have been a result of residues that are buried within the folded protein being 
exposed in the partially folded conformation, thereby forming unwanted contacts. 
 
Analysis of the CD results for Danio rerio Hsp47 in our lab suggested that the protein exists 
in a hyperstable conformation, which withstood denaturation when heated to 80 oC. These 
results indicate that self-insertion of the RCL has occurred. As Hsp47 does not possess 
protease inhibitory properties, cleavage by the RCL is unlikely. Therefore it seems likely that 
RCL insertion has occurred without cleavage; forming the latent form. Another possibility is 
that the protein had polymerised, where the RCL of one serpin inserts itself into the A-sheet 
of another serpin. The latent and polymerised forms of serpin conformations have been shown 
to have similar stabilities; both denaturing at temperatures between 70 oC and above 100 oC. 
Results from the size exclusion chromatography indicate that Danio rerio Hsp47 existed as a 
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trimer. This did not come as a surprise as mouse Hsp47 has also been shown to exist as trimer 
and it is thought that this may be significant to the association of Hsp47 to collagen [87]. 
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CHAPTER 4: Purification and Characterisation of Wild Type (WT) Mus 
musculus Hsp47 
 
4.1 Introduction 
Most of the previous work on WT Hsp47 has used the mouse form of the protein due to facile 
manipulation of the gene into vectors and non-problematic uptake of host bacterial strain 
cells. Furthermore, protein solubility and inconsistent protein expression have been a major 
issue in Hsp47 purification studies. 
 
As shown in Chapter 3, Xenopus laevis and Danio rerio Hsp47 were difficult to purify and it 
was proving problematic to produce Hsp47 free of any C-terminal tags. Therefore, a more 
reliable source of the protein was required in order to study the effect of pH on the structure 
and function of Hsp47. As the gene for Mus musculus Hsp47 had been successfully cloned 
previously and generally, mHsp47 had been shown to express a reliable, soluble form of the 
protein, it was decided that mHsp47 would be used for studying the effect of pH on the 
secondary and tertiary structure of Hsp47. WT mHsp47 contains five tryptophan residues and 
fourteen histidine residues. As explained in section 1.8, the binding and release of Hsp47-
collagen is pH dependent, occurring at a pH that is extremely close to the pKa of histidine 
residues. It is therefore widely believed that the protonation/deprotonation of histidine 
residues are involved in triggering the pH-dependent conformational change of Hsp47. El-
Thaher and coworkers [97] have studied this pH dependency and found that mutation of 
certain histidine residues altered the collagen binding activity of mHsp47. 
 
Examination of the sequences of Hsp47 from all species revealed eleven histidines that are 
conserved in over 90% of Hsp47 sequences (Figure 4.1). Two of these histidines (H302 and 
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H335) are conserved across the serpin superfamily, making them less likely to be involved in 
the activity of the chaperone. 
 
H220 H197 & H198 
H255 & H256 
H191 
H244 
H90 
H368 
H135 
H302 
H297 
H335 
H140 
Figure 4.1. Model Hsp47 structure illustrating positioning of histidine residues. 
 
The previous construct utilised a heat shock promoter to attempt to purify the untagged 
protein using a collagen affinity purification method. This is not ideal for mutant proteins that 
are thermally unstable and/or do not exhibit collagen binding. Therefore it was important to 
develop a construct that does not rely on collagen affinity (for example, using an added hexa-
hisidine tag) and that used a different induction system (such as an IPTG inducible promoter). 
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The gene for mHsp47 was cloned into the pCR®T7/NT-TOPO® vector by Dr. Taka and Dr. 
Olerenshaw at Imperial College. Expression of the protein was achieved by transformation 
into BL21 star (DE3) One Shot pLysS competent cells.  
 
This chapter details the analysis of this new construct. Mus musculus Hsp47 was 
overexpressed in E. coli and purified using collagen affinity chromatography. A pH gradient 
of 0.3 M phosphate pH 9.0 to 3.0 was used to elute the protein. The absorbance (at 280 nm), 
pH and salt concentration were recorded throughout the purification in order to establish when 
the protein eluted and the conditions under which this occurred. To probe the pH-dependent 
interaction of Hsp47 with collagen further, the secondary structure and stability of the protein 
was examined using CD spectroscopy. AUC was used to determine the approximate 
molecular weight and hence oligomeric state of the protein. The effect of pH on secondary 
structure was studied by monitoring changes in CD signal as protein solutions were titrated 
from pH 8.0 to 2.5. The activity of the eluted Hsp47 was established by observing its effect on 
collagen fibrillisation. 
 
Previous studies on the pH-dependent binding and release of Hsp47 from its substrate 
collagen by El-Thaher and coworkers [97] have shown that the interaction is abolished below 
pH 6.3. In order to elute the protein, El-Thaher and coworkers lowered the pH to 5.3 using 
Tris-HCl. The elution method used in this study differed from this in that a pH gradient was 
used so that the exact elution pH could be determined. Another difference was that in this 
study, the salt concentration was monitored to investigate its effect on the interaction of 
Hsp47 and collagen. Furthermore, the collagen-affinity chromatography method has an 
advantage in that any protein that is eluted upon reduction of the pH below 6.3 would be 
active as it remained bound to the  collagen during the wash and high pH elution gradient. A 
disadvantage of the affinity purification as opposed to the gel filtration method used by El-
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Thaher and coworkers was that the oligomeric state of the protein could not be determined 
immediately. However, in this study this was overcome by using AUC which provided 
information on the molecular weight as well as the polymeric nature of proteins.  
 
Collagen fibril formation 
The effect of the protein on collagen fibrillisation was investigated by measuring the effect of 
Hsp47 on the turbidity of collagen from calf Achilles tendons (method described in section 
2.2.13.5). Thomson and Ananthanarayanan have used physicochemical techniques to 
demonstrate the binding of Hsp47 to native and denatured collagen. They have shown Hsp47 
to prevent the in vitro aggregation of collagen into fibrils at neutral but not acidic pH [96], 
which is in agreement with the hypothesis of Hsp47 being involved in preventing the 
premature association of procollagen in the ER and during its transportation from the ER in 
vitro.  
 
Much of the studies of growth of collagen fibrils in vivo and the precipitation of collagen in 
vitro have focused on appearance using electron microscopy. The kinetics of fibril formation 
from collagen solutions has been studied in detail by G.C. Wood and coworkers [190-192]. 
They have investigated the precipitation of collagen fibrils in vitro in an attempt to better 
understand fibrillogenesis in vivo. This involved systematic studies examining how the pH, 
ionic strength, temperature and collagen concentration effect the rate of collagen fibril 
formation. The source of collagen was calf dermis that comprised of non-striated filaments, 
without any collagen fibrils. The course of precipitation was followed by measuring the 
turbidity of the solution. All precipitation curves consisted of a lag phase (where no 
precipitation occurred) and a subsequent growth phase that had a sigmoidal shape. It has been 
suggested that the two phases of the curves signify two consecutive steps in the precipitation 
process; both of which are enhanced by a rise in temperature. Therefore collagen fibril 
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formation is known to comprise of two phases; the nucleation phase which involves 
aggregation of particles in solution to form nuclei and a growth phase that consists of 
accumulation of the soluble material to form a precipitate [191]. Bensusan and Hoyt [193] 
showed that the width of the collagen fibrils in vitro is determined in the course of the lag 
phase, prior to any notable precipitation occurring. Therefore, it can be said that the lag phase 
is primarily associated with the creation of microfibril nuclei [194].  
 
The method used in this study was solely to study the collagen de-fibrillisation activity of the 
protein; therefore measurements were taken at a constant neutral pH. The collagen used was 
made from fresh calf Achilles tendons and isolated using acetic acid (method described in 
section 2.2.13.5). 
 
 
4.2 Results 
The PCR and cloning of mHsp47 were carried out by Dr. Olerenshaw and Dr Taka at Imperial 
College. All constructs were sequenced, the results of which are shown in the Appendices 
(Chapter 11, Appendix C). 
 
Purification of Mus musculus Hsp47 
Following successful cloning, the protein was expressed in E. coli and purified using collagen 
affinity chromatography using a pH gradient from pH 9.2 to 3.0, produced by varying 
quantities of 0.3 M dibasic sodium phosphate (pH 9.2) with 0.3 M monobasic potassium 
phosphate (pH 3.0). Data of absorbance, salt concentration and pH were recorded and an 
elution profile plotted (Figure 4.2). 
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Figure 4.2. Elution profile of WT Mus musculus Hsp47. The pH-dependent elution of Hsp47 was 
probed using a gelatin-agarose column and pH elution gradient from high pH to low pH. The graph 
exhibits two distinct absorbance peaks (pink trace), each of which represents a point at which protein 
was eluted from the column. Peak A corresponds to protein that was eluted at approximately pH 8.0 
whilst Peak B signifies protein that was eluted at approximately pH 6.1.  
 
The chromatogram illustrates two distinct absorbance maxima that signify the presence of two 
different forms of mHsp47. Peak A (eluted between 5-10 mins) represents a form that is salt 
concentration dependent. This is demonstrated in the profile as protein elution correlates with 
an increase in salt concentration, however the pH remains above 8.0. Peak B (eluted between 
32-40 mins) represents a form which is independent of salt concentration but dependent upon 
the pH. This is evident from the profile as the position of the peak correlates with a drop in 
pH whilst the salt concentration remains constant. The binding of this material to collagen 
was also salt-resistant. The pH at which this species was eluted was 6.1. This observation of 
two species is novel as this is the first instance in which peak A has been detected. Monitoring 
and varying the salt concentration enabled differentiation between two species of Hsp47 that 
require different conditions in order to be eluted from collagen. 
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Elution fractions were collected during the purification and analysed by SDS-PAGE. 
 
Lanes
 
  1        2        3       4      5      6      7       8       9    10
        Lane 1:   Protein molecular          
weight markers 
175 
        83 Lane 2:   Cell lysate 
Lane 3:   Cell debris 62 
 Lane 4:   Flow through kDa 
Lane 5:   Elution 1 47.5 
Lane 6:   Elution 5  
Lane 7:   Elution 6 32.5 Lane 8:   Elution 14  Peak A Lane 9:   Elution 15 
Lane 10: Elution 16             
                 (a) 
Hsp47 
 
Lanes
     1      2      3        4       5      6       7      8      9     10
 
 
    
    
175 Lane 1:   Protein molecular      
   weight markers 
Lane 2:   Elution fraction 59 83 
Lane 3:   Elution fraction 60 62 Lane 4:   Elution fraction 61 
kDa Lane 5:   Elution fraction 62 
Lane 6:   Elution fraction 63 47.5 
Lane 7:   Elution fraction 64 
Lane 8:   Elution fraction 65 32.5 
Lane 9:   Elution fraction 66 Peak B         
Lane 10: Elution fraction 67 
          
                (b) 
Figure 4.3. SDS-PAGE of purification of WT Mus musculus Hsp47. (a) Lanes 1-4 show fractions 
collected at each step of the purification procedure. Lanes 5-10 represent fractions corresponding to 
the salt dependent species (represented by the first peak in the absorbance curve). (b) Lanes 4-10 
correspond to the pH dependent, salt independent protein species (represented by the second peak in 
the absorbance curve). 
 
Analysis of the SDS-PAGE results show that most of the WT mHsp47 was present in the 
soluble form as there is a distinct band at 47 kDa in the cell lysate fraction (lane 1, Figure 
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4.3(a)) whereas the cell debris fraction (lane 3, Figure 4.3(a)) contained only a very small 
amount of insoluble Hsp47. The presence of Hsp47 in the flow-through fraction (lane 4, 
Figure 4.3(a)) suggested that not all of the soluble Hsp47 applied to the gelatin-agarose 
column bound and therefore was inactive. Lanes 5-10 (Figure 4.3(a)) illustrate protein 
fractions of the salt dependent, pH independent species. Figure 4.3(b) demonstrates protein 
fractions that were eluted upon reduction of the pH to 6.1; thereby being pH dependent. All 
the pH dependent fractions show a predominantly single band, indicating pure protein. 
 
Western blotting was used to confirm that the protein seen by SDS-PAGE was Hsp47.  
 
Lanes
      1       2       3      4      5      6       7      8       9 
175 Lane 1: Protein molecular weight 
 markers 83 
Lane 2: Cell lysate 62 
Lane 3: Flow-through 
47.5 Lane 4: Wash 
kDa Lane 5: Salt dependent species 32.5 Peak A Peak B Lane 6: Salt dependent species 
Lane 7: Elution fraction 
25 Lane 8: Elution fraction 
Lane 9: Elution fraction 16.5 
 
Figure 4.4. A western blot confirming the protein as Hsp47. The use of monoclonal, anti-Hsp47 
antibody enabled the identification of Hsp47 in the protein samples. The presence of bands at 47 kDa 
confirms that the protein was Hsp47. 
 
Structural characterisation of WT mHsp47 
CD was used to determine the folded state and α-helical and β-sheet content of the protein. 
CD requires chiral molecules that have helical electron motion. The CD signal is due to the 
stereochemistry of the amide bond and other side chains. The difference in the magnitude of 
absorption of left- and right- handed circularly polarised light provides information on the 
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secondary structure of molecules. α-helical content is denoted by minima at 208 and 222 nm 
and β-sheet content is signified by a minimum at 216 nm. A positive signal at 200 nm 
represents a folded protein species. 
 
A thermostatically controlled 0.2 cm pathlength quartz cuvette and a final protein 
concentration of 0.2 mg/ml were used for CD measurements. 
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Figure 4.5. CD spectra for WT Mus musculus Hsp47. The data for both the salt dependent and pH 
dependent species show spectra that are characteristic of a folded protein. Both forms produced 
minima at 208, 222 and 216 nm, suggesting the presence of α-helices and β-sheets, respectively. 
 
The stability of the protein was assessed using thermal denaturation by heating from 20 to 90 
oC at a constant temperature of 1 oC/min. A CD signal at 222 nm was measured in order to 
detect any changes that occur in the α-helix structure. The change in the ellipticity was 
monitored during the heating process. Such stability experiments can distinguish between the 
subforms of the serpin superfamily, notably the five stranded A-sheet which has a melting 
point between 50-70 oC and the six stranded A-sheet that has a melting point exceeding 90 oC.  
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slight unfolding 
Figure 4.6. Thermal denaturation curves for WT Mus musculus Hsp47. The pH dependent species 
demonstrated a clear transition with a midpoint of 55 oC in comparison to the salt dependent species 
which showed a slight transition with an increase in temperature. 
 
The CD data suggests that both the salt dependent and pH dependent forms are in the folded 
state and show spectra which demonstrate the presence of α-helix and β-sheet character. The 
thermal denaturation curves imply that the salt dependent species is of higher stability than 
the pH dependent species as it resists any major structural conformational rearrangement. This 
suggests that this species is in either the polymeric or latent serpin conformation. In the case 
of a polymeric conformation, the small transition observed between 50-60 oC may be due to 
destabilisation of the Hsp47 molecules at either end of a polymer. On the hand, if this species 
was to be in the latent serpin conformation, the destabilisation could be due to only partial 
insertion of the sixth β-strand into the A-sheet. Subsequently, the A-sheet would still lack the 
full complement of β-strands, making it less stable than an A-sheet containing six β-strands, 
and consequently reducing its resistance to destabilisation. The transition for the pH 
dependent species has a midpoint of 55 oC, denoting a five stranded A-sheet and thereby the 
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native serpin conformation. The metastable native fold is the biologically active form of a 
serpin due to the A-sheet lacking the full complement of β-strands. 
 
Comparison of the CD data for Xenopus laevis (Figures 3.27 and 3.28) and Mus musculus 
Hsp47 (Figures 4.5 and 4.6) revealed the structural differences in the protein from each of the 
species. The spectrum for Mus musculus Hsp47 (Figure 4.5) illustrated more defined minima 
at 216 and 222 nm, which are characteristic of β-sheet and α-helix, respectively. In 
comparison to this, the spectrum for Xenopus laevis Hsp47 (Figure 3.27) did not show distinct 
minima at either 216 or 222 nm. The thermal stability curves for Xenopus laevis and Mus 
musculus Hsp47 (Figures 3.28 and 4.6, respectively) also exhibit differences. Whilst the pH 
dependent species of Mus musculus Hsp47 demonstrated a sharp transition with a midpoint at 
55 oC and the salt dependent species revealed only a very slight unfolding, the denaturation 
curve of Xenopus laevis Hsp47 was intermediate between those of the two species of WT Mus 
musculus Hsp47. 
 
AUC was used to determine the oligomeric state of each of the species by centrifugation of 
protein samples at 40,000 rpm for 8 hours at 4 oC. The protein distribution in each cell was 
measured by continuously monitoring protein absorbance at 280 nm. SEDFIT was used to fit 
the data and obtain a sedimentation distribution. 
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Figure 4.7. AUC for WT Mus musculus Hsp47. The fit of the data revealed that the salt dependent 
species produced two peaks of similar intensities, suggesting the presence of polymers. The pH 
dependent species produced a predominantly single peak at 1.7 S. 
 
Analysis of the AUC data implied that the hyperstable, salt dependent species contains 
polymeric as well as monomeric species. The metastable, pH dependent species is 
predominantly monomeric (as illustrated by a single peak) with a sediment coefficient of 1.7 
S. This is similar to that of archetypal non-inhibitory serpin ovalbumin that has a sediment 
coefficient of 1.8 S and a molecular mass of 45 kDa. Transformation of the data for this study 
allowed calculation of an approximate molecular mass of 45-50 kDa; in agreement with the 
mass of monomeric Hsp47. 
 
Prior to the pH titration experiment, phosphoric acid was manually titrated into a 0.3 M 
phosphate solution at pH 9.3 to determine the volume and concentration of phosphoric acid 
required to reduce the pH of the solution to 6.0. The results were used to plot a titration curve 
(Figure 4.8) that allowed the identification of the points of inflection in relation to pH. 
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Figure 4.8. pH titration using phosphoric acid. The point of inflection is shown to be between pH 6.0 
and pH 5.0. 
 
The acid induced conformational change was probed by carrying out a pH titration 
experiment. This involved decreasing the pH of protein in solution from pH 8.0 to pH 3.0 by 
the addition of 2.5 μl aliquots of 1.52 M phosphoric acid using an autotitrator. The change in 
structure of the protein was monitored by measuring the CD signal at 222 nm which is 
sensitive to a change in α-helical character.  
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Figure 4.9. pH titrations of WT Mus musculus Hsp47. Both the salt dependent and pH dependent 
species gave a transition with a midpoint of pH 6.6, close to the pKa of histidine residues. The 
transition between pH 2.0 and 3.0 is due to glutamate and aspartate residues. 
 
The titrations illustrate that both species were able to undergo a structural transition upon a 
reduction in pH. 
 
Biological activity determination 
Collagen fibrillisation assays (outlined in section 2.2.13.5) were performed to establish the 
activity of the two forms of mHsp47 discovered. This involved investigating collagen fibril 
formation in the absence and presence of each of the species. The turbidity of the sample was 
monitored at 313 nm at 34 oC and any change would be indicative of a change in the 
fibrillisation of collagen. This was repeated at least three times for each species to check the 
reproducibility. Results for each of the species were extremely similar and repeats for the 
same mutant illustrated identically shaped curves.    
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Figure 4.10. Effect of WT Mus musculus Hsp47 on collagen fibrillisation. The fibrillisation of 0.1 
mg/ml collagen alone showed a large increase in scattering with time; reaching a maximum of 0.76 
absorbance units.  There was a decrease in the fibrillisation of collagen in the presence of the WT salt 
dependent species. A distinct decrease in collagen fibrillisation was also observed following the 
addition of the pH dependent species of WT mHsp47. 
 
The fibrillisation experiments revealed some interesting results. As expected, the fibrillisation 
of collagen alone followed the typical collagen fibril formation pattern. Initially there was a 
nucleation (lag) phase (0-150 minutes) which was followed by a rapid growth phase (150-250 
minutes) that preceded a deceleration phase (150-360 minutes) towards a maximum turbidity. 
In contrast to this, collagen fibrillisation in the presence of the polymeric WT salt dependent 
species had a reduced lag phase (0-100 minutes), a longer but less rapid growth phase (100-
340 minutes) and a much shorter deceleration phase (340-360 minutes). The effect of the WT 
monomeric pH dependent species was different still; the lag phase was reduced further (0-70 
minutes), the reduction in the growth of the fibrils was more pronounced (100-150 minutes) 
as the turbidity only increased from 0.05 to 0.24 in comparison to the 0.05 to 0.73 increase for 
collagen alone. 
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The above findings imply that both the salt dependent and pH dependent species of WT 
mHsp47 have effective collagen anti-fibrillisation activities, although the pH dependent 
species is more potent at doing so. More intriguingly, the lag phase is greatly reduced in the 
presence of Hsp47, suggesting that nucleation of collagen chains is facilitated by Hsp47. This 
suggests that Hsp47 is somehow involved in the bringing together of collagen chains but 
hindering the uncontrolled fibrillisation of these chains.  
 
Electron Microscopy 
Transmission electron microscopy was used to examine the topography and morphology of 
collagen fibrils in the absence and presence of Hsp47. Furthermore, the results from the 
collagen fibrillisation assays (Figure 4.10) could be compared to the electron microscopy 
observations to determine whether the findings from two different experiments correlate, 
providing strength to the proposed hypotheses. Prior to fibrillisation and in the absence of 
Hsp47 small, disordered collagen fibres were visualised (Figure 4.11(a)). Following 
fibrillisation of collagen alone, there was evidence of fibrils, however the majority of the 
sample had an aggregate-like morphology (Figure 4.11(b)). The fibrillisation of collagen in 
the presence of Hsp47 resulted in the formation of more ordered and longer fibrils (Figure 
4.11(c)). 
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Figure 4.11. Electron micrographs of collagen fibrillisation. (a) Collagen pre-fibrillisation. The 
grid illustrated very few collagen fibrils alongside many small, randomly distributed fibres. (b) 
Collagen post-fibrillisation. Many bundles of collagen fibrils were observed as well as large 
aggregate-like structures. (c) Fibrillisation of collagen in the presence of WT mHsp47. WT pH 
dependent species and collagen were combined prior to the initiation of the fibrillisation assay. A 
reduced number of aggregate-like features and shorter, more ordered fibrils were visualised.  
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The electron microscopy results demonstrated that initially collagen comprised of small, 
unorganised structures which were converted to larger collagen-like fibrils after fibrillisation. 
This is in agreement with the results from the fibrillisation assays (Figure 4.10) that illustrated 
that the turbidity of collagen before fibrillisation was zero whilst the turbidity post-
fibrillisation was 0.76 absorbance units; signifying the appearance of fibrils with time. 
Furthermore, comparison of Figures 4.11(b) and 4.11(c) showed that there was a reduction in 
fibril formation in the presence of Hsp47. This correlates with the fibrillisation results (Figure 
4.10) that illustrated a decrease in turbidity in the presence of Hsp47 in comparison to 
collagen alone. This correlation between two different experiments strengthens the validity of 
the results obtained. 
 
Although Figure 4.11 illustrates only single electron micrographs for each of the different 
fibrillisation time points, at least five fields were examined for each of the samples and 
similar features were visualised throughout. 
 
4.3 Discussion 
The protein purification procedure in this study involved a salt concentration gradient as well 
as a pH gradient. Monitoring of these conditions allowed the identification of two distinct 
mHsp47 species, a finding that has not been reported previously. Comparison of previous 
purification methods indicates that a difference in protein purification is likely to be the 
reason for this novel observation. For example, Nagata and coworkers [195] first isolated and 
purified Hsp47 from chick embryo fibroblasts using gelatin-affinity chromatography. 
Impurities were removed with 0.4 M salt prior to elution of gelatin-binding proteins by 
boiling in Laemmli’s SDS gel electrophoresis sample buffer. This single-step elution 
produced a single elution peak that consisted of Hsp47 and other minor contaminants, notably 
one at 83 kDa. The high ionic strength wash buffer may have resulted in the release of the 
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weakly binding, salt dependent form of Hsp47. Therefore, the binding would have been 
reported as non-specific rather than weak and dependent upon the salt concentration. The use 
of a single, low pH elution buffer did not allow the exact pH of protein elution to be 
identified. The use of a pH gradient for protein elution, as used in this study is advantageous 
as it can be applied to any species of Hsp47 to determine the elution pH. It is particularly 
useful for the comparison of protein from different species or studying the effects (if any) of 
sequence mutations on the pH-dependency of Hsp47.  
 
The purification of mrmHsp47 by El-Thaher and coworkers [97] involved affinity 
chromatography using collagen-sepharose followed by gel filtration. Although stringent ionic 
conditions (50 mM Tris-HCl, pH 8.0, containing 400 mM NaCl and 5 mM EDTA) were used 
for the washing of the column following the application of Hsp47, proteins present in the 
wash fraction were not reported. Again, a low pH, single elution buffer (50 mM Tris-HCl, pH 
5.8, containing 150 mM NaCl and 5 mM EDTA) was used to elute Hsp47 and a single 
monomeric species was identified [97]. 
 
More recently, the pH dependent interaction of Hsp47 and collagen has been examined by 
Dafforn and coworkers [87] and Olerenshaw and coworkers (unpublished) [181]. As 
previously, Dafforn and coworkers used affinity chromatography for protein purification 
using collagen-sepharose. Following washing away of impurities under high ionic strength, 
once more a single low pH buffer was used for protein elution. Subsequently, gel filtration 
was used to separate pure protein from contaminant peptides. Consequently two oligomeric 
species were identified; a monomer at ~45 kDa and a trimer at ~147 kDa. This identification 
of two molecular species is similar to the finding of two pH dependent oligomeric forms of 
Hsp47 in this study. However, unlike in the study by Dafforn and coworkers, in this study the 
two species could be separately in one step using the method detailed below. 
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Previous work on the interaction of collagen and Hsp47 has revealed that the 
association/dissociation of the chaperone for its substrate is pH-dependent. Thus, a pH 
gradient was used in order to probe this pH-dependency and determine the point at which the 
Hsp47-collagen complex dissociates. Collagen affinity chromatography enabled pure, active 
Hsp47 to be obtained. The elution profile for WT mHsp47 illustrated a novel finding in that 
two species were present. The first was a salt dependent species that was eluted early in the 
purification and was dependent upon salt concentration. The second species was eluted late in 
the purification, at pH 6.1 and a constant salt concentration of approximately 7 mS/cm. This 
implied that the elution of this species was pH dependent and salt independent. The presence 
of two distinct species of this chaperone has not been reported prior to this study. 
 
The study by El-Thaher and coworkers [97] of Hsp47 and collagen revealed that pH-
dependent binding and release of procollagen/ collagen coincides with the pH-driven trans-
conformational changes in Hsp47 indicating that these conformational changes alter the 
binding affinity of the chaperone for its substrate. CD and fluorescence allowed the 
identification of three structural states. The Alkali state (above pH 6.4) consisted of 25% and 
36% α-helix and β-sheet, respectively. The Intermediate state (pH 6.2) comprised of 15% α-
helix and 51% β-sheet and the transition from the Alkali to the Intermediate state showed 
marked changes in secondary structure. In the Acid state (below pH 5.7), the protein 
contained 11% and 57% α-helix and β-sheet character, respectively.  These results suggest 
that a pronounced difference in secondary structure composition was indicative of the 
transition from the Alkali to Intermediate to Acid states. The results of collagen elution 
studies by El-Thaher revealed an elution maximum at pH 6.2. In relation to the results 
obtained in our study, this corresponds to the second peak which represents the pH dependent, 
salt independent species. The consistency of the elution pH of the pH dependent, salt 
independent species with other studies suggests that the method of a protein gradient is 
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reliable for monitoring the pH at which Hsp47 and collagen dissociation occurs. This all 
implies that the N-terminal His tag is not altering this aspect of Hsp47 behaviour.  
 
The finding of the salt dependent, pH independent species is novel as a salt concentration 
gradient has not been used previously when attempting to separate Hsp47 from its substrate. 
The presence of two species that are released upon differing conditions makes for an 
interesting theory, in that there are two types of collagen binding Hsp47 forms. The first being 
dependent on salt concentration and the second upon the surrounding pH. Disruption of the 
interaction between the salt dependent species and collagen by an increase in conductivity to 
7 mS/cm and a constant pH of 8.0 implies that this form is weakly binding. Once this species 
was eluted, even an increase in salt concentration to 20 mS/cm did not disrupt the interaction 
of the pH dependent species with collagen. Thereby, it can be said that this form binds 
collagen more strongly and the interaction involves bonds other than electrostatic/ionic 
interactions which are perturbed by salt. Covalent, hydrophobic and hydrogen bonds are those 
that are not affected by the presence of salt. Therefore, it is likely that the pH dependent 
species-collagen complex has additional or different bonds to the ones found in the salt 
dependent species-collagen complex. These stronger links between Hsp47 and its substrate 
collagen provide increased stability to the complex. Another possibility is that residues that 
are exposed in the pH dependent species, therefore able to interact with collagen, are buried in 
the polymer. Thus, they can no longer form bonds with the collagen α chains, resulting in 
weaker Hsp47-collagen association. The difference in exposed/buried residues between the 
monomeric and polymeric chaperone conformations could affect the binding position of 
Hsp47 on collagen. Furthermore, this inaccessibility to certain residues could result in 
reduced strength of Hsp47-collagen complex. 
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The results of the CD experiments suggested that the salt dependent species was folded and 
highly stable as it resisted denaturation when heated to 90 oC. This implied that it could not be 
in the native serpin conformation and was either the latent, cleaved or polymeric form. 
Multiple peaks from the AUC scan and a single band on SDS-PAGE implied that it was in the 
polymeric conformation. The sediment coefficient of the polymer is double that of the 
monomer, implying the presence of a dimer or trimer. The slight melting noted on the thermal 
CD titration (Figure 4.5) may be due to only partial insertion of the RCL of one molecule into 
the A-sheet of the second molecule. Such a structure was reported by Carrell and coworkers 
for the antithrombin dimer [158]. They reported the dimer as consisting of two molecules; one 
active and one inactive. The RCL of the active molecule was predicted as having a 
conformation compatible with the entry of two residues into the A-sheet of the inactive 
molecule whilst the inactive molecule was proposed to have a fully incorporated RCL, as in 
latent PAI-1 [158]. Results for the effect of the salt dependent species on collagen 
fibrillisation showed that it reduced fibril formation as the turbidity at A313nm at t=360 minutes 
diminished from 0.73 to 0.43. This reduction in collagen fibril formation is in agreement with 
earlier hypotheses that Hsp47 is involved in preventing the aggregation of collagen. The 
observation that the lag phase is reduced in the presence of the salt dependent species of 
Hsp47 implied that it not only has anti-fibrillisation activity but is also involved in the 
acceleration of the nucleation of collagen chains. 
 
The electron microscopy results were in agreement with the findings of the collagen 
fibrillisation assays. Grids of collagen prior to the fibrillisation assay showed very few fibres. 
Fibrillisation of collagen produced disordered protein fibres that were distinct from those seen 
pre-fibrillisation. The presence of Hsp47 reduced the number of fibrils formed and these 
fibrils were more ordered than those formed in the absence of the chaperone. This is 
consistent with the finding of the collagen fibrillisation assays whereby Hsp47 reduced 
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collagen fibril formation (Figure 4.9) and is also in agreement with the hypothesis that the 
chaperone is involved in ordered association of collagen chains.  
  
The CD results for pH dependent species revealed a folded protein that was metastable as it 
denatured when heated from 30 to 90 oC, with a midpoint inflection of 55 oC. This denotes the 
presence of the native serpin form. This is in agreement with the results obtained by Dafforn 
and coworkers for the native state of mrmHsp47. They demonstrated that the metastable form 
of the protein was ‘a typical α/β-protein’ that was folded and underwent a sharp thermal 
transition with a point of inflection at 54.7 oC [87]. A predominately single peak from the 
AUC scan and a single band on SDS-PAGE strengthened the finding of the pH dependent 
species being in the native conformation. As seen with the highly stable salt dependent 
species, collagen fibrillisation was distinctly reduced in the presence of the pH dependent 
species in comparison to collagen alone with a final A313nm of 0.30. The native pH dependent 
form was more effective at de-fibrillisation of collagen than the polymeric salt dependent 
species. This may be due to the difference in the binding site on collagen and/or the type of 
interaction between the different Hsp47 species and collagen. In addition to this, like the 
hyperstable polymer, the metastable monomer reduced the nucleation phase of fibre 
formation. 
 
The results show that the ability to reduce the nucleation phase is common to both forms of 
WT Hsp47 and each one is just as effective as the other. The anti-fibrillisation activity, on the 
other hand, although true for both forms, is greater for the metastable form. This may be due 
to the dimeric and monomeric nature of the salt dependent and pH dependent species, 
respectively. It could be that the monomer has more binding sites for the binding of collagen 
chains whereas in the polymer, some or part of these binding sites are inaccessible as they are 
being occupied/ blocked by the binding of one Hsp47 molecule to another during 
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oligomerisation. Monomeric Hsp47 would therefore have more points of contact with the 
collagen chains, thereby having enhanced collagen anti-fibrillisation activity in comparison to 
the polymeric, salt dependent species. It may also be that the each of the species binds to the 
collagen molecules with different affinities which would in turn affect the binding of Hsp47 
to its substrate. This would be consistent with the results of the elution profile (Figure 4.2) 
whereby disruption of the interaction between the hyperstable, polymeric species occurred 
upon increasing the salt concentration to approximately 4 mS/cm. In comparison to this, the 
metastable, pH dependent species required a reduction in the pH to 6.1. 
 
To summarise, this study has revealed two distinct species of Mus musculus Hsp47; a salt 
dependent species and pH dependent species. The salt dependent form has been shown to be 
polymeric and hyperstable whilst the pH independent form was revealed to be predominantly 
monomeric and metastable. Both form of the protein underwent a conformational change 
upon a reduction in pH. The presence of each of species was able to reduce collagen fibril 
formation; however the pH dependent species was more potent at doing so than the salt 
dependent species. 
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CHAPTER 5: Probing the Importance of the Breach Region in the 
Structural Transition of Hsp47 by mutating H191, H197 and H198 
 
5.1 Introduction 
Unlike common globular proteins, where the native form is the most stable state, the serpin 
native form exists in a metastable state. It is this metastability that is thought to be critical for 
their biological functions. The serpin structure consists of three β-sheets surrounded by nine 
α-helices and an exposed reactive centre loop (RCL). For the inhibitory class of serpins 
binding of a target protease to the RCL results in its insertion into the A-sheet and the 
formation of a stable serpin-protease complex [122]. Mutational analyses of the archetype 
serpin, α1-AT, revealed unusual interactions, such as unusual side chain packing, 
unfavourable hydrophobic environments, buried polar groups and cavities as the structural 
basis of native metastability [21]. These interactions seem to have a destabilising effect on the 
interaction of helix F and the proceeding loop with the A-sheet. As the inhibitory activity of 
α1-AT was affected by mutations in the loop insertion region and not by mutations at the 
hydrophobic core, local stability rather than global stability was considered vital for the 
regulation of the inhibitory function of α1-AT [21, 22, 125, 196, 197].  
 
Structural studies on the folding of plasminogen activator inhibitor-1 (PAI-1) have shown that 
it folds initially into an active conformation which slowly converts into a low-activity latent 
conformation [198]. This spontaneous conversion involves extensive conformational changes 
in both the proximal and distal hinge region of the RCL. P1-P1’ residues on the RCL act as 
the pseudo-substrate for the corresponding proteinase [199]. At the N-terminal, the RCL is 
connected to s5A via the proximal hinge. At the C-terminal, the RCL is connected to s1C (the 
distal hinge region) [200]. Therefore the hinge domain is vital for the structural arrangement 
and functional transitions of serpins. The breach region lies adjacent to the proximal hinge 
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region and is also in close proximity to the distal hinge region (Figure 1.14). It is therefore 
likely that breach region is important in the structural rearrangement of serpins. 
 
The denaturation and folding of active and latent PAI-1 were investigated using the EP8 
mutant (T339E) [115]. This mutation in the RCL was designed to slow the kinetics of 
conversion from the active to latent state, based on the model that latency involved the 
formation of s4A [201]. The results demonstrated that folding into the active conformation is 
favoured over the latent conformation. Furthermore, latent PAI-1 retained its secondary 
structure upon denaturation whereas active PAI-1 underwent significant losses in secondary 
structure and was more susceptible to proteolysis near the A-sheet. It was therefore thought 
that the enhanced stability of the latent conformation may be due to a difference in secondary 
structure, specifically, the formation of s4A, loss of s1C and a surface helix [115]. 
 
Proteolysis or partial denaturation leads to conversion of the A-sheet from a 5-stranded, 
metastable state to a 6-stranded hyperstable form [87]. In addition to the native and latent 
forms, serpins can self-assemble into homopolymers via β-strand/β-strand interactions [126, 
158, 165, 178]. The biophysical properties of the polymers are determined by the type of 
linkage of the polymers. Polymers of α1-AT that are formed by linkages that involve the 
packing of the A-sheet are highly stable [119, 202].  
 
Although mobility of the reactive loop is necessary for inhibitory activity, it is also involved 
in forming aberrant conformations that are associated with disease [123]. The Z, Siiyama and 
Mmalton variants of α1-AT are caused by the insertion of the RCL of one molecule into the β-
sheet of a second molecule [126, 203, 204]. The resulting ordered polymers accumulate in the 
ER of hepatocytes subsequently leading to cirrhosis, juvenile hepatitis and hepatocellular 
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carcinoma [175, 205]. Angio-oedema, emphysema and thrombosis are associated with 
dysfunctional mutants of C1-inhibitor, α1-antichymotrypsin and antithrombin, respectively. 
 
The expression of Hsp47 has been seen to correlate with increased collagen deposition, which 
subsequently leads to diseases such as myocardial infarction [206], arteriosclerosis [207, 208] 
and fibrosis [209-211]. Upregulation of Hsp47 expression has been seen in various animal 
models of fibrosis, including murine bleomycin-induced pulmonary fibrosis [212, 213], 
carbon-tetrachloride induced rat liver fibrosis [209] and peritoneal sclerosis in rats [214]. 
Furthermore, increased expression of human Hsp47 has been seen lesions of idiopathic 
pulmonary fibrosis [215], peritoneal sclerosis [216] and fibrotic transplanted kidney [217]. 
These findings along with the co-expression of Hsp47 with collagen suggest a role for Hsp47 
in fibrotic diseases. Dafforn and coworkers discovered a trimeric form of mrmHsp47 and 
structural analysis demonstrated results that were consistent with those obtained for polymers 
of α1-AT and α1-antichymotrypsin that were formed by insertion of the RCL of one monomer 
as a fourth strand in the A-sheet of another monomer [87]. As this oligomerised form of 
Hsp47 maintained the ability to bind collagen, Dafforn and coworkers proposed that the 
binding site was not on the A-sheet but in a cleft between helices hA and hG/hH [87, 182]. 
 
The association and dissociation of Hsp47 and collagen is initiated in the lumen of the ER at 
neutral pH [218]. It is here where the Hsp47-collagen complex is formed. Collagen trimer 
formation leads to transportation of collagen chains with bound Hsp47 to the cis-Golgi 
compartment. The reduction in pH from the ER to the Golgi [219] triggers pH induced 
conformational changes in the chaperone and subsequent dissociation of Hsp47 from 
collagen. It has been previously proposed that histidine residues may be responsible for the 
pH dependent conformational mechanism of mrmHsp47 [87, 97]. The altered affinity of 
Hsp47 for collagen between pH 7.0 and 5.8 correlated with the protonation and deprotonation 
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of histidine which has a pKa of 6.2. El-Thaher and coworkers reported a three phase model for 
the changes in structure, whereby Hsp47 underwent a ‘two-step conversion’ from an alkali to 
acid state via an intermediate state [97]. This pH dependent binding was also seen by Dafforn 
and coworkers during the investigation of the binding of Hsp47 to (PPG)10. They noted a 
reduction in the binding following a drop in pH from 7.0 to 6.0. The change in pH from 
neutral to acidic is thought to promote a conformational change and consequently a 
diminution in the binding affinity of Hsp47 for collagen. This results in dissociation of Hsp47 
from collagen and diminished biological activity [87]. El-Thaher and coworkers constructed 
single (H335L) and double (H197Q: H198N) site-specific mutants, both of which had 
irregular biological activities. The single mutant remained collagen bound even at pH 6.1 
whereas the double mutant lacked any collagen binding properties at all [97].  
 
Examination of the sequences for Hsp47 from species that have been sequenced identified 
fourteen histidines residues that are conserved in 90% of Hsp47 sequences. Of these fourteen 
histidines, five are conserved within the serpin superfamily, making them less likely to be 
important specifically for Hsp47. The remaining nine histidines are found in three clusters 
around the Hsp47 molecule. The cluster located near the top of the A-sheet (Figure 5.1 below) 
is of particular significance as this is the region of serpins that is involved in conformational 
changes involving insertion of the RCL into the A-sheet. The three histidines in this cluster 
are H191, H197 and H198. Histidine to alanine amino acid substitutions were designed in an 
attempt to better understand the structural basis and functional role of the non-inhibitory 
serpin, Hsp47.  
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Strand 3A 
 
Figure 5.1. Model of native Hsp47 illustrating mutated histidine clusters. 
 
This chapter explains three mutations (H191, H197 and H198) that were constructed to 
further study the importance of the histidine cluster in the breach region on Hsp47 structure 
and function. These mutations were made on the Mus musculus Hsp47 6xHis template 
described in chapter 4. 
 
 
5.2 Results 
H191A 
Protein purification  
As with WT Hsp47, each of the mutants was expressed in E. coli and purified using collagen-
affinity chromatography using a phosphate buffer pH gradient from pH 9.2 to 3.0. The 
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absorbance, salt concentration and pH were monitored constantly throughout the purification 
procedure and an elution profile plotted. 
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Figure 5.2. Elution profile of H191A mHsp47. The absorbance curve shows two different sets of 
peaks, each of which represent different forms of Hsp47. Peak A symbolises protein that is elutes by 
an increase in salt concentration (orange curve), thus a salt dependent species whereas the peak B 
illustrates protein that elutes upon a reduction in the pH (green curve), namely a pH dependent species.  
 
The presence of two sets of absorbance peaks signifies the existence of multiple species of 
Hsp47. Peak A denotes protein that elutes at a relatively constant pH and an increase in salt 
concentration. This therefore designates a salt dependent, pH independent species. The peak 
of the elution of this salt dependent species correlates with the peak for the salt concentration. 
Peak B corresponds to a second species of Hsp47, elution of which occurred upon a reduction 
in the pH, during which the salt concentration was being reduced from its maximum. These 
findings suggest that it is a pH dependent, salt independent species.  
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Samples were collected at steps during the purification of the protein in order to monitor the 
path taken by the protein and to determine the point(s) of elution of Hsp47. 
 
 
(a) 
 
 
 (b) 
Figure 5.3. SDS-PAGE for H191A mutant. (a) Lane 1 illustrates that some Hsp47 was produced as 
there is a band at 47 kDa. Occurrence of bands at 47 kDa in lanes 4 and 5 demonstrate that there was 
some protein that did not bind (hence was eluted in the flow-through) and some that bound weakly 
(hence being eluted in the wash fraction). Lanes 8 and 9 represent the species that eluted in the first 
peak of the purification. (b) The protein bands present in lanes 5, 6 and 7 designate protein that was 
eluted in the second peak. Lane 8 shows protein that remained on the gelatin agarose beads following 
completion of the purification.  
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Results of SDS-PAGE showed that most; if not all the Hsp47 being produced was in the 
soluble fraction due to the absence of a 47 kDa band in the cell debris lane (lane 3, Figure 5.3 
(a)). The bands in lanes 8 and 9 of Figure 5.3 (a), albeit very faint, correspond to the salt 
dependent, pH independent species that was eluted between 5-10 minutes. The intensity of the 
bands implies that only a small amount of protein being produced by the H191A Hsp47 
mutant was the salt dependent form. The bands in lanes 5-7 of Figure 5.3 (b) correspond to 
the pH dependent species that was eluted at pH 6.1. 
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Structural characterisation  
CD and AUC were used to determine secondary structure composition, stability and 
oligomerisation state, respectively. pH titration experiments were performed to detect the 
ability of the protein to undergo a conformational transition upon a reduction in pH. The 
biological activity was determined by collagen fibril formation assays in the presence of 
variant Hsp47. 
 
As with WT, a 0.2 cm quartz cuvette was used for all CD measurements. The protein 
concentration was 0.2 mg/ml. 
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Figure 5.4. CD spectra for H191A mutant. Spectra for both species are typical of that for a folded 
protein. Minima at 208 and 222 nm are typical for α-helical structures and a minimum at 216 nm 
denotes the presence of β-sheet character. 
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Thermal denaturation was used to determine protein stability. Changes in the CD signal were 
monitored whilst the samples were heated from 20 to 90 oC. 
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Figure 5.5. Thermal stability curves for H191A mutant. Both the salt dependent, pH independent 
and the pH dependent, salt independent species show that there is no change in structure upon heating 
from 20 to 90 oC. 
 
The CD results demonstrated that the salt dependent and pH dependent species were folded 
with α-helix and β-sheet character. Figure 5.5 illustrates that the two forms of Hsp47 
produced by the H191A mutant were highly stable as they were resistant to a conformational 
transition during the thermal denaturation experiment. This indicated that these species are 
either in the polymeric or latent conformations. 
 
AUC was used to clarify which of the hyperstable forms was present for each of the species. 
The samples were centrifuged at 40,000 rpm for 8 hours at 4 oC and the protein absorbance at 
280 nm was monitored.   
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Figure 5.6. AUC results for H191A mutant. The data fit illustrates that the salt dependent species 
produced one distinct peak and a smaller broad peak. This is indicative of the presence of protein with 
more than one molecular mass. The pH dependent species produced a single peak, indicative of a 
monomeric species. 
 
The salt dependent species illustrated two peaks, one at approximately 1.6 S and a second at 
3.2 S. It is therefore possible that the first peak represents a monomer whilst the second peak 
signifies a polymeric species. These data are in agreement with the AUC data for the salt 
dependent species of WT mHsp47, which revealed two peaks at similar positions. The pH 
dependent species illustrated a single peak at approximately 1.7 S, consistent with the pH 
dependent species of WT mHsp47 (Figure 4.7). 
 
Understanding the pH dependence of each of the Hsp47 mutants will provide an insight into 
Hsp47 function. The pH sensitivity of Hsp47 is thought to be mediated by the ionisation of 
histidine residues thus a shift in the pH dependency of conformational change in the mutants 
would highlight any histidines that are important in controlling the conformational change. 
The six-stranded latent conformation adopted by the pH dependent species stabilises the 
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central β-sheet. Involvement of the A β-sheet in the pH dependent conformational change 
would perturb the extent of the conformational change and/or its pH dependency.  
 
The pH titration experiment was thus performed to investigate this pH dependency of 
conformational change. The CD signal was monitored, by measuring change in α-helical 
content (at 222 nm), whilst the pH of the protein solution was decreased from pH 8.0 to 3.0. 
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Figure 5.7. pH titrations of H191A mutant. The pH was reduced from 9.0 to 3.0 by the addition of 
2.5 μl aliquots of 1.52 M phosphoric acid. Both the salt dependent and pH dependent species showed a 
characteristic conformational change with a midpoint of 6.6. 
 
Each of the species for the H191A mutant was able to undergo a conformational change, 
suggesting that mutation of the histidine at position 191 does not affect the pH dependency of 
the protein. This is the first instance in which the conformational change has been observed 
for the stabilised (latent) conformation. WT polymers were also shown to undergo this pH 
dependent conformational change. 
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The collagen fibrillisation assay was performed to test the ability of the two species of the 
H191A mutant to arrest collagen fibrillisation. 
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Figure 5.8. Effect of H191A mutant on collagen fibrillisation. The salt dependent species of the 
H191A mutant effected the total collagen fibre formation greatly as the final turbidity was similar to 
that of collagen fibrillisation in the presence of WT pH dependent species. The pH dependent species 
of the mutant was equally as potent as the salt dependent species at preventing collagen fibrillisation 
as it reduced the turbidity as much as the former. 
 
The salt dependent species of the H191A mutant was more active than the WT salt dependent 
species as the turbidity of the final sample (at t=360) was reduced further in the presence of 
the variant than the WT equivalent. More interestingly, however, mutation of the histidine at 
position 191 appeared to affect the lag phase of collagen fibrillisation, reducing it 
considerably in comparison to collagen alone. Consistent with WT results, the mutant H191A 
pH dependent species possessed anti-fibrillisation activity of collagen but unlike WT Hsp47, 
the salt dependent species was just as effective at reducing collagen fibril formation as the pH 
dependent species. This implied that the mutation of H191 not only enhances the biological 
activity of the pH dependent species but also has a positive effect on the activity of the salt 
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dependent species. Moreover, collagen fibril formation in the presence of the latter species 
comprised a very small lag phase, suggesting that this variant somehow decreased the 
nucleation time before fibre formation was initiated. 
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Figure 5.9. Elution profile for H197A:H198A mutant. Purification using a pH and salt 
concentration gradient revealed two distinct peaks of protein elution. The first peak represents protein 
that eluted upon an increase in salt concentration whilst the second peak denotes protein that required 
a reduction in the pH for dissociation from collagen. 
 
As with the WT and H191A mutant, the H197A:H198A double mutant of mHsp47 yielded 
two species of the protein. A salt dependent species; elution of which was parallel to an 
increase in salt concentration and a pH dependent species; elution of which correlated with a 
reduction in pH.  Once all the salt dependent protein was eluted, a further increase in the salt 
concentration had no effect on the binding of the pH dependent protein to collagen. This 
suggests that the pH dependent species was independent of salt concentration. Likewise, the 
salt dependent species does not depend on the pH as application of the pH gradient prior to 
the salt concentration gradient did not result in protein elution. 
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Figure 5.10. SDS-PAGE for H197A:H198A mutant. Lane 1 shows a band at 47 kDa, demonstrating 
the production of Hsp47. Small amounts of protein were present in the flow through and wash 
fractions (lanes 4 and 5, respectively). Lanes 6 and 7 represent protein that was eluted in the first 
absorbance peak of the elution profile while lanes 8 and 9 represent protein that eluted in the second 
absorbance peak. 
 
The results of SDS-PAGE illustrate that the H197A:H198A mutant yielded a significant 
amount of soluble Hsp47 (Figure 5.10, lane 1). Absence of a band at 47 kDa in the cell debris 
fraction (Figure 5.10, lane 3) indicates the lack of insoluble material. Hsp47 in the flow-
through and wash fractions (Figure 5.10, lanes 4 and 5, respectively) shows that some of the 
protein did not bind and some was weakly binding as it eluted when washing the gelatin 
column with water.  Salt dependent Hsp47 is present in lanes 6 and 7 and pH dependent 
Hsp47 is present in lanes 8 and 9. Lane 10 shows that there was no protein retained on the 
gelatin-agarose beads following completion of the purification procedure. 
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Structural characterisation 
Determination of the structural information on each of the species for the H197A:H198A 
mutant used CD and AUC. 
 
CD was used to establish the secondary structure composition by measuring the CD signal 
between 105-300 nm and analysing the resulting spectra. The stability of each of the species 
was investigated by monitoring the change in CD signal whilst heating from 20 to 90 oC. A 
0.2 cm quartz cuvette and a protein concentration of 0.2 mg/ml were used for all CD 
measurements. 
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Figure 5.11. CD spectra for H197A:H198A mutant. Both the salt dependent and pH dependent 
species illustrate spectra with a positive signal at 200 nm and minima at 206, 218 and 222 nm typical 
for a folded protein containing α-helix and β-sheet character. 
 
The spectra revealed that both the salt dependent and pH dependent forms of the 
H197A:H198A variant were folded α/β proteins. 
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Thermal denaturation was used to determine protein stability. This involved heating of the 
protein and constantly measuring the CD signal. Transformation of the data into graph form 
allowed any conformational transitions to be distinguished as this would be accompanied by a 
large change in CD signal. 
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Figure 5.12. Thermal stability curves for H197A:H198A mutant. The CD signal for both species 
remained relatively constant when heated from 20 to 90 oC. No distinct transition can be seen from the 
results above. 
 
The CD results (Figures 5.11 and 5.12) indicate that both the salt dependent and pH 
dependent species were folded with minima at 208 and 222 nm for α-helical composition and 
a minimum at 216 nm for the presence of β-sheets. Both forms were hyperstable as they 
resisted a distinct conformational change upon being heated to 90 oC. These findings suggest 
the presence of the polymeric or latent form of Hsp47. It cannot be the cleaved form as SDS-
PAGE revealed a single band, signifying a single peptide. 
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Figure 5.13. AUC results for H197A:H198A mutant. The salt dependent species revealed a curve 
with a predominant peak at approximately 1.5 S and a smaller peak at 2.6 S. The pH dependent 
species produced a single peak at 1.7 S. 
 
The AUC results suggest that the salt dependent species comprised a mixture of monomeric 
and oligomeric protein whilst the pH dependent species was monomeric. 
 
Taken together, the CD and AUC data imply that the salt dependent species was folded, 
hyperstable and oligomeric; all characteristics that are typical for a polymer. The pH 
dependent species was shown to be folded, hyperstable and monomeric; distinctive of the 
latent serpin conformation.  
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The pH dependent conformational change of the latent and polymer forms of H197A:H198A 
mHsp47 was probed using the pH titration method. 
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Figure 5.14. pH titrations of H197A:H198A mutant. Both species showed a conformational 
transition with a midpoint of pH 6.6.  
 
Mutation of the histidines 197 and 198 did not affect the ability of the protein to undergo a 
conformational change as both species underwent a transition between pH 6.0 and 7.0. 
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The effect of the mutations of histidines at positions 197 and 198 on the biological activity of 
Hsp47 was investigated by the collagen fibrillisation assay. Fibril formation was monitored in 
the absence and presence of the mutant. 
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Figure 5.15. Effect of H197A:H198A mutant on collagen fibrillisation. The absorbance of collagen 
in the presence of each of the mutant species was greatly reduced in comparison to collagen alone.  
 
The salt dependent form of the H197A:H198A mutant was able to reduce collagen 
fibrillisation as the final turbidity of collagen with Hsp47 was 0.4 in contrast to the 0.76 of 
collagen alone. The pH dependent form of H197A:H198A mutant mHsp47 significantly 
reduced collagen fibril formation, giving a final turbidity of 0.13. Therefore, both the salt 
dependent and pH dependent species were able to reduce collagen fibril formation, albeit to 
different extents. Comparison of the effect of WT and H197A:H198A mutant Hsp47 salt 
dependent species showed that the mutant form was less effective at the anti-fibrillisation of 
collagen chains than its WT counterpart. On the other hand, the mutant form of the pH 
dependent species was a more potent collagen anti-fibrillisation agent than the WT equivalent. 
This suggested that mutation of the histidine residues enhances the biological activity of the 
pH dependent protein but reduced the activity of the salt dependent species. 
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Furthermore, each of the mutant species seemed to affect the lag phase of the fibrillisation 
process. The lag phase for the fibrillisation of collagen in the presence of the WT salt 
dependent species was reduced in comparison to that for collagen alone. Moreover, the 
mutant salt dependent species further decreased the lag phase to 10 minutes. The effect of the 
pH dependent species on lag phase duration, however, was less obvious. The WT pH 
dependent species reduced the lag phase in comparison to collagen alone, but less so than the 
H197A:H198A mutant mHsp47 pH dependent species which seemed to prolong the lag time. 
However, this species also greatly reduced the acceleration phase thus it was difficult to 
distinguish whether the reduced turbidity was due to lag phase elongation or acceleration 
phase suppression.  
 
Electron microscopy was used to visualise the effect of the H197A:H198A variant of Hsp47 
on collagen fibre production. 
 
Figure 5.16. Electron micrograph of collagen post-fibrillisation, in the presence of 
H197A:H198A Hsp47. The grid illustrates that some fibre formation was occurring; however the 
short length of the fibres imply that fibril formation was reduced. 
 
Collagen fibres 
200 nm
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The electron micrograph suggested that some fibre formation was occurring, as illustrated by 
the thin, rod-like structures. Comparison of Figures 4.10(b) and 5.16 revealed that the 
aggregate-like structures formed by collagen fibrillisation alone were not evident post-
fibrillisation in the presence of the H197A:H198A mutant, implying that this mutant 
prevented fibril formation/aggregation. The difference between Figures 4.10(a) and 5.16 
demonstrate that some fibrillisation of collagen was taking place as the fibres visualised post-
fibrillisation in the presence of H197A:H198A (Figure 5.16) were larger than those observed 
pre-fibrillisation (Figure 4.10(a)). However, the size of these fibres was reduced in 
comparison to those formed in the presence of WT Hsp47, indicating that the H197A:H198A 
mutant was a more potent anti-fibrillisation protein that its WT counterpart. Furthermore, the 
scarcity of the fibrils in the presence of the variant strengthened the hypothesis that mutation 
of histidines 197 and 198 to alanine enhanced the anti-fibrillisation potential of Hsp47. In 
addition to this the fibres formed in the presence of the variant were more ordered, taking the 
appearance of long rods, than those formed by collagen alone. Moreover, the observation of 
reduced fibre production correlated with the results of the collagen fibrillisation assay (Figure 
5.15), whereby the turbidity of the solution after completion of the fibrillisation experiment 
was lower in the presence of the H197A:H198A variant than WT Hsp47. 
 
 
5.3 Discussion 
The aim of these mutations was to probe the acid induced conformational change and the 
effect on collagen binding biological activity of Hsp47 by substitution of histidine residues 
near the apex of the A-sheet. This hinge region, near the A-sheet is known to be important in 
the inhibitory mechanism of serpins and it has been suggested that a similar conformational 
change may be involved in the structural transition of Hsp47. The pH of the Hsp47 
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conformational transition is thought to be close to pH 6.0, which is close to the pKa of 
histidine, therefore it was decided that each of the histidines would be mutated to alanine.  
 
Sequence alignment and homology modelling identified a histidine cluster within this region. 
A single mutant (H191A) and a double mutant (H197A:H198A) were constructed and both 
produced pure, soluble protein that was active. Structural analysis of the protein produced by 
each of the mutant constructs revealed a salt dependent species that was in the native serpin 
conformation and a pH dependent species that was in the latent serpin conformation. The 
discovery of the two different species as well as the latent serpin conformation was novel for 
Hsp47.  However, the latent form of mrmHsp47 was modelled by Davids and coworkers and 
was shown to comprise of a six stranded A-sheet, comparable to latent, non-inhibitory PAI-1 
[139, 182]. Formation of the latent serpin state is accompanied by insertion of the RCL into 
the A-sheet (the central β-sheet). In inhibitory serpins, the latent conformation is associated 
with reduced or no activity [139, 220] whereas in non-inhibitory serpins it frequently modifies 
serpin activity. This conformation provides the serpin with enhanced structural stability as the 
A-sheet now contains a full complement of β-strands, allowing the formation of numerous 
backbone hydrogen bonds.   
 
The elution profiles for the single H191A mutant and the double H197A:H198A mutant were 
similar to that of the WT Hsp47 in that a salt dependent and pH dependent species were 
produced. Closer examination of the chromatograms revealed that the mutants produced a 
smaller peak for elution of the pH dependent species than WT mHsp47, suggesting that 
substitution of histidine at positions 191, 197 and 198 to alanine reduced the production of the 
more tightly binding pH dependent species. This implies that the interaction of the pH 
dependent species and collagen is weakened/ disrupted by the removal of the histidine 
residues. Therefore, it is feasible to propose that these histidine residues may play an 
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important role in the binding of collagen to its chaperone, Hsp47. Production of the salt 
dependent species, on the other hand, seemed to be unaffected by the mutations as a similar 
amount was produced by each of the mutants and the WT. This indicates that the ionic 
interaction between collagen and Hsp47 is unperturbed by the mutation of H191, H197 and 
H198. 
 
Structural analysis studies of the salt dependent species of the double and single mutants 
demonstrated similar results. CD spectra and thermal titration data implied an α-helix and β-
sheet containing protein that was hyperstable. The AUC results revealed multiple peaks, 
suggesting the presence of oligomeric species. The H191A mutant produced two peaks; the 
first at 1.7 S and a second at 3.2 S, possibly representing monomeric and polymeric Hsp47. 
The H197A:H198A mutant also showed two peaks; one at approximately 1.3 S followed by a 
second, smaller peak at 2.6 S. In both cases, the first peak was dominant; therefore the protein 
being produced was predominantly monomeric but oligomeric protein was also formed. This 
high molecular weight, non-denaturing species must therefore be in a polymer form. Although 
serpin oligomerisation is common, it is interesting that only two distinct forms (for example, 
monomer and dimer) are present in this case. Antithrombin is the only other serpin that is 
known to form discrete oligomers. In circulation, insertion of the RCL of one molecule into 
the β-sheet C of a second latent antithrombin molecule causes dimer formation [158, 183]. 
The oligomers produced by the H191A and H197A:H198A mutants are different from those 
observed in the study of mrmHsp47 by Dafforn and coworkers [87] although the results 
obtained do have some similarities. As with their trimeric mrmHsp47, the polymer form in 
this study, resisted thermal denaturation when heated to 90 oC. Furthermore, comparison of 
the thermal titration results suggest that the polymer was more resistant to thermal unfolding 
as the trimer underwent a slow linear reduction in secondary structure [87] whereas polymeric 
mHsp47 did not show as much of a transition (Figures 5.5 and 5.12 for H191A and 
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H197A:H198A, respectively). The trimer was able to bind to the (PPG)10 collagen mimic 
peptide, therefore possessing biological activity [87]. Likewise, the dimer was able to reduce 
collagen fibrillisation, retaining its biological activity. Furthermore, the anti-fibrillisation 
activity of each of the mutant polymer species was enhanced in comparison to WT mHsp47.  
 
The CD spectra for the pH dependent species of the H191A and H197A:H198A mutants were 
characteristic of the folded protein state, thus it can be said that mutation of these residues 
does not prevent the folding of Hsp47. However, although the mutations did not interfere with 
the protein adopting a folded state, the actual folded conformation of the pH dependent 
species of H191A and H197A:H198A mHsp47 was different to that of WT mHsp47. This is 
evident from the results of the experiments performed for structure determination. The 
stability curve and AUC data (Figures 4.5 and 4.6, respectively) for the WT pH dependent 
species signify a low stability, monomeric serpin state, namely the native conformation. By 
contrast, the thermal stability curves for the pH dependent species of the H191A and 
H197:H198A mutants (Figures 5.5 and 5.12, respectively) revealed curves characteristic of 
highly stable proteins that retained a folded conformation even when heated to 90 oC. The 
AUC data (Figures 5.6 and 5.13) illustrated a single peak for the pH dependent species 
produced by each of the mutants, denoting the presence of a monomeric species. Taken 
together, these results propose a highly stable, monomeric serpin state, namely the latent 
conformation. Therefore, substitution of histidines 191, 197 and 198 to alanine promotes the 
formation of the latent serpin conformation of mHsp47. This high stability, 6 stranded A-
sheet, monomer has not been seen for Hsp47 prior to this study. 
 
The conformation of Hsp47 is known to be very pH-sensitive and is thought to provide a 
highly pH-dependent mechanism for the binding and release of Hsp47 and collagen. Previous 
studies and results for WT mHsp47 in this study have revealed extreme changes in Hsp47 
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structure below pH 7.0. These conformation changes occur in a two stage process, involving 
two structural transitions. The first transition takes place at a pKa of 6.5 and results in reduced 
α-helix and increased β-sheet character. This is thought to involve the ionisation of one or 
more histidine residues in the protein. The second transition occurs at lower pH, with a 
midpoint at pH 4.0 and is a result of altered ionisation of glutamate and aspartate residues. 
Discovery of an active, latent form of Hsp47 allowed the possibility of further investigating 
this highly pH dependent mechanism. As the latent state was active, it was thought that this 
conformation could either disrupt the acid induced conformational change or leave it 
unperturbed. If the conformational change was disturbed, it could be proposed that the 
substituted residues were involved in the structural transition or that the strand insertion did 
not alter the ability of the protein to undergo a pH induced conformational change. On the 
other hand, unaffected conformational changes would imply that structures involved in latent 
formation were distinct from those involved in the acid induced conformational transition. 
Data analysis for the conformational change and affinity of the native WT and latent mutant 
species suggested that the structural transition has not been altered by the formation of the 
latent serpin conformation. Previous other studies have shown that formation of the latent 
state, resulting from strand insertion into the A-sheet, greatly enhances the stability of the 
serpin as a consequence of a more stable A-sheet. This increased stability is signified by a 
dramatic enhancement in thermal stability of the serpin. The latent forms of both mutants 
revealed a stable A-sheet that resisted thermal denaturation. The fact that structural change 
occurred despite the insertion of the RCL into the A-sheet, implies that neither the A-sheet or 
the RCL are not involved in the acid induced conformational change. If either of these did 
play a role in the structural transition, perturbation of structural changes would have been 
seen. 
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Figure 5.17. Model structures of native and latent Mus musculus Hsp47. 
 
The transition from the native, 5-stranded A-sheet to the latent, 6-stranded A-sheet causes 
numerous changes in the surface of Hsp47 that may subsequently affect the binding of the 
chaperone to collagen. The biological activity was investigated by measuring collagen 
fibrillisation in the absence and presence of Hsp47 (Figures 4.8, 5.8 and 5.15 show results for 
WT, H191A mutant and H197:H198A mutant, respectively). These data show that the latent 
Hsp47 conformation was able to bind collagen and reduce collagen fibrillisation. This 
suggests that the collagen binding site is not close to the regions that are altered by the native 
to latent transition. There are three regions in particular that are affected by this conversion. 
The RCL is removed following its insertion into the A-sheet, resulting in exposed residues at 
the top of β-sheets B and C. Insertion of the RCL into the A-sheet leads to expansion of the 
central β-sheet and as a consequence, movement of surface residues in strands 1, 2, 3, 5 and 6. 
Finally, the C-terminal end of the RCL is stretched from the C-sheet down the entire edge of 
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s6A. Our findings therefore imply that these regions are not vitally important for the binding 
of Hsp47 to collagen. The data obtained from this study is consistent with the results obtained 
by Davids and coworkers [182] and Dafforn and coworkers [87], leaving their hypothesis of 
the collagen binding site being in a cleft between helices hA and hG/hH feasible. 
 
As the acid induced conformational change occurs at a pH that is close to the pKa of histidine, 
it is likely that the structural rearrangements are instigated by the ionisation of histidines. 
Sequence studies have highlighted histidine residues that are conserved across Hsp47 
expressing organisms but not amongst the serpin superfamily as a whole. It is therefore 
proposed that one or more of these histidines is involved in the conformational transition of 
Hsp47 in acidic conditions. The location of histidines 191 197 and 198, around the hinge 
region, makes them probable candidates for such a role. The H191A mutant of mHsp47 
produced a conformational transition that was similar to that of WT mHsp47, with a midpoint 
of pH 6.6 (+/- 0.04). However, the pH dependency of the latent conformation was perturbed 
by the mutation of histidines 197 and 198, implying the involvement of one or both of these 
residues in the pH dependent conformational change of Hsp47. Although a conformational 
rearrangement did occur upon reduction of the pH, the midpoint was shifted to pH 6.2 (+/- 
0.06). This is a further 0.3 pH units from that of WT and the H191A mutant of mHsp47, 
implying that removal of these histidines makes mHsp47 less sensitive to reducing pH. This 
requirement of more acidic conditions and alteration in the pKa indicates the involvement of 
this cluster in the pH dependent conformational mechanism.  
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CHAPTER 6: Probing the Importance of the Breach Region in the 
Conformational Transition of Hsp47 by mutating H220 
 
6.1 Introduction 
 
H220 
H197 
H198 
H191 
Figure 6.1. Location of histidine 220 on model Hsp47 structure. 
 
 
The effect of the H197A:H198A variant on Hsp47-collagen binding led to the opinion that 
other histidines within this region may also play a role in the interaction between mHsp47 and 
collagen. Histidine 220 is another of the conserved histidines and is located in the breach 
region (above the A-sheet), close to histidines 197 and 198. Consequently, a H220A mHsp47 
mutant was designed to investigate the importance (if any) of this histidine in the binding/ 
release of Hsp47 from its substrate. 
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As mentioned in Chapter 5, the region above the A-sheet has been shown to be important in 
the conformational transition from the native to the latent state. Furthermore, mutation of 
H197 and H198 in this region resulted in the formation of the latent state of mHsp47, 
suggesting that the mutation of H220 may also effect the conformation or biological activity 
of the protein.   
 
As with the other mutants, the H220A construct encoded a His tag that would allow non-
gelatin binding proteins to be purified via metal affinity chromatography.  
 
 
6.2 Results 
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Figure 6.1. Elution profile of H220A Mus musculus Hsp47. The absorbance trace shows a dominant 
single peak between 5-10 minutes (Peak A). This peak coincides with an increase in the salt 
concentration (orange curve) but the pH remains relatively constant. A reduction in the pH below 6.0 
did not result in further release of Hsp47. 
A
Section A 
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The chromatogram produced during gelatin agarose purification showed an absorbance peak 
between 5-10 minutes which correlated with a peak in the ionic strength (for example, salt 
concentration) in the early washing steps of the column where the pH remained above 6.0. 
This peak represented a salt dependent binding species of mHsp47. A further increase in the 
salt concentration did not release further protein, implying that all the salt dependent form of 
Hsp47 was released in the first peak. This is consistent with the results for WT, H191A and 
H197A:H198A mHsp47. However, there is a key difference with this mutant in comparison 
to each of those studied thus far, that is an absence of a peak in the latter part of the 
purification following reduction of the pH from alkali to acid which signifies a lack of the pH 
dependent species. This implied that mutation of H220 abolished any pH dependent binding 
of Hsp47 to collagen, suggesting that this residue may be important in the interaction.  
 
Each of the fractions collected during the purification was analysed by SDS-PAGE. 
 
Lanes 
   1       2       3      4       5       6      7      8       9  
175 Lane 1: Cell lystae  
Lane 2: Cell debris 83 
Lane 3: Flow through  
Lane 4: Wash 
 
 Figure 6.3. SDS-PAGE for H220A mutant. Lanes 3 and 4 show that much of the protein produced 
was present in the flow-through and wash fractions, respectively. Lanes 5 and 6 represent the salt 
dependent species. Lanes 7 and 8 correspond to protein that was eluted upon reduction of the pH and 
confirm the absence of any pH dependent species.  
 
kDa 47.5 
62 
Lane 5: Elution fraction 9       Section A 
Lane 6: Elution fraction 10 
 Lane 7: Elution fraction 70       Section B Lane 8: Elution fraction 72 32.5 
Lane 9: Protein molecular weight markers 
25
 211
Analysis of the SDS-PAGE results show that most, if not all, of the Hsp47 produced was 
soluble as it was present in the cell lysate fraction (Figure 6.3, lane 1) and not in the cell 
debris fraction (Figure 6.3, lane 2). As most of the protein was released in the flow-through 
and wash fractions; it implied that it was not binding to the gelatin-agarose, thereby 
suggesting that mutation of H220 interfered with the binding of Hsp47 to collagen. Lanes 5 
and 6 (Figure 6.3) signify the salt dependent species and the low intensity confirmed that only 
a minute amount of this weakly binding species was produced. Absence of a peak for the pH 
dependent species in the elution profile was confirmed by the absence of a protein band at 47 
kDa in lanes 7 and 8; consistent with the proposal that the H220A mutation abolished the pH 
dependent species of mHsp47. The low intensity of the bands for the salt dependent species 
inferred that the mutation also affected the binding of the salt dependent species. 
 
The concentration of the salt dependent species was too low for analysis of secondary 
structure by CD and AUC. The flow-through and wash fractions were therefore subjected to 
purification on Nickel-Nitrilotriacetic acid (Ni-NTA) resin.  
 
Ni-NTA affinity purification procedure 
Purification of 6xHis tagged mHsp47 was performed under native conditions using a batch 
procedure. The batch process involved binding of the protein to Ni-NTA resin in solution 
prior to packing the protein-resin complex in a column for washing and elution steps. This 
method is thought to promote efficient protein binding, particularly when the protein 
concentration is low. 
 
Cells were lysed by washing with Tris-HCl, pH 8.0 buffer containing 300 mM NaCl and 20 
mM imidazole. Low concentrations of imidazole reduce the potential for binding background 
contaminants. The imidazole group is part of the structure of histidine and can therefore bind 
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to the nickel ions immobilised by the NTA groups on the matrix. Binding of imidazole to the 
nickel ions interferes with the binding of dispersed histidines of non-tagged background 
proteins. Low concentrations of imidazole can therefore reduce low-affinity, non-specific 
binding of contaminant proteins whilst still allowing high-affinity binding of 6xHis tagged 
proteins. The matrix was then washed with 20 mM imidazole, pH 8.0. This was repeated three 
times to ensure removal of background contaminants. Protein elution involved washing the 
matrix with 250 mM imidazole. The increased imidazole concentration resulted in 
dissociation of the 6xHis tagged protein as they could no longer compete for the binding sites 
on the Ni-NTA resin. 
 
Samples of the purification using Ni-NTA were analysed by SDS-PAGE. 
 
Lanes 
 
Figure 6.4. SDS-PAGE of purification of H220A Mus musculus Hsp47 on Ni-NTA. Lane 3 
represents protein that did not bind the Ni-NTA. Lanes 4 and 5 denote non-specifically bound protein. 
Lanes 6 and 7 show weakly binding protein that was eluted with 20 mM imidazole. Lanes 8 and 9 
show tightly binding protein that required an increased imidazole concentration to be released from the 
Ni-NTA. Protein in Lane 10 is Hsp47 that remained bound to Ni-NTA after elution with 250 mM 
imidazole. 
 
1      2      3      4      5     6       7      8    9       10
175 
Lane 1:   Flow-through from gelatin-agarose     
purification 83 
Lane 2:   Protein molecular weight markers  
Lane 3:   Unbound protein 62 
Lane 4:   Wash 50 mM Tris-HCl pH 8.0 (1) kDa 47.5 Lane 5:   Wash 50 mM Tris-HCl pH 8.0 (2) 
 Lane 6:   Wash 20 mM imidazole (1) 
 Lane 7:   Wash 20 mM imidazole (2) 
32.5 Lane 8:   Elution with 250 mM imidazole (1) 
Lane 9:   Elution with 250 mM imidazole (2) 
Lane 10: Ni-NTA resin after purification 
25 
Hsp47 
 213
Purification on Ni-NTA revealed that only a small amount of the flow-through from the 
gelatin-agarose column interacted with the Ni-NTA. Reapplication of the unbound protein 
onto Ni-NTA resulted in further binding and elution as shown in Figure 6.4. Of the protein 
that bound to the Ni-NTA beads, some bound non-specifically and eluted with 50 mM Tris-
HCl (pH 8.0) (Figure 6.4, lanes 4 and 5) whilst some was weakly binding and eluted with 20 
mM imidazole (Figure 6.4, lanes 6 and 7). 250 mM imidazole was used to elute any strongly 
binding Hsp47 (Figure 6.4, lanes 8 and 9) whilst some protein remained bound to the Ni-
NTA, even after the stringent wash and elution conditions (Figure 6.4, lane 10).  
 
Purification on Ni-NTA produced pure Hsp47 (single band on SDS-PAGE) that was used for 
secondary structure analysis. 
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Structural characterisation of H220A mHsp47 
As with WT and previous mutants, H220A Hsp47 was subjected to circular dichroism studies 
to determine secondary structure composition and protein stability whilst AUC was used to 
determine its oligomerisation state (results shown below). Subsequently, pH titration 
experiments were performed to investigate the ability of the mutant to undergo the pH-
dependent conformational transition and the collagen fibrillisation assay was carried out to 
determine the biological activity of the chaperone. 
 
All CD experiments were performed using a 0.2 cm quartz cuvette and a protein concentration 
of 0.2 mg/ml. 
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Figure 6.5. CD spectrum of H220A mHsp47. Minima at 208, 216 and 222 nm are typical of an α-
helix and β-sheet containing protein, whilst a positive signal at 195 nm signifies protein that is in a 
folded state. 
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The thermal stability of the protein was investigated using a thermal titration experiment that 
involved an increase in temperature from 20 to 90 oC by 1 oC increments. 
-8
-7
-6
-5
-4
-3
-2
-1
0
20 30 40 50 60 70 80 90
Temperature (oC)
E
lli
pt
ic
ity
 (m
de
g)
 
Figure 6.6. Thermal stability curve for H220A mHsp47. Heating the protein from 20 to 90 oC 
shows a slight change in the CD signal. This implies that there may have been some gradual loss of 
secondary structure; however the protein was not denatured as there was no sharp transition and no 
distinct change in CD signal. 
 
The CD results revealed an α/β-protein that was folded and resisted thermal denaturation upon 
heating to 90 oC, therefore being highly thermostable. 
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Figure 6.7. AUC for H220A mHsp47. Multiple peaks signify the presence of oligomers. 
 
Numerous peaks from the AUC results illustrate that the protein was a mixture of monomeric 
and polymeric. 
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The dependency of the protein fold on pH was monitored by reducing the pH from alkali to 
acid using phosphoric acid and monitoring the change in CD at 222 nm. 
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Figure 6.8. pH titration of H220A Mus musculus Hsp47. The pH transition was characteristic of 
Hsp47; whereby the acid induced conformational change had a midpoint inflection at pH 6.6. 
 
The ability of the mutant to undergo a pH induced conformational change suggests that 
mutation of H220 did not affect the pH sensitivity of the protein structure. As the pH 
dependent conformational transition is thought to be mediated by the ionisation state of 
histidine residues, it is expected that the mutation of histidine residues which are involved in 
this conformational change would be accompanied by a shift in the pH dependency of the 
protein. Thus, it can be said that H220 is not important for controlling the conformational 
transition of mHsp47. 
 
Biological activity determination 
As with the WT and other mHsp47 variants, the effect of the H220A mutant on collagen fibril 
formation was investigated by monitoring the turbidity of collagen in the absence and 
presence of the H220A Hsp47 variant (Figure 6.9).   
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Figure 6.9. Effect of H220A mutant on collagen fibrillisation. The blue curve illustrates that the 
mutant was unable to reduce the fibrillisation of collagen as the turbidity at the end of the experiment 
was very similar to that of collagen alone. 
 
Upon comparison of collagen fibril formation results for WT and variant it was evident that 
the H220A mutant of mHsp47 did not possess anti-fibrillisation activity despite mutation of 
H220. The final turbidity of the solution comprising of collagen and mutant protein was 0.78 
compared with 0.73 of collagen alone. Interestingly, this non-gelatin binding (purified by Ni-
NTA chromatography) protein was the only mutant which lost its biological activity upon 
substitution of histidine 220 for alanine. In addition to this, the collagen fibrillisation curve in 
the presence of H220A mHsp47 showed a much reduced nucleation phase compared with that 
of collagen alone and collagen with WT mHsp47.  
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6.3 Discussion  
The elution profile of H220A Hsp47 from gelatin-agarose demonstrated a single peak that 
represented the salt dependent species of mHsp47 as it coincided with a peak for the salt 
concentration. This is consistent with the result for WT and H197A:H198A, both of which 
produced a salt dependent species that correlated with an increase in the salt concentration at 
an alkali pH. However, when the corresponding fractions were analysed by SDS-PAGE, the 
protein was hardly visible suggesting that there was very little salt dependent collagen binding 
species. The absence of a pH independent species for this mutant implied that mutating 
histidine 220 somehow increased the likelihood of the protein to elute from collagen with salt, 
thereby suggesting that H220 is important in the pH dependent binding/release of Hsp47 to 
collagen. The low concentration of the H220A variant salt dependent species in comparison to 
WT, H191A and H197A:H198A mutants suggested that the interaction of this species with 
gelatin was also affected by the H220A substitution. The finding that most of the Hsp47 
produced by the H220A mutant did not bind gelatin and was present in the flow through 
fraction of the purification, indicated that the binding of the chaperone to its substrate was 
perturbed. These results allow for two feasible proposals: 
(i) The binding site of Hsp47 for collagen is likely to be at or near the region of H220. 
This could be investigated by the ability of the mutant to bind its substrate. 
(ii) H220 is in close proximity to the important site for the conformational change 
trigger. This could be investigated by a pH gradient as the conformational 
transition is as follows: 
pH 
 
Each of these proposals is discussed below. 
BINDING NON-BINDING 
pH 
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Figure 6.10.  Model structure of native Mus musculus Hsp47. 
 
Collagen binding studies by El-Thaher and coworkers in which part of helix A of Hsp47 was 
deleted resulted in diminished collagen binding. They therefore concluded that this region 
comprised of all or part of the collagen binding site. Since this study, Davids and coworkers 
have modelled the three-dimensional structure of inhibitory and latent mrmHsp47 using 
cleaved hPCI as template [182]. The specificity and high affinity binding of Hsp47 to 
procollagen/collagen peptides at physiological pH [180, 221, 222] can be explained by the 
long, deep cleft of mrmHsp47. Helices hA and hG/hH form the sides of the cleft whilst the 
base is formed by β-sheet B. The B β-sheet projects hydrophobic side chains toward the cleft 
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whilst the helices project hydrophilic amino acid side chains at the sides of the cleft. Deletion 
mutants of mrmHsp47 were designed to test the hypothesis of the proposed binding cleft. 
Two deletion mutants, NΔ1 and CΔ3, were unable to bind collagen (Nagata, unpublished). 
The NΔ1 mutant lacked the first 32 amino acids of the N-terminal whilst CΔ3 was missing the 
last 34 amino acids of the C-terminal. Both deleted regions comprised of extensive regions of 
the putative procollagen/collagen binding groove [182]. These findings together with the 
findings of C-terminal His tagged Xenopus laevis and Danio rerio Hsp47 in this study 
(Chapter 3) denote the importance of an unperturbed Hsp47 C-terminus for the function of the 
protein. As helix A has been discovered as being central to the mechanism of conformational 
change for serpins, it was suggested, it is likely that this region is also structurally important 
Hsp47.  
 
The H220A mutation had a similar effect to that of the L266A mutation by Miller and 
coworkers whereby the substitution resulted in a complete loss in the collagen binding ability 
of Hsp47. As the L266A mutation is relatively conservative it was thought unlikely that it 
would have an adverse affect on the conformational dynamics of the protein (Olerenshaw and 
coworkers unpublished). The proposed hydrophobic cleft was further investigated by a double 
mutant; L32A:F34S that was located in helix A. The placement of the side chain of L32 
implied that it would affect the hydrophobicity of the cleft, thereby affecting collagen binding. 
And indeed, the double mutant (L32A:F34S) was unable to bind and release collagen.  
 
SDS-PAGE confirmed the result of the elution chromatogram by illustrating the presence of 
only a salt dependent and not a pH dependent species. The intensity of the salt dependent 
species was also reduced in comparison to that produced by WT mHsp47. Furthermore, it was 
evident that most of the Hsp47 produced by the H220A mutant either did not bind (pH 
dependent species) or bound very weakly (salt dependent species) to gelatin and was present 
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in the flow-through and wash fractions, respectively. This implied that mutation of the H220 
resulted in a change in Hsp47 that disrupted the ability of the chaperone to bind its substrate. 
Thus, both the proposals above are still possible.        
 
Following purification using Ni-NTA, unbound protein from the flow-through fraction was 
used for structural analysis in an attempt to investigate the reasoning behind the non-binding 
property of the H220A mHsp47 mutant. The CD spectrum showed the protein to be folded, 
demonstrating that the mutation did not affect the folding ability of the protein. It remained 
unknown however, whether it was true at a side chain level. Thus, it remained indefinite 
whether the substitution of histidine with alanine resulted in a disruption in Hsp47-collagen 
binding due to a difference in the folded conformation of the protein or by disabling the 
protein from forming a bond with the gelatin. The thermal stability experiment demonstrated 
that the protein was highly stable, resisting denaturation upon heating to 90 oC. AUC results 
exhibited multiple peaks, characteristic of a polymeric protein and a peak at approximately 
1.7 S, corresponding to monomeric material. The number of peaks was more than was 
observed for the WT salt dependent species (Figure 6.7), thus it is possible that the mutation 
led to an increase in the number of oligomeric species of the protein. Taken together, these 
results suggest the presence of a stable, oligomeric form of Hsp47 that was non-collagen 
binding. 
 
The acid induced conformational change was probed by the pH titration experiment. It was 
evident from the results that the mutant underwent a conformational change similar to that of 
the salt dependent species of WT mHsp47, denoting that the H220A substitution did not 
interfere with the folding of the protein into a pH labile conformation or the ability of the 
serpin to undergo a conformational transition upon a reduction of pH. As mentioned 
previously, histidine residues are thought to be central to the pH sensitivity of Hsp47 and so 
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modification of histidine residues that play a role in instigating the conformational change of 
the protein is likely to bring about a variation in the pH induced transition. Therefore, as the 
transition of the H220A mutant is largely similar to that of WT mHsp47, it can be said that 
histidine 220 is not involved in the mechanism of conformational change of the protein and 
that polymeric Hsp47 can still undergo the transition. 
 
According to the collagen fibrillisation data, the H220A mutant was unable to reduce fibril 
formation. This is not surprising as the inability of the protein to bind tightly to gelatin-
agarose during protein purification led to the opinion that it would have no or very little 
biological activity. The agreement and consistency of results provide strength to the data 
collected. Figure 6.9 illustrated that there was no reduction in collagen fibril formation in the 
presence of H220A mHsp47 in comparison to collagen alone. This implied that the region of 
the protein responsible for the sensitivity to pH may be distinct from the protein region 
involved in collagen binding as the H220A variant lost its ability to bind to gelatin/collagen 
but retained its capability to undergo conformational change upon a reduction in pH (Figure 
6.8). 
 
Hence, when analysed together, the secondary structure data from this study and other Hsp47 
mutation studies are not in complete accordance with either of the proposals put forward 
earlier. The finding that the H220A variant was unable to bind gelatin suggests that histidine 
at position 220 is important for the binding of mHsp47 to its substrate. It could be that the 
histidine itself is involved in the binding or that the substitution of histidine for alanine 
abolished any interaction(s) holding the Hsp47 in the non-binding conformation; thereby 
preventing an Hsp47-collagen complex. His 220 however, is located on s3C; at the top β-
sheet A and evidence from previous work (discussed above) strongly suggests that the 
binding site of Hsp47 for collagen on helix A. It is therefore unlikely that His 220 is part of 
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this binding site. H220 is in close proximity to H197 and H198 and as seen in Chapter 5.0, 
mutation of histidines 197 and 198 perturbed the pH sensitivity of the protein, highlighting 
their importance in the Hsp47-collagen binding. The inability of the H220A mutant to bind 
collagen further emphasises the significance of the breach region in the Hsp47-collagen 
interaction. Thus, it is feasible to propose that there may be a secondary collagen binding site 
on Hsp47, involving His 220. Requirement of an Hsp47-collagen interaction at both primary 
and secondary binding sites would explain the inability of the H220A variant to associate with 
collagen.  
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CHAPTER 7: Probing the Importance of the Gate Region in the Structural 
Transition of Hsp47 by mutating H255 and H256 
 
7.1 Introduction 
 
H255 & H256 
Figure 7.1. Location of histidines 255 and 256 on model Hsp47 structure. 
  
Histidines 255 and 256 make up the gate cluster of Hsp47 which neighbours the gate region 
that is located near the end of β-sheet C. In the serpin superfamily, H255 is frequently 
substituted with tyrosine or asparagine and therefore may not play such an important role in 
maintaining the serpin fold. H256 on the other hand, is conserved within the Hsp47 serpin 
family, and thus may be involved in the conformational dynamics of the protein.  
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Figure 7.2. Model structures of native and latent Hsp47. 
 
Although not very much is known about the gate cluster, the gate region is thought to undergo 
movement upon formation of the latent state in many serpins. Partial insertion of the RCL into 
the A-sheet requires repositioning of s1C away from the remaining β-sheet C, leaving the C-
sheet with only three β-strands [157]. This movement of s1C is thought to be hindered by 
s3C, s4C and the turn connecting these strands [139].  Latent serpins are unable to interact 
with proteases and are not protease inhibitors. The transition to latency represents a control 
mechanism for the serpin PAI-1. PAI-1 is released in the inhibitory conformation, however, it 
spontaneously adopts the latent conformation following removal from vitronectin, which 
holds the serpin in an active form [223, 224]. The spontaneity of conversion of PAI-1 to the 
latent form is thought to be due to flexibility of this gate region (composed of s4C-s3C) [123]. 
This hypothesis was based on the gate region of native PAI-1 having strong hydrophobic 
interactions with turn connecting s1C to s4B which need to be overcome so as to permit s1C 
to reside as in the latent conformation [201, 220].  
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In α1-AT, this region is restrained by a disulphide bond; thereby impeding spontaneous 
conformational adaptation to the latent state. Mutation of one of the cysteines involved in the 
formation of the double bond abolishes the inhibitory activity of α1-AT. Destabilisation of 
native interactions in α1-AT by substitution of residues in s1C resulted in conversion from the 
native, metastable state to a stable, latent conformation. This signified the importance of the 
interactions in the B/C barrel region in the conformational transition of serpins. These 
findings highlight the importance of the gate region in the activity of serpins. Furthermore, 
mutations of residues that would perturb hydrophobic interactions in this region of α1-AT, 
namely F208A of s4C and F370A of s4B, did not result in conversion to the stable, latent 
state [220]. These findings imply that there may be a difference in the controlling of the 
conformational transition amongst serpin proteins. As the native and latent states of various 
serpins share the same features however, it is highly likely that destabilisation of the B/C β 
barrel is involved in the conformational transition of other serpins [161]. 
 
As mentioned above, the spontaneous transition to the latent state of PAI-1 is thought to be 
due to the disordered and mobile gate region [139]. PAI-1 variants have been engineered to 
either prevent or reduce the rate of s4A insertion into the A-sheet, these included mutants that 
were designed to stabilise the gate region. The mobility of the gate region was covalently 
restrained by engineering a disulphide bond in PAI-1, producing a CC variant. Furthermore, 
residues 203-213 of the gate of most serpins are bound in a hydrophobic pocket. In latent 
PAI-1, however, this position is occupied by the C-terminal, preventing the gate region from 
occupying the pocket, allowing its mobility [201]. According to modelling studies, leucine at 
position 280 and arginine at position 30 were likely to be responsible for the displacement of 
the C terminus of PAI-1. Mutants (L280I and R30T) that enabled the C terminus to take up its 
normal position and restrain mobility of the gate were engineered to test this hypothesis. 
Analysis of the gate mutants showed a 2.6-fold increase in the half life relative to WT PAI-1. 
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This increase in half life signified a decreased rate of transition to the latent state. Moreover, 
an R30E mutant, designed to disrupt the salt bridge with Glu 350 and destabilise the latent 
conformation, resulted in a two-fold increase in the T1/2 [225]. The significant enhanced 
stability of the gate and disulphide variants provide evidence of the interactions in the gate 
region being important for the stability of active serpins [201]. 
  
A variant of histidines in position 255 and 256 of the gate cluster was engineered to 
investigate the importance of these residues in the serpin fold and/or conformational 
transition. Perturbation of the pH dependency of the mutant would indicate that one or both of 
these residues play a significant role in the pH dependent conformational change of Hsp47. 
As explained above, the gate cluster has been shown to be important in the latency transition 
for PAI-1 and α1-AT. It would therefore be interesting to investigate whether mutations in this 
region of Hsp47 have a similar stabilising effect on the non-inhibitory serpin. 
 
 
7.2 Results 
Protein Purification 
Protein was purified using collagen-affinity chromatography as per previous methods by 
loading 50 ml of the cell lysate onto a column of gelatin-agarose beads and reducing the pH 
from alkali to acid. 
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Figure 7.3. Elution profile of H255A:H256A Mus musculus Hsp47. The absorbance curve shows 
multiple peaks; the peaks between 5-20 minutes represent the salt dependent species whereas the peak 
at 35 minutes corresponds to elution of the pH dependent species. The peaks denoting the salt 
dependent species coincide with an increase in the salt concentration whilst the pH curve demonstrates 
that a reduction in the pH to acid correlates with the absorbance peak at 35 minutes. 
 
The elution profile for the H255A:H256A mutant was similar to that of WT in that there were 
salt dependent and pH dependent species. However, the salt dependent species for the WT 
was eluted in three peaks rather than a singleton. Each peak however, did coincide with a 
peak for the salt concentration on the column. The first peak for salt concentration (between 
5-10 minutes) resulted in the elution of some salt dependent protein. A further increase in the 
salt concentration released further Hsp47 that was salt dependent (represented by the peak 
between 10-15 minutes). A further increase in the salt concentration still, resulted in more salt 
dependent species being eluted (as illustrated by the peak between 15-20 minutes). This 
implied a concentration dependent release of the salt dependent species, whereby the protein 
affinity for gelatin varied. Thus, the more tightly bound protein required an increased salt 
concentration to abolish its interaction with gelatin in comparison to protein that had a lower 
Section A Section B 
 230
affinity for the substrate. The pH dependent species was eluted in a single peak (at 35 
minutes) when the pH was decreased to 6.3. The elution of this species occurred when the salt 
concentration was constant; implying the release from gelatin was independent of salt 
concentration.  
 
Samples taken during the purification procedure were analysed by SDS-PAGE. 
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1      2      3      4       5      6    7      8       9    10 
175 Lane 1:   Protein molecular weight markers 
Lane 2:   Cell lysate 
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Lane 4:   Flow-through 
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Lane 6:   Elution fraction 17 
Lane 7:   Elution fraction 25 
 
Figure 7.4. SDS-PAGE for H255A:H256A mutant. (a) Lanes 1 and 2 show that the Hsp47 produced 
was present in the cell lysate and not the cell debris fraction, respectively. This signified that the 
protein was soluble. Lanes 7 and 8 represent the salt dependent species that eluted in the first peak, 
whilst lanes 8-10 correspond to the salt dependent species that eluted in the second peak. (b) Lanes 1 
and 2 denote the salt dependent species that was released in the third and final peak for this species. 
Lanes 4-9 illustrate the fractions of the pH dependent species. Lane 10 demonstrates that there was no 
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protein on the gelatin-agarose resin following the purification and had therefore eluted in the 
purification. 
 
Structural characterisation 
The secondary structure of each of the species was investigated by CD. Protein used was from 
the first peak in Section A of Figure 7.3. A thermostatically controlled 0.2 cm pathlength 
quartz cuvette and a final protein concentration of 0.2 mg/ml were used for CD 
measurements. 
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Figure 7.5. CD spectra for H255A:H256A mutant. Both the salt dependent and pH dependent 
species illustrated spectra characteristic of a folded protein. Minima at 208 and 222 nm signify α-
helices and a minimum at 216 nm denotes β-sheet character. 
 
The stability of the protein was determined by thermal denaturation studies. Any change in 
the ellipticity was monitored whilst the protein was heated from 20 to 90 oC. 
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Figure 7.6. Thermal denaturation curves for H255A:H256A mutant. The salt dependent species 
showed a gradual loss of some secondary structure as illustrated by a slow change in the ellipticity. 
The pH dependent species demonstrated a clear transition with a midpoint at 45 oC, denoting a 
significant conformational alteration. 
 
Results from the CD experiments imply that salt dependent species was folded, comprised of 
α-helix and β-sheet character (typical of serpins) and was highly stable as it resisted 
denaturation upon thermal titration. From this it was deduced that the salt dependent species 
could be in either the latent or polymeric serpin conformation. Although the salt dependent 
species resisted complete denaturation when heated, some unfolding can be seen on the 
denaturation trace (Figure 7.6). In the case of the polymeric state this could be due to the 
unfolding of monomers at either end of the polymer and in the case of the latent state, this 
unfolding could be due to incomplete insertion of the RCL into the A-sheet. The pH 
dependent species was illustrated as being in a folded, low stability form that denatured when 
heated producing a transition with a midpoint at 45 oC. Again, α-helix and β-sheet character 
was evident and the pH dependent species was thought to be in the native serpin 
conformation. 
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AUC was used to determine the oligomeric state of the protein and to deduce which of the 
serpin conformations each of the species was in. 
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Figure 7.7. AUC for H255A:H256A mutant. The salt dependent species illustrated multiple peaks, 
suggesting the presence of polymers. The pH dependent species produced a single peak at 1.8 S, 
signifying a monomer. 
 
Taken together, the structural analysis data suggested that the salt dependent species 
contained monomer as well as high molecular weight species that resisted thermal unfolding 
and comprised of α-helix and β-sheet content; satisfying properties of the polymeric serpin 
conformation. The pH dependent species was revealed to be a low molecular weight species, 
with a sediment coefficient of 1.8 S (approximately 45 kDa), that underwent a thermal 
transition with a midpoint of 45 oC and also comprised of α-helix and β-sheet content, 
properties of the native serpin fold. 
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The pH dependent conformational change of each of the H255A:H256A species was probed 
by the pH titration experiment. 
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Figure 7.8. pH titration of H255A:H256A mutant. Reduction of the pH from alkali to acid resulted 
in a conformational transition for both the salt dependent and pH dependent species. Both species 
showed a transition with a midpoint of pH 6.6. 
 
As both the salt dependent and pH dependent species demonstrated a conformational 
transition, it implied that mutation of histidines 255 and 256 did not alter the pH dependency 
of the protein. This therefore suggested that H255 and H256 are not involved in the 
mechanism of conformational change of mHsp47. 
 
The activity of the species was investigated by the collagen fibrillisation assay which 
determined protein activity by measuring its anti-fibrillisation efficiency. 
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Figure 7.9. Effect of H255A:H256A mutant on collagen fibrillisation. The salt dependent species 
produced by the mutant suppressed fibril formation completely as the turbidity remained constant and 
no nucleation, growth or deceleration phase was seen. The H255A:H256A pH dependent species 
greatly reduced collagen fibrillisation as the final turbidity was 0.12, compared with 0.73 of collagen 
alone. 
 
The results of the collagen fibrillisation assays revealed that both the mutant species were 
effective at reducing collagen fibrillisation. The H255A:H256A salt dependent species 
completely abolished fibril formation as the turbidity was kept at the basal level throughout 
the assay. The pH dependent species, although less effective than the salt dependent species, 
markedly diminished collagen fibril formation as turbidity of the solution did not exceed 0.13. 
Furthermore, each of the mutant species was found to be more potent at anti-fibrillisation of 
collagen than their WT equivalent. The presence of WT salt dependent species did decrease 
collagen fibrillisation compared with collagen alone, reducing the turbidity from 0.73 to 0.43. 
However this was less so than the H255A:H256A salt dependent species which did not show 
any significant increase in the turbidity, suggesting lack of fibril formation. In the same 
context, the WT pH dependent species reduced the turbidity to 0.30 and the H255A:H256A 
 236
pH dependent species decreased this further still to 0.13. These results therefore implied that 
mutation of histidines 255 and 256 enhanced the biological activity of mHsp47. 
 
 
7.3 Discussion 
This double mutant was produced to investigate the importance of the histidines near the 
Hsp47 gate region in the conformational transition of Hsp47. Histidines 255 and 256 are 
located in close proximity to the end of β-sheet C, forming the gate cluster (Figure 7.1). This 
region is important in the conformational dynamics of serpins but it has not been probed in 
terms of Hsp47 and its interaction with collagen. The gate region undergoes movement upon 
formation of the latent serpin state, and lies adjacent to the gate cluster. It was therefore 
feasible to propose that the histidine gate cluster might be involved in the serpin fold or 
conformational transition of Hsp47. 
 
Protein elution by a pH gradient from collagen produced two species; a salt dependent and pH 
dependent species. This is consistent with WT, H191A and H197:H198A mutants, suggesting 
that mutation of histidine at positions 255 and 256 does not affect the production of two 
distinct species. Comparison of the chromatogram for the H255A:H256A mutant with those 
of the H191A and H197A:H198A mutants demonstrated a slight increase in the salt 
concentration at which this species (H255A:H256A) eluted from the gelatin-agarose column. 
The chromatogram for the H255A:H256A mutant (Figure 7.3) showed that a salt 
concentration of 8.278 mS/cm was required for the release of further salt dependent species. 
The release of all the H191A and H197A:H198A salt dependent species was at 4.644 and 
4.654 mS/cm, respectively. In comparison to this, the release of all the WT salt dependent 
species required a salt concentration of 20.331 mS/cm. The observation that the mutants 
required a reduced salt concentration to be eluted from collagen compared to its WT 
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counterpart is another fascinating finding as it suggests that mutating histidine residues 
perturbed the binding of the salt dependent species. As the release of the salt dependent 
species from the gelatin-agarose column was instigated by a lower salt concentration, it seems 
that substitution of histidine for alanine reduced the binding affinity of the salt dependent 
species for collagen. Ionic interactions are amongst those that would be disrupted upon 
substitution of histidine residues for alanine. A reduction in these interactions would result in 
the destabilisation of the whole molecule. This suggests that the double mutation of the 
histidines in the gate cluster may diminish the binding affinity of Hsp47 salt dependent 
species to collagen as it required a reduced salt concentration, compared with WT, to be 
released. This mutant, however, required a higher salt concentration for the release of all the 
salt dependent species compared with the H191A and H197A:H198A mutants, implying that 
mutation of histidine at positions 191, 197 and 198 further reduced the affinity of the salt 
dependent species for collagen. It can therefore be said that the breach region and gate cluster 
are important in the binding affinity of the salt dependent species of Hsp47 to collagen and 
the breach region is more so than the gate cluster.  
 
Mutation of the histidines showed a less pronounced effect on the H255A:H256A mutant pH 
dependent species, however, with maximal elution at pH 6.08. This was close to pH 6.1 of 
WT pH dependent species, implying that mutating histidines 255 and 256 did not alter the 
binding affinity of the pH dependent species for collagen. Therefore, it can be proposed that 
the binding site of collagen on Hsp47 does not comprise the gate cluster.   
 
The pH titration experiments revealed that both the salt dependent and pH dependent species 
of the H255A:H256A mutant produced the characteristic two-phase transition. This suggested 
that histidines 255 and 256 were not involved in the acid-induced conformational transition of 
Hsp47. 
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 The results of secondary structure analysis were similar to that of WT mHsp47. The CD 
spectra were characteristic of α-helix and β-sheet containing, folded proteins. The thermal 
denaturation curves were consistent with the WT form of the protein in that the salt dependent 
species showed resistance to temperatures as high as 90 oC with only slight unfolding whilst 
the pH dependent species underwent a transition with a midpoint of 45 oC. The midpoint of 
the transition for the pH dependent species was lower than for the WT (55 oC), implying that 
mutation of histidines 255 and 256 reduced the stability of this species. The AUC data was 
again similar to that of WT mHsp47 whereby the salt dependent species produced multiple 
peaks, denoting the presence of oligomeric species and the pH dependent species revealed a 
dominant single peak, representing monomeric protein. A difference to be noted, however, the 
potentially trimeric peak produced by WT pH dependent species was not seen for the 
H255A:H256A mutant. Therefore, it was possible that mutation of histidines 255 and 256 
reduced the likelihood of trimer formation for this species.  
 
The ability of the mutant species to bind and suppress collagen fibrillisation implied that the 
histidines that made up the gate cluster were not part of the binding site of mHsp47 to 
collagen. Furthermore, mutation of H255 and H256 enhanced the de-fibrillisation activity of 
both the salt dependent and pH dependent species of the protein in comparison to the WT 
equivalents. For the WT salt dependent species and pH dependent species, nucleation, growth 
and deceleration phases were evident and a final turbidity of 0.43 and 0.30 was reached, 
respectively. The H255A:H256A mutant salt dependent and pH dependent species, on the 
other hand, did not show clear nucleation, growth or deceleration phases, with the turbidity 
increase being very slow indeed. The salt dependent species prevented any collagen 
fibrillisation from taking place, maintaining the turbidity at baseline levels throughout the 
experiment, whilst the pH dependent species produced a final turbidity reading of 0.13. The 
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reduced turbidity levels corresponded to reduced fibril formation in the presence of mutant 
species, indicating that the histidine to alanine mutations improved the biological activity of 
mHsp47.  
 
The enhanced biological activity of the H255A:H256A mutant was an interesting finding as 
the mutation of the histidines did not alter the binding affinity or the ability of the mutant to 
undergo an acid-induced conformational transition in comparison to the WT equivalent. The 
secondary structure analysis was also similar to the WT, indicating a folded, thermostable 
conformation for the salt dependent species and a folded, metastable state for the pH 
dependent species. Therefore such an improvement in collagen anti-fibrillisation is an 
interesting finding. It could be that the substitution of histidine with alanine residues removed 
any hydrogen bond interactions, allowing a less restrained Hsp47 structure that was able to 
bind collagen in a way that interfered with collagen fibril formation more readily. It could 
also be that this less restrained H255A:H256A mutant had more than one point of contact 
with its substrate, allowing further ‘bending’ of collagen chains, which ultimately resulted in 
reduced collagen fibril formation. 
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F    F F  F F  F F  F F Spectrum 
               Transition pH titration 
n/e    > <  < <  < <  < < Fibril 
formation 
<    < >  n/e >  < >  < < Lag phase Collagen 
fibrillisation 
               Melt 
F    F F  F F  F F  F F Spectrum CD 
               Oligomer  
               Monomer AUC 
** - - * ** * * ** * ** * * - ** ** Protein purification  
FT pH9 pH6 FT pH9 pH6 FT pH9 pH6 FT pH9 pH6 FT pH9 pH6 
H220A H191A H255A: H256A H197A: H198A WILD TYPE  
F: folded   n/e: no effect 
 
Table 7.1. Summary of results for Mus musculus Hsp47. 
CHAPTER 8: Crystallography 
 
8.1 Introduction 
X-ray crystallography is a means by which the arrangement of atoms within a crystal can be 
determined. When a beam of X-rays makes contact with a crystal, it scatters into many 
directions. The angles and intensities of these scattered beams can be used to construct a 
three-dimensional model of the electron density within the crystal. This density of electrons 
can be used to deduce the position of atoms within the crystal, as well as their chemical bonds 
and disorder. 
 
Protein crystals are most commonly grown in solution and involve a slow decrease in 
solubility of the protein. Crystal growth in solution is characterised by two processes; 
nucleation and growth (Figure 8.1). Identification of solution conditions that favour the 
formation of a single, large crystal is important as larger crystals provide higher resolution. 
D C B A
Protein 
concentration 
Precipitation zone 
Nucleation zone - CRYSTALS 
Metastable zone 
Undersaturation 
Solubility line 
Precipitant concentration  
Figure 8.1. X-ray crystallography phase diagram. The space represented when plotting the 
concentration of crystallisable protein against concentration of precipitant can be divided into several 
areas.  
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High concentrations of both protein and precipitant result in protein precipitation and 
formation of amorphous material. Lowering the concentrations may result in the formation of 
crystal nuclei that can develop into diffracting crystals. A further reduction in concentration 
stops nuclei formation and therefore crystals do not appear. However, if a nucleus is placed in 
this solution it will form a large crystal. This area where crystal growth but not nucleation can 
proceed is the metastable zone. The lowest protein and precipitant concentration results in 
completely soluble protein and therefore undersaturation. As it is difficult to predict beneficial 
conditions for the nucleation or growth of well-ordered crystals, screening is used to identify 
favourable conditions. 
 
Towards the end of the research period, a pilot attempt was made to produce crystals of 
Hsp47. The latent state of the protein that was discovered in this research was used for the 
crystal trays due to its enhanced stability and resistance to denaturation. Latent Hsp47 from 
the H197A:H198A variant was concentrated to approximately 4 mg/ml using a viva spin 
column. Subsequently the protein was dialysed against 50 mM Tris-HCl, pH 8.0 to remove 
the phosphate that was present in the elution buffer. The ‘Hanging Drop Method’ was used 
for growing protein crystals whereby a drop of protein solution was suspended over a 
reservoir of buffer and precipitant (Figure 8.2). 
 
coverslip 
suspended drop of  
protein solution 
diffusion of water  
from drop to well well solution containing 
buffer and precipitant 
 
Figure 8.2. The Hanging Drop Method. 
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Structure and JCSG commercial screens were used to set up crystal trays to determine 
optimum conditions for crystal growth. Out of the many conditions used a few produced 
interesting results that could be Hsp47 crystals. All potential Hsp47 crystals shown below 
were grown for just over a year. 
 
 
8.2 Results 
Results from JCSG Screen 
Buffer conditions: 0.02 M calcium chloride, 0.1 M sodium acetate, pH 4.6 and 30 % v/v 
MPD. 
 
Figure 8.3. Crystal growth in the presence of 0.02 M calcium chloride, 0.1 M acetate and 30 % 
v/v MPD. The larger structures in the centre of the photograph illustrate crystals. 
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Buffer conditions: 0.2 M zinc acetate, 0.1 M sodium acetate, pH 4.5 and 10% w/v PEG 3000.  
 
Figure 8.4. Crystals growth in the presence of 0.2 M zinc acetate, 0.1 M sodium acetate and 10% 
w/v PEG 3000. 
 
 
Results from Structure Screen 
Buffer conditions: 0.1 M Na Hepes, pH 7.5 and 1.5 M lithium sulphate monohydrate. 
 
 
Figure 8.7. Crystal growth in the presence of 0.1 M Na Hepes and 1.5 M lithium sulphate 
monohydrate. 
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Buffer conditions: 0.01 M nickel chloride hexahydrate, 0.1 M Tris, pH 8.5 and lithium 
sulphate. 
 
Figure 8.8. Crystal growth in the presence of 0.01 M nickel chloride hexahydrate, 0.1 M Tris and 
lithium sulphate. 
 
Buffer conditions: 0.2 M magnesium acetate tetrahydrate, 0.1 M Na cacodylate, pH 6.5 and 
20% PEG 8000. 
 
Figure 8.9. Crystal growth in the presence of 0.2 M magnesium acetate tetrahydrate, 0.1 M Na 
cacodylate and 20% PEG 8000. 
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Buffer conditions: 0.1 M Na Hepes, pH 7.5 and 1.5 M lithium sulphate monohydrate. 
 
Figure 8.10. Crystal formation in the presence of 0.1 M Na Hepes and 1.5 M lithium sulphate 
monohydrate. 
 
Due to time restrictions, no further attempts have yet been made on crystallisation of the 
protein. However, the results obtained look promising and will be used to continue the 
crystallisation work. 
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CHAPTER 9: General Discussion, Conclusions and Future work 
 
9.1 General Discussion and Conclusions 
This research represents the investigation of the structure, stability and biological activity of 
the collagen-specific non-inhibitory serpin, Hsp47 [195, 221]. Though the Hsp47-collagen 
interaction has been strong enough to withstand disruption even in the presence of 2 M NaCl, 
a reduction in the pH below 6.3 causes the dissociation of Hsp47 from collagen [180]. Under 
conditions of stress, Hsp47 plays a major part in the quality control system for procollagen, 
preventing the secretion of procollagen with an abnormal conformation [75]. An RDEL 
sequence at the C-terminus of Hsp47 acts as an ER-retention sequence, localising the 
glycoprotein to the ER and the intermediate compartment between the ER and Golgi body 
[226]. It is the conservation of this carboxyl terminus sequence, along with N-terminus 
hydrophobic signal sequence and the potential glycosylation sites that provide part of the 
sequence homology between Hsp47 from different species. 
 
Previous work has examined the expression of the Hsp47 gene in Mus musculus (mouse), 
Gallus gallus (chicken), Ratus (rat), Xenopus laevis (frog), Homo sapiens (human) and Danio 
rerio (zebrafish) [110, 227-231]. This study focused on the endothermic Mus musculus, 
poikilothermic Xenopus laevis and ectothermic Danio rerio species. The difference in 
properties of these species was considered advantageous as the purification conditions may 
favour one species more than the others, increasing the possibility of expression of soluble 
protein. Comparison of structure, stability and activity of the same protein from different 
species can also provide an insight into the factors that influence their stability, propensity for 
aggregation and mechanism of action. Previous examination of proteins with similar tertiary 
folds has provided understanding of the sequence factors involved in their folding mechanism 
and stability [232-240].  
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In particular, the folding and stability of members of the serpin superfamily has been 
extensively studied due to their ability to undergo intrinsic conformational transitions [111-
116, 118, 220, 241, 242]. Whilst this conformational change is vital for the inhibitory serpins, 
a similar structural rearrangement in some human serpins leads to self-association, which 
subsequently results in various conformational diseases [123, 163, 171, 243, 244]. Non-
inhibitory serpins use the conformational transition as part of their function. The native 
(stressed) forms of the non-inhibitory serpins thyroxine-binding globulin and cortisol binding 
globulin have a higher affinity for their substrates than their cleaved (relaxed) counterparts. 
Thus, these serpins do not use cleavage of the RCL and conversion from the stressed to 
relaxed states for protease inhibition, but instead for the release of ligands [245-247]. 
 
The non-inhibitory serpin Hsp47 has not been studied as widely as other members of the 
superfamily and therefore its biophysical characterisation is lacking detail. Recent studies on 
the pH dependent conformational switch of Hsp47 and its binding and release of collagen 
imply that the interaction of the chaperone with its substrate coincides with the pH dependent 
conformational changes in Hsp47 [87, 97]. Not much focus has been applied to the binding 
region of collagen on Hsp47 and whether the binding or release is affected by a modification 
in the amino acid sequence of the glycoprotein. Therefore, this thesis focused on determining 
the structural regions that were important in the Hsp47-collagen interaction, with the general 
aim of investigating the ability of the protein to undergo a pH dependent conformational 
change. Additionally, perturbations in this structural transition following amino acid 
substitutions by mutagenesis were monitored to observe whether Hsp47 behaved in a manner 
that was similar to members of other clades of the serpin superfamily. 
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Cloning and Purification of Xenopus laevis and Danio rerio Hsp47 
The first part of this research concentrated on the optimisation of expression and purification 
conditions of Xenopus laevis, Danio rerio and Mus musculus Hsp47 in E. coli. Much of the 
previous work on Hsp47 has been hindered by low expression levels and instability of pure 
protein. Although the above organisms have a highly homologous Hsp47 amino acid 
sequence resulting in the proteins having a similar fold; characteristics such as protein yield, 
thermal stability and folding/unfolding pathways may differ from one organism to another. 
Therefore three different species were used in an attempt to increase the possibility of 
producing milligramme quantities of pure Hsp47 that could be used to study Hsp47 and its 
involvement in collagen biosynthesis from a structural perspective. 
 
The majority of the previous work in our lab studied murine Hsp47. However, the expression 
of this form of the protein has commonly met with aggregation problems, low yields of 
soluble protein and/or contamination by higher molecular weight oligomers. Therefore, the 
Xenopus laevis and Danio rerio gene for Hsp47 was used to try to overcome these obstacles. 
Difficulties in expressing high yields of recombinant serpins commonly arise due to their 
tendency to self-associate. For example in E. coli, some serpins are expressed in inclusion 
bodies and consequently require unfolding in the presence of denaturant and subsequent 
refolding [248]. Taking these characteristics into account, it is likely that the difference in in 
vivo and in vitro conditions can affect the expression, solubility and activity of Xenopus laevis 
and Danio rerio Hsp47. It is therefore not surprising that these proteins revealed reduced 
yields and aggregated during expression. In addition to this, the presence of fusion tags in the 
pET vectors and the inability to cleave the C-terminal His tag interfered with the Hsp47-
collagen interaction. Furthermore, the circular dichroism and size exclusion chromatography 
results implied that the protein was in a partially unfolded state. It is therefore feasible to 
propose that the C-terminus His tag prevented the correct/complete folding of the protein and 
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consequently its biological activity. Incomplete or inaccurate protein folding results in 
residues that would normally be buried within the structure to be exposed to the environment 
and vice versa, affecting inter- and intra- molecular contacts. 
 
The expression and purification of Xenopus laevis and Danio rerio Hsp47 in E. coli was also 
attempted using the IMPACT expression system (New England Biolabs) where the gene of 
interest is fused to an intein with a chitin binding domain, thereby allowing purification on a 
chitin affinity column. This system was thought to be advantageous as it allowed protein 
purification in a single step, exploiting the facile cleavage of the guest protein from the fused 
adduct, intein, in the presence of thiols [249-251]. Thomson and Ananthanarayanan 
successfully expressed and purified recombinant rat Hsp47 using this technique [249]. They 
found that induction of the cells at a reduced temperature of 14 oC in comparison to the usual 
37 oC resulted in a higher yield of soluble Hsp47. In comparison to the milligramme 
quantities of pure protein obtained by Thomson and Ananthanarayanan, intein fused-Danio 
rerio Hsp47 from this study did not elute from the chitin affinity beads following on-column 
cleavage with DTT. However, similar to findings of Thomson and Ananthanarayanan, the 
majority of the protein was in the insoluble form. Most of the intein fused-Xenopus laevis 
Hsp47 was once again insoluble and although some pure protein was obtained, the 
concentration was very low, barely visible on SDS-PAGE. Furthermore, as with Danio rerio, 
the majority of the soluble protein applied to the chitin column remained bound following on-
column cleavage (even after overnight induction) and subsequent elution. The IMPACT-CN 
system allows fusion of a self-cleavable intein tag to either the N- or C-terminus of the target 
protein. Preference for one or the other fusion for different target proteins with structural 
restraints allows correct folding of the fusion precursor and a higher level of protein 
expression. pTYB12, an N-terminal fusion vector was used in this study as protein expression 
was less affected by the target protein and it contained compatible restrictions sites for 
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cloning. However, this compromised the cleavability of the fused adduct, intein, from the 
target protein as the disadvantage of this vector was that the on-column cleavage was less 
efficient than in other vectors, usually requiring a higher induction temperature and a longer 
incubation time before elution. Unfortunately, this problem with the self-cleavage of the 
intein tag for this vector could not be overcome by the extended cleavage times or increased 
temperatures. 
 
Cloning and Purification of Mus musculus Hsp47 
At this point in the research a decision had to be made between persisting with the Xenopus 
laevis and Danio rerio constructs with an N-terminal His tag or moving to a clone of Mus 
musculus Hsp47 with an N-terminal His tag that had become available. Due to the 
unsuccessful expression of an adequate supply (several milligrammes) of Xenopus laevis or 
Danio rerio Hsp47, availability of a successfully cloned construct of Mus musculus Hsp47 
(by colleagues at Imperial College) that looked promising and the time restraint, it was 
decided that this form of the protein would be tried for the expression and purification of 
Hsp47. Advantageously, the mature recombinant mouse Hsp47 gene was cloned into the 
pCR®T7/NT-TOPO® vector, which unlike the previously used pET vectors did not contain a 
C-terminal His tag that could potentially interfere with the correct folding or activity of the 
protein. As previously published protocols using gelatin [180] or antibody affinity [252] 
chromatography resulted in low yields and/or aggregation, a novel protocol for protein 
purification (adapted from [181]) was employed. This procedure proved valuable as it enabled 
the production of milligramme quantities of Hsp47. The CD spectrum and thermal CD 
titration results obtained (typical of a serpin fold) were similar to those obtained by Dafforn 
and coworkers [87], which suggested the presence of a metastable monomer, comprising of a 
5-stranded A-sheet and a hyperstable oligomer. A variety of heat-shock proteins and 
molecular chaperones are known to undergo oligomerisation. For example, the ATPase of BiP 
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is considered to be due to the conversion of inactive oligomers to active monomers [253]. 
Heat-shock proteins Hsp12.2 and Hsp12.3 form tetramers [254] while the ER stress protein, 
Erp29, forms dimers by self-association. Hsp47 has been previously shown to exist in more 
than one polymerisation state [87, 249, 252]. Dafforn and coworkers identified the oligomeric 
species as a trimer with a molecular weight of 147 kDa [87]. However, the AUC data for WT 
Hsp47 in this study demonstrated the oligomer as being only double the weight of the 
monomer and therefore a dimer. Both the monomeric and oligomeric species were found to be 
active as each was able to reduce the self-association of collagen into fibrils. This reduction in 
collagen fibril formation in the presence of Hsp47 is in agreement with the findings of 
Dafforn and coworkers [87] and Thomson and Ananthanarayanan [249]. The former 
investigated the interaction between Hsp47 and a collagen mimic peptide (PPG)10 by 
measuring changes in intrinsic tryptophan fluorescence and reported that Hsp47 prevented 
collagen fibrillisation and the binding was pH dependent as it was markedly reduced upon 
reduction of pH from 7.0 to 6.0 [87]. Thomson and Ananthanarayanan examined collagen 
fibril formation by monitoring turbidity [96, 249] and found that a 1:2 ratio of collagen to 
Hsp47 resulted in the prevention of collagen fibrillisation [96]. This reduction was observed 
as being considerably diminished in the presence of reducing agent and Hsp47 together [249]. 
Thomson and coworkers therefore hypothesised that Hsp47 may need to oligomerise in order 
to function as a collagen chaperone. Our results however disagree with this proposal as we 
observed a pronounced reduction in collagen fibril formation by the WT pH dependent 
species, which consisted only of monomeric Hsp47. Furthermore the inhibition of collagen 
fibril formation by monomeric Hsp47 was more so than its polymeric counterpart (Figure 
4.9). On the other hand, our results are in agreement with those of Nagata and coworkers 
[222], which demonstrated the binding of Hsp47 monomers to collagen. 
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Metastability in other proteins 
It is not necessary that members of the same protein family, consisting of similar folds and 
high sequence homology, share similar characteristics such as stability, folding/unfolding 
pathways and biological activity of a certain fold/state. Frataxin, a small protein involved in 
iron-sulphur clusters is such an example. The human, yeast and bacterial orthologues of 
frataxin have high sequence homology and share a similar fold but there is great variability in 
their stability [255]. The stability of members of the growth hormone family is another 
example. Bastiras and coworkers studied how the denaturation of porcine growth hormone 
(pGH) differed from other members of the protein family [256]. Though pGH, human growth 
hormone (hGH) and bovine growth hormone (bGH) have similar three-dimensional structures 
[257, 258] and high sequence identities (91% between pGH and bGH and 68% between pGH 
and hGH) [256], their unfolding pathways differ. Whereby bGH and pGH unfold via a mutli-
state pathway but hGH exhibits a two-state unfolding mechanism, without an intermediate 
[259-261]. A final example, which is more closely related to this study, is the difference in 
activity of members of the serpin superfamily itself. Though all serpins possess essentially the 
same serpin fold, the non-inhibitory serpins make use of common components in a different 
manner to that of the inhibitory serpins. As mentioned above, the RCL is a component which 
is used by inhibitory serpins to trap and inactivate their target protease. Though they have lost 
their inhibitory activity, the non-inhibitory serpins can utilise the metastability of the fold for 
the binding and release of ligands [245-247]. These studies reveal how members of the same 
protein family demonstrate different characteristics. These variations can assist in the 
identification of factors that cause such changes and site-directed mutagenesis can be used to 
investigate these variations. Site-directed mutagenesis is a means by which differences in the 
primary amino acid sequence can be used to examine differences in protein behaviour, 
highlighting the features that are important for characteristics such as function, stability or 
activity. 
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There is compelling evidence that even a single amino acid substitution in a serpin can 
significantly alter the stability of the protein [21, 123, 163, 171, 262-264]. As described 
previously, histidine residues are likely to be important in the conformational transition of 
Hsp47 that occurs upon a reduction in pH from 7.0 to 6.0. This is due to the histidine 
imidazole group having a pKa value close to 6.2. It was therefore decided that the importance 
of histidine residues in the pH dependent conformation of Hsp47 would be examined by 
substitution to alanine. In the past, Nagata and coworkers have performed site-specific 
mutagenesis and formed two mutants; a single mutant (H335L) and a double mutant 
(H197Q:H198N) [97]. Although both variants were reported as having aberrant collagen 
binding properties (results unpublished), the effect of the substitutions on the structure of 
Hsp47 was not investigated. We examined the effect of histidine substitutions on the 
structure, stability and activity of Hsp47 and subsequently investigated the effects of the 
mutations on collagen binding properties of the chaperone. Mutants of Hsp47 were designed, 
taking into consideration the regions of other serpins that were thought to be important in the 
conformational transition. Histidines residues that were highly conserved amongst the serpin 
superfamily were omitted as it was thought unlikely that these residues would play such an 
important role in the pH dependent conformational change of Hsp47. 
 
As expected, the strategic rational design approach proved very successful; allowing the 
identification of residues that are vital for the Hsp47-collagen interaction as well as residues 
which when mutated, enhance the chaperone activity of Hsp47. Four variants were 
synthesised: H191A, H197A:H198A, H220A and H255A:H256A (histidine positions 
illustrated in Figure 9.1). As His 197 and His 255 each had an adjacent His residue (His 198 
and His 256, respectively), double mutants were designed to determine the effect of knocking 
out consecutive histidine residues. It is important to stress that the mutants made in this study 
were not the same as those made by Nagata and coworkers (unpublished) and they were 
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ultimately used to probe the pH dependent conformational change of the protein. Fortuitously, 
the mutants also allowed investigation of the binding site of collagen on Hsp47, examination 
of structural changes in Hsp47 as well as its ability to act as collagen chaperone.  
H197 & H198 
H220 
H255 & H256 
proximal hinge  
region 
H191 
strand 3A 
 
Figure 9.1. Model structure of Hsp47. Illustrating the positions of histidine residues that were 
mutated.  
 
Firstly, WT Hsp47 revealed results that had not been seen prior to this study. Whilst the pH 
dependent monomer has been commonly observed, the salt concentration dependent polymer 
is distinct from any form of Hsp47 identified previously. Though Dafforn and coworkers have 
identified polymeric Hsp47 in the past [87], they reported a trimeric species whilst this 
research revealed a dimeric species. More interestingly however, the dimer was released from 
collagen by an increase in salt concentration rather than a drop in pH, as was the case for the 
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trimer. This observation of a pH dependent, monomeric and salt concentration dependent, 
dimeric species simultaneously suggested two forms of Hsp47 that associate with collagen via 
different interactions. As the polymer dissociated from the gelatin column upon an increase in 
salt concentration, ionic bonds are likely to prevail between polymeric Hsp47 and collagen. 
On the other hand, the monomer does not dissociate from collagen after an increase in salt 
concentration implying that monomeric Hsp47-collagen contact is likely due to hydrophobic 
contact and/or hydrogen bonds. Additionally, polymeric Hsp47 (identified as a dimer by 
AUC) possessed beneficial characteristics contrary to the commonly believed hypothesis that 
in the majority of proteins, β-sheet expansion and subsequent polymerisation is 
disadvantageous [126, 265]. The results from the collagen fibrillisation assay revealed that 
dimeric Hsp47 retained some collagen anti-fibrillisation activity, reducing collagen fibril 
formation in comparison to collagen alone, albeit that this reduction was not as pronounced as 
the effect of monomeric Hsp47. Therefore, once again, these results disagree with the earlier 
hypothesis by Thomson and coworkers [249] and Dafforn and coworkers [87] that Hsp47 
functions only as a monomer or trimer as the dimer revealed in this study also showed 
functionality.    
 
Histidines 191, 197 and 198 form a breach cluster near the hinge region of Hsp47. This 
cluster was particularly noteworthy as it is in the region of serpins that is involved in the 
conformational change that accompanies insertion of the RCL into the central β-sheet (A-
sheet). In the past, this region has been shown to be important for the function of other serpins 
[21, 125, 198, 200, 201]. Both the single mutant, H191A and the double mutant, 
H197A:H198A induced a change in the state of the serpin to the latent state.  Formation of the 
latent state led to an increase in the stability of the protein and enhanced the anti-fibrillisation 
activity of Hsp47. This was a surprising result as it was expected that such a large adjustment 
in the conformation of Hsp47 would affect the collagen binding site of the chaperone, thereby 
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reducing its biological activity. This leads to the hypothesis that the binding site is not situated 
near the region of the serpin that is disrupted during latent state formation. It was also 
expected that the change to the stabilised structure represented by the latent conformation 
would constrain the protein in a way that altered the pH dependent conformational transition 
of the serpin. This effect was also not observed. As both variants retained the ability to 
undergo the pH induced conformational change, it was evident that histidines 191, 197 or 198 
were not the sole residues involved in controlling the pH induced conformational transition of 
Hsp47.  
 
Implications of the latent state of Hsp47 on structure and function 
The induction of an active latent serpin state by these variants is novel. Firstly, this is the 
initial observation of the latent conformation for Hsp47 and secondly, this is the first sighting 
of a latent serpin conformation that is active. Although the latent conformation has been 
observed for PAI-1 [139] and α1-AT [220], both these proteins have been inactive [139, 163, 
220]. Conversely, the latency conversion of Hsp47 had the opposite effect on the activity of 
the chaperone. Rather than losing its functionality, latent Hsp47 was more effective at 
preventing collagen fibril formation. A ruptured hydrogen-bonded network is the likely 
reason for this increased anti-fibrillisation activity. It may be that the latent form simply has 
increased biological activity or it could be that the disruption of hydrogen bonds removes 
some of the structural restraint on the protein, producing a more flexible molecule that can 
form additional/stronger contacts with collagen chains and consequently reduce collagen fibril 
formation.  
 
The spontaneous conversion of serpins from the native to latent state is prevented by a 
hydrogen-bonded network [101] and examination of polar residues that are highly conserved 
in all serpins has identified a buried polar cluster in the shutter region (beneath the A-sheet) 
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that is found to stabilise both the stressed and relaxed serpin states via a rearrangement of 
hydrogen bonds [124]. The critical role of these regions has been discussed with the structure 
of PAI-2, in which both backbone and sidechain atoms such as Thr, Ser, Asn and His form 
circles of hydrogen bonds [124]. Additionally, asparagine and histidine residues on β-strands 
within the A-sheet straddle the site of β-strand insertion. Insertion of the RCL to form s4A 
requires disruption of this network and consequently some of the hydrogen bonds are broken 
in PA1-2. In the stressed state, the RCL is held in position by a network of hydrogen bonds in 
the proximal hinge supported by sidechain electrostatic interactions. The C-termini of s3A 
and s4A in the central β-sheet are prised apart by the steric effects of Trp194 and the 
electrostatic interactions restraining the sidechain of Glu342 at the C-terminus of s5A. 
Interaction with protease results in the breaking of hydrogen bonds holding the proximal 
hinge (residues P13-P16). Upon formation of a covalent acyl-intermediate with the protease, 
β-strand s4A partially inserts into the A-sheet up to about P14-P10. Subsequently, there is 
rearrangement of the hydrogen-bonded pattern by the buried polar residues, allowing 
separation of the strands in the middle section of the central β-sheet [124]. Examination of 
this region in the partially inserted form of intact antithrombin revealed many ruptured 
hydrogen bonds between strands s3A and s5A [266]. In a normal β-sheet, optimal inter-strand 
interactions occur by cross-strand residue pair interactions [267]. These inter-stand sidechain 
interactions are important for protein stability [268]. Examination of other stressed proteins 
revealed that this hydrogen bond network is conserved in α1-AT [153] and ovalbumin [269]. 
The stability of this hydrogen-bonded network is enhanced by the balance of opposite charges 
on the proximal hinge of the RCL and the loop between s3A and the proceeding residues. The 
former usually carries a charge of -1 whilst the latter is normally neutral or +1 [124]. 
According to the Hsp47 model structure (Figure 9.1), histidines 191, 197 and 198 are in close 
proximity to both the proximal hinge region and the residues proceeding s3A in β-sheet A. 
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Formation of the latent serpin conformation by the H191A and H197A:H198A variants can 
be explained in terms of this network of hydrogen bonds. Substitution of histidine residues for 
alanine in the hinge region would result in a disruption of the hydrogen-bonded network that 
prevents premature insertion of the RCL in the A-sheet. This is because of the drastic 
difference in the side chains of histidine and alanine, whereby the former can form hydrogen 
bonds but the latter cannot. Disruption of hydrogen bonds above the A-sheet would result in 
concomitant breakage of bonds in the central β-sheet, allowing insertion of the RCL as s4A 
and consequent latent state formation. Furthermore, the mutations would also compromise the 
charge balance between the proximal hinge of the RCL and the loop between s3A and the 
subsequent residues, destabilising the native structure. 
 
Effect of mutations on pH dependent conformational change 
Additionally, a difference in the pH at maximum protein elution of the pH dependent species 
was noted upon further examination of the elution profiles of WT, H191A and 
H197A:H198A. Whereas WT and H191A mutant pH dependent species eluted at 
approximately pH 6.1, the H197A:H198A variant equivalent eluted at approximately pH 5.8. 
This indicated that substitution of histidines 197 and 198 increased the affinity of Hsp47 for 
collagen as the H197A:H198A variant required a lower pH to be eluted from the gelatin 
column. This shift in pH suggests that H197 and H198 are in the region that is involved the 
conformational transition of Hsp47, although these residues do not by themselves account for 
the complete conformational switch. As the substitutions did not abolish the collagen binding 
properties of Hsp47; it may be that the alteration in pH dependency of the conformational 
change was due to the loss/weakening of interactions within the molecule. That is to say that 
histidines 197 and 198 are important for the structural transition of Hsp47, not because they 
themselves are involved in the pH dependent conformational change but because of the 
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intramolecular interactions that they form. The significance of this cluster was to be expected 
due to the location of the histidines, in the region near the RCL and the A-sheet.  
 
Histidines 255 and 256 form the gate cluster and are located in a turn between β-sheet C and 
α-helix G. As histidine 256 is conserved within the Hsp47 proteins from different species it 
was thought likely to be important in the conformational change of the chaperone. The results 
for the CD spectra and thermal titrations revealed that this mutant behaved similar to its WT 
counterpart, with the salt dependent species being polymeric and hyperstable and the 
monomeric pH dependent species being metastable. Interestingly however, the collagen 
fibrillisation assays (Figure 7.9) demonstrated a difference in the effect of the WT and mutant 
on collagen fibril formation. Both the H255A:H256A monomer and polymer had a more 
pronounced effect on the prevention of collagen fibril formation than their WT counterparts, 
implying that the substitution of amino acids near the gate cluster enhanced the biological 
activity of the chaperone. Even more interesting was the finding that the mutations did not 
alter the binding of the polymer or the monomer during gelatin affinity purification. This 
suggests that the variant altered the binding of the protein to collagen in such a way that 
influenced its biological activity. However it should also be noticed that this did not disturb its 
conformational transition upon a reduction in the pH. As both species of Hsp47 produced by 
the H255A:H256A variant were able to undergo a conformational transition upon a reduction 
in pH and possessed biological activity by interaction with collagen, it is evident that H255 or 
H256 are not involved in initiating the pH dependent structural changes or the binding site for 
collagen. 
 
The H220A mutant also produced an extremely exciting result and probably the most 
interesting in terms of the collagen binding region on Hsp47. Substitution of the histidine for 
alanine at the 220 position completely abolished and greatly reduced the binding of the pH 
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dependent and salt dependent species to gelatin, respectively. This suggested that His 220 was 
important for the binding of Hsp47 to its substrate. The location of His 220 however, below 
the hinge region at the top of the A-sheet is over 20 Ǻ from helix A, which is thought to be 
the likely binding site for collagen, according to previous convincing mutation studies 
(Nagata, unpublished). However, the deletion mutants, CΔ3 and NΔ1 involved removal of 
large sections of C- and N- terminals, respectively. Therefore it could be that the diminished 
binding properties of the variants were an effect of the deletion of vast regions of the protein 
affecting intramolecular interactions rather than location of the binding cleft. It is also 
possible that these large deletions led to a large destabilisation of the protein fold as a whole. 
Interestingly no data was presented in this paper to show that the protein was still intact. 
However recent experiments by collaborators involving deletion of residues on hA by Miller 
and coworkers (Olerenshaw and coworkers, unpublished) have shown that this region may 
indeed be important for collagen binding. For these reasons it was expected that H220 would 
not be involved in the primary binding site of Hsp47 for collagen. However the results from 
this work indicate that it does affect collagen binding and may instead be part of a secondary 
binding site. 
 
Taken together, the results for each of the mutants tell a story about the levels of importance 
of the different regions in Hsp47. Mutations near the A-sheet and RCL, in the breach cluster 
(H191, H197 and H198) resulted in formation of the latent serpin state, emphasising the 
significance of this region in the pH dependent conformational change. Furthermore, another 
mutation (H220) in this region completely abolished Hsp47-collagen binding and 
consequently presence of the mutant did not affect collagen fibrillisation. This accentuates the 
significance of H220 in the collagen binding interaction. Mutations at the bottom of β-sheet 
C, in the gate cluster (H255 and H256) did not perturb the binding/release of Hsp47 from 
collagen but greatly enhanced the biological activity of the chaperone, markedly reducing 
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collagen fibril formation in its presence. These data highlight the importance of this region in 
anti-fibrillisation of collagen. The electron microscopy experiments allowed visualisation of 
the effect of the absence and presence of Hsp47 on collagen fibril formation and consequently 
identifying a possible mechanism of action of Hsp47. 
 
In conclusion, this research has provided insight into the behaviour of the non-inhibitory 
serpin, Hsp47 and enabled the discovery of characteristics that were previously unknown. 
Most importantly, it has allowed identification of the regions that are vital for its chaperone 
function, stability and biological behaviour. Moreover, the findings of this thesis are in 
agreement with previous work on the serpin mechanism of action; providing strength to the 
data. This study has shown that Hsp47, a non-inhibitory serine protease inhibitor, exists in 
two different species; each requiring different conditions to be eluted from its substrate, 
collagen. Furthermore, rationally designed mutants of Hsp47 dramatically affected the ability 
of Hsp47 to bind collagen and its potency to prevent collagen aggregation via its chaperone 
activity. The physiological relevance of these findings needs to be investigated. 
 
 
9.2 Future Work 
This thesis has attempted to investigate the regions of importance in the structural transition 
of the non-inhibitory serpin, Hsp47. Many of the questions have been answered and a number 
of novel findings have been reported. There is a number of ways in which this research can be 
extended to emphasize the structural significance of histidine residues in Hsp47. 
 
Chapter 3 identified that Xenopus laevis and Danio rerio Hsp47 proved difficult to clone and 
purify a suitable amount (milligramme quantities) of stable protein from either of the species. 
Due to time constraints, Xenopus laevis and Danio rerio Hsp47 were not cloned into the 
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pET®T7/NT-TOPO® construct that proved extremely successful for Mus musculus Hsp47. 
Cloning of the Hsp47 from the former species and purification following the collagen affinity 
chromatography method would be particularly interesting as it would allow comparison of the 
behaviour of the chaperone between different species. Even more interesting would be the 
examination of whether two distinct species (salt dependent and pH dependent) are produced 
and investigation of the serpin conformation resulting from histidine to alanine amino acid 
substitutions at the same positions (for example, His 191, 197, 198, 220, 255 and 256). 
Additionally, thermal denaturation and the effect on collagen fibril formation of the Hsp47 
produced by Xenopus laevis and Danio rerio could be compared to that of Mus musculus, 
which would provide insight into the stability and anti-fibrillisation potency of each of the 
species. Consequently, the differences and similarities of Hsp47 between different species 
would enable comparison of the behaviour of the protein between poikilothermic, 
endothermic and ectothermic vertebrates. Characteristics of the protein in different species 
would be interesting to investigate. 
 
The results presented in Chapter 4 revealed the latent Hsp47 conformation and subsequently 
highlighted the differences in the stability and biological activity of the native conformation 
compared to the latent conformation. It can therefore be speculated that the enhanced 
biological activity is a direct consequence of the formation of a more stable serpin structure 
that binds its substrate in such a way that enhances function. Therefore an interesting 
extension to this part of the study would be to engineer mutations, other than histidine, in the 
breach region to establish whether it is the substitution of histidine residues that triggers the 
formation of stabilising interactions. Both the H191A and H197A:H198A variants produced 
the latent serpin conformation. For the double mutant, however, it is impossible to distinguish 
whether it is H197A or H198A mutation that results in the conversion from the native to 
latent state. Synthesising single mutants; H197A and H198A would allow determination of 
 264
the histidine(s) that are responsible for causing the structural transition. To further probe 
latent state formation in Hsp47, it would be intriguing to investigate whether it is only 
histidine mutations in the breach region that instigate its formation or whether amino acid 
substitutions in other regions can also result in increased stability of the protein. Mutation of 
histidine residues in other regions can be performed to elucidate this. 
 
Alanine substitution of His 220 (Chapter 5) revealed that this side chain was crucial for the 
interaction between Hsp47 and collagen. Additional amino acid substitutions at this position 
will reveal structural and functional requirements at this locus for chaperone-substrate 
binding. Furthermore, as this mutant was unable to bind collagen it was speculated that it 
formed part of a secondary binding site for collagen. Substitution of other amino acids in 
close proximity to His 220 would be able to verify/dismiss this suggestion. Mutation of 
residues within this region may provide further insight into the pH dependent conformational 
mechanism of Hsp47 and/or the putative binding of chaperone to substrate. Collagen fibril 
formation did not seem to be affected by the presence of the H220A variant. It would be 
interesting to visualise the collagen fibrils, by electron microscopy, in the presence of the 
mutant and compare them to those formed in the absence of Hsp47.  
 
Chapter 6 revealed that although the H255A:H256A double mutant showed similar collagen 
binding properties to WT Hsp47, its biological activity was greatly enhanced as it 
significantly reduced fibril formation. Modelling to show bonds formed by His 255 and His 
256 and interactions diminished by substitution of these histidines to alanine would be 
advantageous in determining the contacts that facilitate binding of Hsp47 to collagen and 
subsequently enhance biological activity of the protein. It was also noted that the salt 
dependent species of the mutant released from the collagen at a much lower salt concentration 
in comparison to the WT equivalent. Comparison of molecular models illustrating chemical 
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binds of mutant and WT species would be beneficial in the identification of interactions 
responsible for the structural transition and the binding/release to/from collagen. 
 
Chapter 8 illustrated that the results from the attempted protein crystallisation produced some 
promising results. Firstly, diffraction of a light beam could be used to establish whether the 
crystals were protein or salt. If the crystals were due to Hsp47, they could be used to construct 
a structure of the latent conformation of Hsp47. If however, it was realised that the crystals 
were due to salt, other buffer and precipitant conditions to attempt to crystallise the protein. 
Comparison of crystallography reagents from a number of different suppliers or increased 
purity of the latent Hsp47 may prove successful. 
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CHAPTER 11: Appendices 
 
Appendix A – Primer sequences 
 
Primer sequences for PCR 
Cloning into pET101/D-TOPO®: 
Danio rerio -  Forward:    5’-CAC-CAT-GGA-CAA-AAA-3’ 
           Backward: 5’-CAA-TTC-ATC-TCT-CAT-TTT-3’ 
 
Cloning into pET102/D-TOPO®: 
Xenopus laevis -  Forward: 5’-CAC-CGC-AGA-GAA-AAA-AGT-G-3’  
    Reverse:  5’-CAC-CAT-GGC-AGA-GAA-A-3’   
Danio rerio -      Forward: 5’-CAC-CGA-CAA-AAA-GTT-GAG-CAC-T-3’ 
      Reverse:  5’-CAA-TTC-ATC-TCT-CAT-TTT-3’ 
 
Cloning into pET-32 Xa/LIC: 
The production of compatible sticky stranded when cloning into Xa/LIC required the 
inclusion of the following sequences on the 5’ end of each primer: 
Forward: 5’-GGT-ATT-GAG-GGT-CGC 
Reverse: 5’-AGA-GGA-GAG-TTA-GAG-CC 
 
Xenopus laevis - Forward: 5’-GCT-ATT-GAG-GCT-CGC-TGG-ATG-ATC-AAG-CTT- 
CTA-3’ 
 Reverse: 5’-AGA-GGA-GAG-TTA-GAG-CCT-AAT-TCA-TCT -CGC-
ATT-TTG-TCT-CC-3’ 
Danio rerio -       Forward: 5’-GGT-ATT-GAG-GGT-CGC-GAC-AAA-AAG-TTG-AGC-  
ACT-3’ 
 280
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Reverse: 5’-AGA-GGA-GAG-TTA-GAG-CCC-AAT-TCA-TCT-CTC- 
ATT-TT-3’ 
 
Cloning into pTYB12: 
Xenopus laevis -  Forward: 5’-GGT-ATT-GAG-GGT-CGC-ATG-CAT-GCA-GAG-AAA-
AAA-3’ 
Reverse: 5’-AGA-GGA-GAG-TTA-GAG-CCT-TAT-AAT-TCA-TCT-
CGC-ATT-TTG-TCT-CC-3’ 
 
Danio rerio -    Forward: 5’-GGT-ATT-GAG-GGT-CGC-ATG-CAT-GAG-GAC-AAA-                 
AAG-3’ 
Reverse: 5’-AGA-GGA-GAG-AGT-TAG-AGC-CTT-ACA-ATT-CAT-
CTC-TCA-TTT-TT-3’ 
 
 
 
  
Appendix B – Hsp47 sequence identity between different organisms. 
 
Organism   Sequence 
 
Homo    
Pan 
Bos 
Mus musculus 
Rattus 
Cricetulus 
Gallus 
Alligator 
Xenopus 
Danio 
Carassius 
Oncorhynchus 
Macaca   MWVAPGVLGDTDASTNLLTPLQECAIRSGLACAESLGVGGVSHSEGHAGPRGDSRRPAAW 
Gasterosteus 
Branchiostoma 
Equus 
Ciona 
Sus 
Canis  
Fugu 
Monodelphis 
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Organism   Sequence 
 
Homo    
Pan 
Bos 
Mus musculus 
Rattus 
Cricetulus 
Gallus 
Alligator 
Xenopus 
Danio 
Carassius 
Oncorhynchus 
Macaca   AAEGGSRTQGPGGAGRGRGRGLGRFEGGLWLFLAELGRPPEAFPTFQKFLGTGRRGWGLP    
Gasterosteus 
Branchiostoma 
Equus 
Ciona 
Sus 
Canis  
Fugu 
Monodelphis 
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Organism   Sequence 
 
Homo    
Pan                      MRSLLLLSAFCLLEAA 
Bos 
Mus musculus 
Rattus 
Cricetulus 
Gallus 
Alligator 
Xenopus 
Danio 
Carassius 
Oncorhynchus 
Macaca   YIDPRSRGAGEEQNRVVARERESRPGASPARPRPTVVHENHLPAMHSLLLLSAFCLLAVA    
Gasterosteus 
Branchiostoma 
Equus 
Ciona 
Sus 
Canis                       MRFLLLLNTCCLLAVV 
Fugu 
Monodelphis                MSRSSPSLHPQVPSGGKQGFAPRTAMWPTQLLSALCLLAVA 
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Organism   Sequence 
 
Homo    AEVKKPAAAAAPGTAEKLSPKAATLAERSAGLAFSLYQAMAKDQAVENILVSPVVVAS    
Pan          LAAEVKKPAAAAAPGTAEKLSPKAATLAERSAGLAFSLYQAMAKDQAVENILVSPVVVAS 
Bos    AEVKKPAAAAAPGTAEKLSPKAATLAERSAGLAFSLYQAMAKDQAVENILLSPVVVAS 
Mus musculus   AEVKKPLEAAAPGTAEKLSSKATTLAERSTGLAFSLYQAMAKDQAVENILLSPLVVAS 
Rattus    AEVKKPVEAAAPGTAEKLSSKATTLAERSTGLAFSLYQAMAKDQAVENILLSPLVVAS 
Cricetulus   AEVKKPVEAAAPGTAEKLSSKATTLAERSTGLAFSLYQAMAKDQAVENILLSPLVVAS 
Gallus                   KLSDKATTLADRSTTLAFNLYHAMAKDKNMENILLSPVVVAS 
Alligator              KKLSDKANALADRSATLAFNLYHAMAKDKNMENILVSPVVVAS 
Xenopus       QKMSQHANVLADKSAGLAFNLYQIMAKDKKVENILLSPVVVAS 
Danio           GEDKKLSTHATSMADTSANLAFNLYHNVAKEKGLENILISPVVVAS 
Carassius           LSSHASILADNSANFAFNLYHNLAKEKDIENIVISPVVVAS 
Oncorhynchus             KKLSSHATTMADKSANLAFSLYHTVAKEKGLDNILISPVVVAS 
Macaca         LTAEVKKPAAAAAPGTAEKLSPKAATLAERSAGLAFSLYQAMAKDQAVENILVSPVVVAS    
Gasterosteus             KKLSSYATALADHSANLAFSLYHNMAKDKDTENILLSPVVVAS 
Branchiostoma            SQESTPLADINSEFALELYKTLHKDHP-ENIFFSPFSIST 
Equus       PRAAFAMEQLSTANTHFAVDLFRALNESDPTGNIFISPLSISS 
Ciona 
Sus                 LSEANGTFALRLLKILCQDDPSHNVFYSPVSISS 
Canis          LAAEVKKPAAAAAPGSAEKLSPKAATLAERSAGLAFSLYQAMAKDQAVENILLSPVVVAS  
Fugu          ANIVVLSLLALLASAEDKKLSNHATTLADNSANLAFSLYHNMAKDKNVENILISPVVLAS 
Monodelphis         GAAEVKKPATAGKSG-EAKLSEKASTLAERSAGLAFNLYRVMAQDKGVENILLSPVVVAS 
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Organism   Sequence 
 
Homo    SLGLVSLGGKATTASQAKAVLSAEQLRDEEVHAGLGELLRSLSNSTARNVTWKLGSRLYG    
Pan    SLGLVSLGGKATTASQAKAVLSAEQLRDEEVHAGLGELLRSLSNSTARNVTWKLGSRLYG 
Bos    SLGLVSLGGKAATASQAKAVLSAEQLRDDEVHAGLGELLRSLSNSTARNVTWKLGSRLYG 
Mus musculus   SLGLVSLGGKATTASQAKAVLSAEKLRDEEVHTGLGELLRSLSNSTARNVTWKLGSRLYG 
Rattus    SLGLVSLGGKATTASQAKAVLSAEKLRDEEVHTGLGELVRSLSNSTARNVTWKLGSRLYG 
Cricetulus   SLGLVSLGGKATTASQAKAVLSAEKLRDEEVHKGLGELLRSLSNSTARNVTWKLGSRLYG 
Gallus    SLGLVSLGGKATTASQAKAVLSADKLNDDYVHSGLSELLNEVSNSTARNVTWKIGNRLYG 
Alligator   SLGLVSLGGKAATASQAKAVLSADKLNDDYVHSGLSELLNEVSNSTARNVTWKIGNRLYG 
Xenopus   SLGLVSMGGQASTAAQAKTVLNAEKLSDEHIHSGLAELLNEVSNSTARNVTWKMGNRLYG 
Danio    SLGMVAMGSKSSTASQVKSILKADALKDEHLHTGLSELLTEVSDPQTRNVTWKISNRLYG 
Carassius   SLGLVALGGKSNTASQVKTVLSATTVKDEQLHSGLSELLTEVSNSTARNVTWKISNRLYG 
Oncorhynchus   SLGMVALGGKASTASQVKSVLSADALNDEHLHTGLSELLTEVSDPKTRNVTWKISNRLYG 
Macaca   SLGLVSLGGKATTASQAKAVLSAEQLRDEEVHTGLGELLRSLSNSTARNVTWKLGSRLYG    
Gasterosteus   SLGMVALGGKASTASQVKTVLSADKLKDEHLHAGLSELLSEVSDAKSRNTTWKINNRLYG 
Branchiostoma  CLAMAYLGARNDTAQQMSRVLRFHKMDASDLHVLFHDLLTQLHHSD-RPYTLKTANRLFG 
Equus    ALAMIFLGTRGNTAAQVSKALYFDTV--EDIHSRFQSLNADINKPGAPYIL-KLANRLYG 
Ciona               KGNTAKQIDDAFMFSKIEDGRFHSAFGELHGLLFDKATEKVTAKSSNRVFA 
Sus    ALAMVLLGAKGDTAAQLAQVLSLNTEKD--IHQDFQALLAELNKPSTRYLL-RTANKLFG 
Canis    SLGLVSLGGKATTASQAKAVLSAEQLRDEEVHAGLGELLRSLSNSTARNVTWKLGSRLYG  
Fugu    SLGMVALGGKASTASQVKTVLSADKLKDEHLHAGLSELLTELSDADKRNTTWKINNRLYG 
Monodelphis   SLGLVSLGGKATTASQAKAVLSADKLRDDDVHTGLAELLASVSNNTARNVTWKLGSRLYG 
 
               :  ** *    :         .*   : *   : .        :  .:::. 
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Organism   Sequence 
 
Homo    PSSVSFADDFVRSSKQHYNCEHSKINFR-DKRSALQSINEWAAQTTDGKLPEVTKD--VE    
Pan    PSSVSFADDFVRSSKQHYNCEHSKINFR-DKRSALQSINEWAAQTTDGKLPEVTKD--VE 
Bos    PSSVSFAEDFVRSSKQHYNCEHSKINFR-DKRSALQSINEWAAQTTDGKLPEVTKD--VE 
Mus musculus   PSSVSFADDFVRSSKQHYNCEHSKINFR-DKRSALQSINEWASQTTDGKLPEVTKD--VE 
Rattus    PSSVSFADDFVRSSKQHYNCEHSKINFR-DKRSALQSINEWASQTTDGKLPEVTKD--VE 
Cricetulus   PSSVNFVEDFVHSSKQHYNCEHSKINFR-DKRSALQSINEWASQTTDGKLPEVTKD--VE 
Gallus    PASINFADDFVKNSKKHYNYEHSKINFR-DKRSALKSINEWAAQTTDGKLPEVTKD--VE 
Alligator   PSSISFADDFVKNSKKHYNYEHSKINFR-DKRSALKSINEWASQTTNGKLPEVTKD--VE 
Xenopus   PSSISFSDNFVKDSKKHYNYEHSKINFR-DKRSTLRSINEWAAQTTDGKLPEVTSD--VE 
Danio    PSSVSFAEDFVKNSKKHYNYEHSKINFR-DKRSAINSINEWAAKTTDGKLPEITKD--VK 
Carassius   PSSVSFVDNFLKSSKKHYNCEHSKINFR-DKRSAVKAINDWASKSTDGKLPEVTKD--VE 
Oncorhynchus   PSSVTFADNFVKSSKKHYNYDHSKINLR-DKRSAVNSINEWAAKSTDGKLPEITKD--VQ 
Macaca   PSSVSFADDFVRSSKQHYNCEHSKINFR-DKRSALQSINEWAAQTTDGKLPEVTKD--VE   
Gasterosteus   PSSVSFADDFVKNSKKHYNYDHSKINFR-DKRSAVNSINEWAAKSTDGKLTEITKD--VQ 
Branchiostoma  QNSFEFSQKFLDETSRHYRAQLAPVDFSGNTEGARQTINSWVEEQTENKIQDLLAPGTVT 
Equus    EKTYNFLADFLASTQKMYGAELASVDFQQAPEDARKEINEWVKGQTEGKIPELLVKGMVD 
Ciona    DKHITVLEDY-QDSLSVYSATVESVDFK-MPKSAVKKINDWASDATNGVIKSMLEEDGVN 
Sus    EKSREFLSTFKESCLRFYDAELEQLSFASAAEASRKQINAWVSKKTEGKIPEVLPWNSID 
Canis     PSSVSFAEDFVRSSKQHYNCEHSKINFR-DKRSALQSINEWAAQTTDGKLPEVTKD--VE 
Fugu    PSSVSFSDDFVKSSKKHYKYDHSKINFR-DKRSAVNSINEWAAKATDGKLPEITKD--VQ 
Monodelphis   PSSVSFAEDFVQSSKKHYNYEHSKINFR-DKRSALQSINEWASQTTDGKLPEVTKD--VE 
 
                .   :  .    *     :.:     . : . ** *.   *:. : .:     : 
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Organism   Sequence 
 
Homo    RTDGALLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVMMMHRTGLYNYYDDEKEKL  
Pan    RTDGALLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVMMMHRTGLYNYYDDEKEKL 
Bos    RTDGALLVNAMFFKPHWDERFHHKMVDNRGFMVTRSYTVGVTMMHRTGLYNYYDDEKEKL 
Mus musculus   RTDGALLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVTMMHRTGLYNYYDDEKEKL 
Rattus    RTDGALLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVTMMHRTGLYNYYDDEKEKL 
Cricetulus   RTDGALLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVTMMHRTGLYNYYDDEKEKL  
Gallus    KTDGALIVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVPMMHRTGLYNYYDDEAEKL 
Alligator   KTDGALIVNAMFFKPHWDEKFHHTMVDNRGFMVTRSFTVGVPMMHRTGLYNYFDDETEKL 
Xenopus   KTDGALIVNAMFFKPHWDERFHHQMVDNRGFMVTRSFTVSVPMMHRTGLYKYTDDETNNL 
Danio    NTDGAMIVNAMFFKPHWDEKSHHKMVDNRGFLVTRSHTVSVPMMHRTGIYGFYEDTENRF 
Carassius   KTDGAMIINAMFYKPHWDEQFHHKMVDNRGFLVHRSYTVSVPMMHRTGIYGLFDDTTNNL 
Oncorhynchus   NADGATIANAMFFKPHWDEKFHEKMVDNRGFLVTRSFTVSVPMMHRTGLYKFHDDTENKV 
Macaca   RTDGALLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVMMMHRTGLYNYYDDEKEKL    
Gasterosteus   NTDGAMIVNAMYFKPHWFETFNDQMVDNRGFLVTRSFTVGVPMMHRTGLYDFHEDKENRL 
Branchiostoma  PATMLVLVNAIYFKGSWERKFEESRTRLGTFHISRDEKVEVPMMHQQGRFKLAYDEDLNC 
Equus    NMTKLVLVNAIYFKGNWQEKFMKEATRDAPFRLNKKDTKTVKMMYQKKKFPYNYIEDLKC 
Ciona    NDTALLIINALYFRGNWDYEFDEGRTKRRPFYVSKDKAVETSFMFQNEHFKYAYISELTL 
Sus    EQTRLVLVNAVYFKGRWDQQFDKKYTREMPFRVNQKEQRPVQMMFQEATFRLGRVEEVPA 
Canis     RTDGALLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVTMMHRTGLYNYYDDEKEKL 
Fugu    NADGAMIVNAMFFKPHWDERFHDKMVDTRGFLVTRSHTIGISMMHRTGLYDFYDDEVNRI 
Monodelphis   KTDGALIVNAMFFKPHWDERFHHKMVDNRGFMVTRSYTVGVPMMHRTGLYNYYDDETEKL 
 
       : **::::  *     .  .    * :   :.    :*.:   : 
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Organism   Sequence 
 
Homo    QIVEMPLAHKLSSLIILMPHHVEP----LERLEKLLTKEQLKIWMGK--MQKKAVAISLP  
Pan    QIVEMPLAHKLSSLIILMPHHVEP----LERLEKLLTKEQLKIWMGK--MQKKAVAISLP 
Bos    QMVEMPLAHKLSSLIIIMPHHVEP----LERLEKLLTKEQLKVWMGK--MQKKAVAISLP 
Mus musculus   QMVEMPLAHKLSSLIILMPHHVEP----LERLEKLLTKEQLKAWMGK--MQKKAVAISLP 
Rattus    QLVEMPLAHKLSSLIILMPHHVEP----LERLEKLLTKEQLKTWMGK--MQKKAVAISLP 
Cricetulus   QILEMPLAHKLSSLIILMPHHVEP----LERLEKLLTKEQLKAWMGK--MQKKAVAISLP 
Gallus    QVVEMPLAHKLSSMIFIMPNHVEP----LERVEKLLNREQLKTWASK--MKKRSVAISLP 
Alligator   QIVEMPLAHKLSSMIFIMPNHVEP----LERVEKLLTREQLKTWISK--LKKRSVAISLP 
Xenopus   QILEMPLAHKLSSMIIIMPYHVEP----LERLEKLLTREQVNAWDGK--MKKRAVAVSLP 
Danio    LIVSMPLAHKKSSMIFIMPYHVEP----LDRLENLLTRQQLDTWISK--LEERAVAISLP 
Carassius   LVLDMALAHKMSSIVFIMPYHVES----LERVEKLLTRQQLNTWISK--MEQRAVAVSLP 
Oncorhynchus   FVLDMPLGQKQSSLVFIMPYHLEP----LDRLEKLLTRKQLETWMGK--MEERAVAISLP 
Macaca   QIVEMPLAHKLSSLIILMPHHVEP----LERLEKLLTKEQLKIWMGK--MQKKAVAISLP 
Gasterosteus   FVLNMPLGKKEASMILIMPYHLEP----LARLEKLLTRKQVDTWISK--MENIAVAISLP 
Branchiostoma  QILEMPYQGKHLSMLLVLPEKMD----ALSTIETSLTPDILRRWQKS--MDEVSTMVQIP 
Equus    RVLELPYQGKELSMIILLPDDIEDESTGLEKIEKQLTLEKLREWTKPENLYLAEVNVHLP 
Ciona    QVLEMDYAGKDYSMVLLMPENFE-----LPKVEANLNHANLTKWLSA--LKHESVDLTIP 
Sus    QVLELPYEDRELSMVVLLPDDH----VALSEVERQLTFEKLLAWTKPERMQSLDVEVFLP 
Canis     QIVEMPLAHKLSSLIILMPHHVEP----LERLEKLLTKEQLKIWMGK--MQKKAVAISLP 
Fugu    YVLNMPLGQKQASMILIMPYHLEP----LERLEKLLSKKQVDTWISK--MTNKAVAISLP 
Monodelphis   QMVEMPLAHKLSSLIIIMPHHVEP----LERLEKLLTKEQLKTWLGK--MKKRAVAISLP 
 
 
      ::.:    :  *::.::* .       *  :*  *.   :*       :    . : :* 
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Organism   Sequence 
 
Homo    K--GVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYLASVFHATAFELDTDGN- 
Pan    K--GVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYLASVFHATAFELDTDGN- 
Bos    K--GVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYLASVFHATAFEWDTDGN- 
Mus musculus   K--GVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYLASVFHATAFEWDTEGN- 
Rattus    K--GVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYLASVFHATAFEWDTEGN- 
Cricetulus   K--GVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYLASVFHATAFEWDTDGN- 
Gallus    K--VVLEVSHDLQKHLADLGLTEAIDKTKADLSKISGKKDLYLSNVFHAAALEWDTDGN- 
Alligator   K--VSLEVSHDLQKHLADLGLTEAIDKNKADLSKISGKKDLYLSNVFHAAALEWDTEGN- 
Xenopus   K--VSLEVSHDLQKHLGDLGLTEAIDKSKADLSKISGKKDLYLASMFHAAALEWDTEGN- 
Danio    K--VSMEVSHDLQKHLGELGLTEAVDKPKADLSNISGKKDLYLSNVFHASSLEWDTEGN- 
Carassius   K--VSVEVSHDLQKHLTELGLTEAVDKAKADLSNISGKKDLYLSNVFHASAMEWDTEGN- 
Oncorhynchus   K--VSMEVSHNLQKTLGELGLTDAVDKTKADLSNISGKKDLYLSNVFHASSMEWDIEGN- 
Macaca   K--GVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYLASVFHATAFELDTDGN-  
Gasterosteus   K--IALEVSHNLQKHLAELGLTEAVDKSKADLSNISGKKDLYLSNVFHASALELDVKGN- 
Branchiostoma  K--FKLVHDFVLNEKLADMGMTDLFSMADADLSGITGSRDLHVSQVIHKAFVEVNEEGSE 
Equus    R--FKLEESYDLTSHLARLGVQDLFNRGKADLSGMSGARDLFVSKIIHKSFVDLNEEGTE 
Ciona    K--FKLEETLQLQEVLPKMGVADLFDRQACDLNGIANRNDLFVDQIVHKTVLDVNEQGSE 
Sus    R--FKLDASYDLELLLGHLGVVDAFQQGKADFSAMAPERDLSLSTFVHKSVVEVNEEGSE 
Canis     K--GVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYLASVFHATAFEWDTEGN- 
Fugu    K--ISVDVSHNIQKYLSELGLTEAVDKAKADLSNISGKKDLYLSNVFHASAVELDVDGN- 
Monodelphis   K--GVVEVTHDLQKHLAGLGLTEAMDKNKADLSRMSGKKDLYLASVFHATAFEWDTEGN- 
 
         :    :     : *  :*: : ..   .*:. ::  .** :  ..* : .: : .*. 
 
 
 
 
 290 
 291 
 
 
 
 
Organism   Sequence 
 
Homo    --PFDQDIYGREELRS-PKLFYADHPFIFLVRDTQSGSLLFIGRLVRPKGDKMRDEL 
Pan    --PFDQDIYGREELRS-PKLFYADHPFIFLVRDTQSGSLLFIGRLVRPKGDKMRDEL 
Bos    --PFDQDIYGREELRS-PKLFYADHPFIFLVRDTQSGSLLFIGRLVRPKGDKMRDEL 
Mus musculus   --PFDQDIYGREELRS-PKLFYADHPFIFLVRDNQSGSLLFIGRLVRPKGDKMRDEL 
Rattus    --PFDQDIYGREELRS-PKLFYADHPFIFLVRDNQSGSLLFIGRLVRPKGDKMRDEL 
Cricetulus   --PFDQDIYGREELRS-PKLFYADHPFIFLVRDNQSGSLLFIGRLVRPKGDKMRDEL 
Gallus    --PYDADIYGREEMRN-PKLFYADHPFIFMIKDSKTNSILFIGRLVRPKGDKMRDEL 
Alligator   --PFDADIYGREEIRN-PRLFYADHPFIFLIKDNKTNSILFIGRLVRPKGDKMRDEL 
Xenopus   --PFDQDIYGREELRS-PKLFYADHPFIFLVQDAQSGSLLFIGRLVRPKGDKMRDEL 
Danio    --PFDPSIFGSEKMRN-PKLFYADHPFIFLVKDNKTNSILFIGRLVRPKGDKMRDEL 
Carassius   --PPDTSIYGTDKLKT-PKLFYADHPFIFLVKDKKTNSILFMGRLVQPKGDKMRDEL 
Oncorhynchus   --PFDTSIFGSEKLRN-PKLFYADHPFIFLVKDNKTNSILFIGRMVRPKGDKMRDEL 
Macaca   --PFDQDIYGREELRS-PKLFYADHPFIFLVRDTQSGSLLFIGRLVRPKGDKMRDEL  
Gasterosteus   --PFDTSVYGSGKLTN-PRLFYADHPFVFLVKDNKTNSILYIGRVVKPKGDKMRDEL 
Branchiostoma  AAAATAVNMMKRSLD--GETFFADHPFLFLIRDNDSNSILFLGRLVRPEGLTTKDEL 
Equus    AAAATAGTIMLAMLMP-EENFNADHPFIFFIRHNPSANILFLGRFSSP--------- 
Ciona    AAATTSVRSQCDSVAFNPISFVADHPFLWAIRHRQSELLVFMGRFSRPEGPLLGRDE 
Sus    AAAASALVLMECCMES-GPRFCADHPFLFFIRHNKAKSILFCGRFSSP--------- 
Canis     --PFDQDIYGREELRS-PKLFYADHPFIFLVRDTQSGSLLFIGRLVRPKGDKMRDEL 
Fugu    --PYDTSIFGTEKLKN-PKLFYVDHPFIFLVKDNKTNSIMYIGRVVKPKGDKMRDEL 
Monodelphis   --PFDQDIYGREELRS-PKLFYADHPFIFLVQDAQSGSLLFIGRLVRPKGDKMRDEL 
 
 
              :      * .****:: ::.  :  ::: **.  * 
 
 
Appendix C 
WT Mus musculus Hsp47 
     atgcgctctc tccttctggg caccttatgc ctcttggccg tggccctggc agccgaggtg       60 
     ********** ********** ********** ********** ********** ********** 
     aagaaacccc tagaggcggc agcccctggt actgcggaga agctaagttc caaggcgacc       120 
     ********** ********** ********** ********** ********** **********                    
     acactggcag agcgcagcac aggcctggcc ttcagcctat atcaggcgat ggccaaagac       180 
     ********** ********** ********** ********** ********** ********** 
     caggcggtgg agaacatcct cctgtcaccc ttggtggtgg cctcatccct gggtcttgtg       240 
     ********** ********** ********** ********** ********** ********** 
     tcactgggtg gtaaagccac cacagcgtcg caggcgaagg cagtgctgag cgctgagaag       300 
     ********** ********** ********** ********** ********** ********** 
     ctgcgcgatg aggaggtgca cacggggctg ggtgagctgc tccgctccct cagcaactcc       360 
     ********** ********** ********** ********** ********** ********** 
     actgcgcgca acgtgacctg gaaactgggc agccgcctgt acgggcccag ctccgtgagc       420 
     ********** ********** ********** ********** ********** ********** 
     ttcgccgatg acttcgtgcg cagcagcaag caacactaca actgcgaaca ctccaagatc       480 
     ********** ********** ********** ********** ********** ********** 
     aacttccgag acaagcgcag cgccctgcag tccatcaacg agtgggcctc gcagaccacg       540 
     ********** ********** ********** ********** ********** ********** 
     gacggcaagc tgcctgaggt caccaaggat gtggagcgca cggatggggc actgcttgtg       600 
     ********** ********** ********** ********** ********** ********** 
     aacgccatgt tctttaagcc acactgggat gagaagtttc accacaagat ggtggacaac       660 
     ********** ********** ********** ********** ********** ********** 
     cgtggcttca tggtgacccg ctcctatact gtgggtgtta cgatgatgca ccggacaggc       720 
     ********** ********** ********** ********** ********** ********** 
     ctgtacaact actatgacga cgagaaggag aagctgcaga tggtggagat gcccctggct       780 
     ********** ********** ********** ********** ********** ********** 
     cacaagctct ccagcctcat catcctcatg ccccaccatg tggagccgct cgagcgcttg       840 
     ********** ********** ********** ********** ********** ********** 
     gagaagctgc tgaccaagga gcagctgaag gcctggatgg gaaagatgca gaagaaggct       900 
     ********** ********** ********** ********** ********** ********** 
     gtcgccatct ccctgcccaa gggcgtggtg gaggtgaccc atgacctgca gaaacatctg       960 
     ********** ********** ********** ********** ********** ********** 
     gcaggactgg gcctgaccga agccatcgac aagaacaagg cagacctatc gcgcatgtct      1020 
     ********** ********** ********** ********** ********** ********** 
     ggcaagaagg acctgtacct ggccagtgtg ttccacgcca ctgccttcga gtgggacacc      1080 
     ********** ********** ********** ********** ********** ********** 
     gagggcaacc cctttgacca agacatctac gggcgcgagg agctgcgcag ccccaagctg      1140 
     ********** ********** ********** ********** ********** ********** 
     ttctatgccg accacccctt catcttcctg gtgcgagata atcagagcgg ctccttgctc      1200 
     ********** ********** ********** ********** ********** ********** 
     ttcattggcc gcctggtccg gcccaaggga gacaagatgc gagatgagtt gtag            1254 
     ********** ********** ********** ********** ********** **** 
 
Key: *: Primer F2_C01 *: Primer F3_D01 *: Primer F4_D03 *: Primer F1_B01 
 *: Primer R1_F03  
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H191A Mus musculus Hsp47 
     atgcgctctc tccttctggg caccttatgc ctcttggccg tggccctggc agccgaggtg       60 
     ********** ********** ********** ********** ********** ********** 
     aagaaacccc tagaggcggc agcccctggt actgcggaga agctaagttc caaggcgacc       120 
     ********** ********** ********** ********** ********** **********                    
     acactggcag agcgcagcac aggcctggcc ttcagcctat atcaggcgat ggccaaagac       180 
     ********** ********** ********** ********** ********** ********** 
     caggcggtgg agaacatcct cctgtcaccc ttggtggtgg cctcatccct gggtcttgtg       240 
     ********** ********** ********** ********** ********** ********** 
     tcactgggtg gtaaagccac cacagcgtcg caggcgaagg cagtgctgag cgctgagaag       300 
     ********** ********** ********** ********** ********** ********** 
     ctgcgcgatg aggaggtgca cacggggctg ggtgagctgc tccgctccct cagcaactcc       360 
     ********** ********** ********** ********** ********** ********** 
     actgcgcgca acgtgacctg gaaactgggc agccgcctgt acgggcccag ctccgtgagc       420 
     ********** ********** ********** ********** ********** ********** 
     ttcgccgatg acttcgtgcg cagcagcaag caacactaca actgcgaaca ctccaagatc       480 
     ********** ********** ********** ********** ********** ********** 
     aacttccgag acaagcgcag cgccctgcag tccatcaacg agtgggcctc gcagaccacg       540 
     ********** ********** ********** ********** ********** ********** 
     gacggcaagc tgcctgaggt caccaaggat gtggagcgca cggatggggc actgcttgtg       600 
     ********** ********** ********** ********** ********** ********** 
     aacgccatgt tctttaagcc acactgggat gagaagtttc accacaagat ggtggacaac       660 
     ********** ********** *gca****** ********** ********** ********** 
     cgtggcttca tggtgacccg ctcctatact gtgggtgtta cgatgatgca ccggacaggc       720 
     ********** ********** ********** ********** ********** ********** 
     ctgtacaact actatgacga cgagaaggag aagctgcaga tggtggagat gcccctggct       780 
     ********** ********** ********** ********** ********** ********** 
     cacaagctct ccagcctcat catcctcatg ccccaccatg tggagccgct cgagcgcttg       840 
     ********** ********** ********** ********** ********** ********** 
     gagaagctgc tgaccaagga gcagctgaag gcctggatgg gaaagatgca gaagaaggct       900 
     ********** ********** ********** ********** ********** ********** 
     gtcgccatct ccctgcccaa gggcgtggtg gaggtgaccc atgacctgca gaaacatctg       960 
     ********** ********** ********** ********** ********** ********** 
     gcaggactgg gcctgaccga agccatcgac aagaacaagg cagacctatc gcgcatgtct      1020 
     ********** ********** ********** ********** ********** ********** 
     ggcaagaagg acctgtacct ggccagtgtg ttccacgcca ctgccttcga gtgggacacc      1080 
     ********** ********** ********** ********** ********** ********** 
     gagggcaacc cctttgacca agacatctac gggcgcgagg agctgcgcag ccccaagctg      1140 
     ********** ********** ********** ********** ********** ********** 
     ttctatgccg accacccctt catcttcctg gtgcgagata atcagagcgg ctccttgctc      1200 
     ********** ********** ********** ********** ********** ********** 
     ttcattggcc gcctggtccg gcccaaggga gacaagatgc gagatgagtt gtag            1254 
     ********** ********** ********** ********** ********** **** 
 
Key: *: Primer F2_G03 *: Primer F3_H03 *: Primer F4_D05 
 *: Primer R2_A04 *: Primer R1_E05 
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H197A:H198A Mus musculus Hsp47 
 
     atgcgctctc tccttctggg caccttatgc ctcttggccg tggccctggc agccgaggtg       60 
     ********** ********** ********** ********** ********** ********** 
     aagaaacccc tagaggcggc agcccctggt actgcggaga agctaagttc caaggcgacc       120 
     ********** ********** ********** ********** ********** **********                    
     acactggcag agcgcagcac aggcctggcc ttcagcctat atcaggcgat ggccaaagac       180 
     ********** ********** ********** ********** ********** ********** 
     caggcggtgg agaacatcct cctgtcaccc ttggtggtgg cctcatccct gggtcttgtg       240 
     ********** ********** ********** ********** ********** ********** 
     tcactgggtg gtaaagccac cacagcgtcg caggcgaagg cagtgctgag cgctgagaag       300 
     ********** ********** ********** ********** ********** ********** 
     ctgcgcgatg aggaggtgca cacggggctg ggtgagctgc tccgctccct cagcaactcc       360 
     ********** ********** ********** ********** ********** ********** 
     actgcgcgca acgtgacctg gaaactgggc agccgcctgt acgggcccag ctccgtgagc       420 
     ********** ********** ********** ********** ********** ********** 
     ttcgccgatg acttcgtgcg cagcagcaag caacactaca actgcgaaca ctccaagatc       480 
     ********** ********** ********** ********** ********** ********** 
     aacttccgag acaagcgcag cgccctgcag tccatcaacg agtgggcctc gcagaccacg       540 
     ********** ********** ********** ********** ********** ********** 
     gacggcaagc tgcctgaggt caccaaggat gtggagcgca cggatggggc actgcttgtg       600 
     ********** ********** ********** ********** ********** ********** 
     aacgccatgt tctttaagcc acactgggat gagaagtttc accacaagat ggtggacaac       660 
     ********** ********** ********** *********g cagca***** ********** 
     cgtggcttca tggtgacccg ctcctatact gtgggtgtta cgatgatgca ccggacaggc       720 
     ********** ********** ********** ********** ********** ********** 
     ctgtacaact actatgacga cgagaaggag aagctgcaga tggtggagat gcccctggct       780 
     ********** ********** ********** ********** ********** ********** 
     cacaagctct ccagcctcat catcctcatg ccccaccatg tggagccgct cgagcgcttg       840 
     ********** ********** ********** ********** ********** ********** 
     gagaagctgc tgaccaagga gcagctgaag gcctggatgg gaaagatgca gaagaaggct       900 
     ********** ********** ********** ********** ********** ********** 
     gtcgccatct ccctgcccaa gggcgtggtg gaggtgaccc atgacctgca gaaacatctg       960 
     ********** ********** ********** ********** ********** ********** 
     gcaggactgg gcctgaccga agccatcgac aagaacaagg cagacctatc gcgcatgtct      1020 
     ********** ********** ********** ********** ********** ********** 
     ggcaagaagg acctgtacct ggccagtgtg ttccacgcca ctgccttcga gtgggacacc      1080 
     ********** ********** ********** ********** ********** ********** 
     gagggcaacc cctttgacca agacatctac gggcgcgagg agctgcgcag ccccaagctg      1140 
     ********** ********** ********** ********** ********** ********** 
     ttctatgccg accacccctt catcttcctg gtgcgagata atcagagcgg ctccttgctc      1200 
     ********** ********** ********** ********** ********** ********** 
     ttcattggcc gcctggtccg gcccaaggga gacaagatgc gagatgagtt gtag            1254 
     ********** ********** ********** ********** ********** **** 
 
Key: *: Primer F2_F09 *: Primer F3_G11 *: Primer F1_H11 
 *: Primer R1_B12 *: Primer R2_C12 
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H220A Mus musculus Hsp47 
 
     atgcgctctc tccttctggg caccttatgc ctcttggccg tggccctggc agccgaggtg       60 
     ********** ********** ********** ********** ********** ********** 
     aagaaacccc tagaggcggc agcccctggt actgcggaga agctaagttc caaggcgacc       120 
     ********** ********** ********** ********** ********** **********                    
     acactggcag agcgcagcac aggcctggcc ttcagcctat atcaggcgat ggccaaagac       180 
     ********** ********** ********** ********** ********** ********** 
     caggcggtgg agaacatcct cctgtcaccc ttggtggtgg cctcatccct gggtcttgtg       240 
     ********** ********** ********** ********** ********** ********** 
     tcactgggtg gtaaagccac cacagcgtcg caggcgaagg cagtgctgag cgctgagaag       300 
     ********** ********** ********** ********** ********** ********** 
     ctgcgcgatg aggaggtgca cacggggctg ggtgagctgc tccgctccct cagcaactcc       360 
     ********** ********** ********** ********** ********** ********** 
     actgcgcgca acgtgacctg gaaactgggc agccgcctgt acgggcccag ctccgtgagc       420 
     ********** ********** ********** ********** ********** ********** 
     ttcgccgatg acttcgtgcg cagcagcaag caacactaca actgcgaaca ctccaagatc       480 
     ********** ********** ********** ********** ********** ********** 
     aacttccgag acaagcgcag cgccctgcag tccatcaacg agtgggcctc gcagaccacg       540 
     ********** ********** ********** ********** ********** ********** 
     gacggcaagc tgcctgaggt caccaaggat gtggagcgca cggatggggc actgcttgtg       600 
     ********** ********** ********** ********** ********** ********** 
     aacgccatgt tctttaagcc acactgggat gagaagtttc accacaagat ggtggacaac       660 
     ********** ********** ********** ********** ********** ********** 
     cgtggcttca tggtgacccg ctcctatact gtgggtgtta cgatgatgca ccggacaggc       720 
     ********** ********** ********** ********** ********gc a********* 
     ctgtacaact actatgacga cgagaaggag aagctgcaga tggtggagat gcccctggct       780 
     ********** ********** ********** ********** ********** ********** 
     cacaagctct ccagcctcat catcctcatg ccccaccatg tggagccgct cgagcgcttg       840 
     ********** ********** ********** ********** ********** ********** 
     gagaagctgc tgaccaagga gcagctgaag gcctggatgg gaaagatgca gaagaaggct       900 
     ********** ********** ********** ********** ********** ********** 
     gtcgccatct ccctgcccaa gggcgtggtg gaggtgaccc atgacctgca gaaacatctg       960 
     ********** ********** ********** ********** ********** ********** 
     gcaggactgg gcctgaccga agccatcgac aagaacaagg cagacctatc gcgcatgtct      1020 
     ********** ********** ********** ********** ********** ********** 
     ggcaagaagg acctgtacct ggccagtgtg ttccacgcca ctgccttcga gtgggacacc      1080 
     ********** ********** ********** ********** ********** ********** 
     gagggcaacc cctttgacca agacatctac gggcgcgagg agctgcgcag ccccaagctg      1140 
     ********** ********** ********** ********** ********** ********** 
     ttctatgccg accacccctt catcttcctg gtgcgagata atcagagcgg ctccttgctc      1200 
     ********** ********** ********** ********** ********** ********** 
     ttcattggcc gcctggtccg gcccaaggga gacaagatgc gagatgagtt gtag            1254 
     ********** ********** ********** ********** ********** **** 
 
Key: *: Primer F2_B03 *: Primer F3_C03 *: Primer F4_H05 *: Primer F5_C05 
 *: Primer R0_B05 *: Primer R1_A05 *: Primer R2_D03 
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H255A:H256A Mus musculus Hsp47 
     atgcgctctc tccttctggg caccttatgc ctcttggccg tggccctggc agccgaggtg       60 
     ********** ********** ********** ********** ********** ********** 
     aagaaacccc tagaggcggc agcccctggt actgcggaga agctaagttc caaggcgacc       120 
     ********** ********** ********** ********** ********** **********                    
     acactggcag agcgcagcac aggcctggcc ttcagcctat atcaggcgat ggccaaagac       180 
     ********** ********** ********** ********** ********** ********** 
     caggcggtgg agaacatcct cctgtcaccc ttggtggtgg cctcatccct gggtcttgtg       240 
     ********** ********** ********** ********** ********** ********** 
     tcactgggtg gtaaagccac cacagcgtcg caggcgaagg cagtgctgag cgctgagaag       300 
     ********** ********** ********** ********** ********** ********** 
     ctgcgcgatg aggaggtgca cacggggctg ggtgagctgc tccgctccct cagcaactcc       360 
     ********** ********** ********** ********** ********** ********** 
     actgcgcgca acgtgacctg gaaactgggc agccgcctgt acgggcccag ctccgtgagc       420 
     ********** ********** ********** ********** ********** ********** 
     ttcgccgatg acttcgtgcg cagcagcaag caacactaca actgcgaaca ctccaagatc       480 
     ********** ********** ********** ********** ********** ********** 
     aacttccgag acaagcgcag cgccctgcag tccatcaacg agtgggcctc gcagaccacg       540 
     ********** ********** ********** ********** ********** ********** 
     gacggcaagc tgcctgaggt caccaaggat gtggagcgca cggatggggc actgcttgtg       600 
     ********** ********** ********** ********** ********** ********** 
     aacgccatgt tctttaagcc acactgggat gagaagtttc accacaagat ggtggacaac       660 
     ********** ********** ********** ********** ********** ********** 
     cgtggcttca tggtgacccg ctcctatact gtgggtgtta cgatgatgca ccggacaggc       720 
     ********** ********** ********** ********** ********** ********** 
     ctgtacaact actatgacga cgagaaggag aagctgcaga tggtggagat gcccctggct       780 
     ********** ********** ********** ********** ********** ********** 
     cacaagctct ccagcctcat catcctcatg ccccaccatg tggagccgct cgagcgcttg       840 
     ********** ********** ********** ***cgacga* ********** ********** 
     gagaagctgc tgaccaagga gcagctgaag gcctggatgg gaaagatgca gaagaaggct       900 
     ********** ********** ********** ********** ********** ********** 
     gtcgccatct ccctgcccaa gggcgtggtg gaggtgaccc atgacctgca gaaacatctg       960 
     ********** ********** ********** ********** ********** ********** 
     gcaggactgg gcctgaccga agccatcgac aagaacaagg cagacctatc gcgcatgtct      1020 
     ********** ********** ********** ********** ********** ********** 
     ggcaagaagg acctgtacct ggccagtgtg ttccacgcca ctgccttcga gtgggacacc      1080 
     ********** ********** ********** ********** ********** ********** 
     gagggcaacc cctttgacca agacatctac gggcgcgagg agctgcgcag ccccaagctg      1140 
     ********** ********** ********** ********** ********** ********** 
     ttctatgccg accacccctt catcttcctg gtgcgagata atcagagcgg ctccttgctc      1200 
     ********** ********** ********** ********** ********** ********** 
     ttcattggcc gcctggtccg gcccaaggga gacaagatgc gagatgagtt gtag            1254 
     ********** ********** ********** ********** ********** **** 
 
Key: *: Primer F2_E02 *: Primer F3_F02 *: Primer F4_D04 *: Primer F5_G04 
 *: Primer R0_F04 *: Primer R1_E04 *: Primer R2_G02 
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